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General introduction

General introduction 9
osteoarthritis
according to the World health organization, more than 150 million (± 2.5%) people suf-
fer from osteoarthritis (oa) worldwide 1. above the age of 60 years, these figures even 
rise to 10% 2. in almost 30% of these cases, oa leads to moderate to severe disability 1. 
Thereby, it is the most common joint disease for the middle-aged and older popula-
tion 3. in the Netherlands, oa is estimated to affect more than 650.000 people. annual 
health care costs associated with oa are estimated to be 540 million euro, equivalent to 
0.8% of the total costs of health care in the Netherlands 4. 
before, oa was thought of as being mainly driven by wear and tear of the articular 
cartilage within the synovial joint. in recent years, it is shown that not only cartilage, 
but also the subchondral bone, ligaments, the synovial fluid, and surrounding muscles 
are involved in the oa process 5-7. although the exact aetiology is still unknown, oa is 
in general characterized by loss of articular cartilage, osteophyte formation, and sub-
chondral bone sclerosis 6-8. Clinically, oa is characterized by joint pain and limited joint 
function 3. oa can affect all synovial joints, but is most common in the knee, the hip and 
the hand joints 3. Given the predominance of oa in the knee joint compared to other 
joints, the main focus in scientific studies have been on the knee joint, as is the current 
thesis.
Defining knee osteoarthritis
The diagnosis of oa is mainly based on reported symptoms. Recent released recom-
mendations of evidence-based criteria  for the diagnosis of knee oa are the presence 
of persisting knee pain, brief morning stiffness, functional limitations with additional 
features from physical examination (crepitus, restricted movement, and bony enlarge-
ments) 8. The more positive results a patient presents, the more likely the diagnosis of 
knee oa 8. for scientific studies, classification criteria developed by the american Col-
lege of Rheumatology (aCR) in 1986 are often used to define clinical knee oa 9. To best 
define the presence of knee oa, the aCR criteria combine outcomes from radiographs 
and physical examination. Knee oa is defined as the presence of chronic knee pain (pain 
on most days of the last month) is reported, one or more osteophytes are visible at the 
radiograph and one out of these three features is scored positive: age > 50, morning 
stiffness < 30 minutes, or crepitus 9. for the classification of the structural changes as-
sociated with knee oa, Kellgren and lawrence (K&l) composed criteria for a 5-point 
grading scale using radiographic features, back in 1957 10. These K&l grades range from 
0 (no oa) to 4 (severe oa), with grades ≥ 2 defined as definite knee oa 10. Throughout 
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the years, these criteria have been used in numerous studies. although slightly altered in 
several studies, the original criteria are still recommended for the proper determination 
of radiographic knee oa today 11. Minimal joint space width between the femur and tibia, 
measured on a radiograph, is a surrogate measure for the thickness of articular cartilage 
in the knee joint. The radiographic response to treatment in knee oa is often measured 
as the difference in the rate of the change in joint space width (joint space narrowing, 
JsN), since it is more sensitive to change than the K&l criteria. despite the fact that the 
three measurements all define knee oa (the aCR and K&l criteria) or measure a marked 
feature of knee oa (loss of articular cartilage in JsN), there is only moderate overlap 
between those measurements 12-13. some individuals with distinct structural changes 
in the knee joint do not report pain, and some individuals with substantial knee pain 
show no structural alterations at a radiograph 12, 14. This discrepancy is mainly present in 
the less severe forms of knee oa. The discordance between the several criteria of knee 
oa illustrates that the exact aetiology and pathophysiology of knee oa is still unknown. 
a combination of the three described oa definitions will be used in the preventive 
randomized controlled trial presented in this thesis.
in recent years, magnetic resonance imaging (MRi) has gained popularity for the 
visualisation of structural changes in knee oa. With MRi, contrary to conventional radio-
graphs, it is possible to directly visualize the articular cartilage and detect abnormalities 
to the cartilage, menisci, and in the bone well before knee oa is established or provokes 
joint complaints 15-16. Moreover, MRi provides a three-dimensional view of the knee joint 
and also visualizes abnormalities in the patellofemoral joint, which is often neglected 
in conventional radiographic evaluations. despite the advantages of MRi over conven-
tional radiographs for the visualisation of knee oa, for research purposes and especially 
clinical purposes, the relevance of many MRi findings is still unclear.
risk factors for the incidence of knee osteoarthritis
Knee oa is a multi-factorial disease. The strongest most prevalent risk factors for the in-
cidence of knee oa are overweight or obesity, a higher age, and female sex 17-18. in table 
1.1, the most studied risk factors for incident knee oa out of the most recent systematic 
review from blagojevic and co-workers are presented 18. after the age of 50, incidence in-
creases markedly and incidence levels among women exceed those of men 19. in general, 
two main interlinked pathways are suggested for the onset of knee oa; inflammation 
and biomechanical loading. being overweight or obese increases one’s risk for develop-
ing knee oa by 2 to 7-fold 18, 20-21. biomechanically, a higher body weight increases the 
load on the knee joint due to higher and altered load patterns. besides, it can induce and 
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increase the negative effects of unfavourable alterations in knee joint alignment and 
meniscal and ligament pathologies 5, 22. on the other hand, being overweight or obese is 
also linked to the development of knee oa through the inflammatory pathway. fat mass 
is shown to be an endocrine organ producing a variety of unfavourable factors affecting 
the pathogenesis of knee oa 6. besides, increased load on the cartilage also activates 
the mechanoreceptors that might induce tissue breakdown 22. activation of mechano-
receptors may initiate inflammation at the joint and induce tissue breakdown 22. The 
mechanism behind the increased incidence among women needs to be unravelled still, 
but the drop in oestrogen levels after the menopause and associated increased sensitiv-
ity to inflammatory stimuli is suggested as factor 23. 
treatment of knee osteoarthritis
in dutch general practice, the consultation rate for knee oa is around 8.9 per 1000 regis-
tered persons per year 24. over the last decades a wide variety of pharmacological, non-
pharmacological, and surgical treatment options for patients suffering from complaints 
caused by knee oa have been evaluated. optimal treatment of complaints associated 
with knee oa requires a combination of non-pharmacological and pharmacological 
modalities 25. Non-pharmacological treatment includes, but is not limited to, regular 
aerobic and resistance exercise for all knee oa patients; losing weight for those patients 
who are overweight or obese; the use of walking aids and medical devices to counteract 
possible malalignment of the knee joint. Pharmacological treatment is usually started 
with acetaminophen prescription. additionally, glucosamine sulphate treatment is 
advocated by the guidelines 25, despite the fact that there are many conflicting results 
on the effectiveness of glucosamine sulphate 26. studies that did show a positive effect 
of glucosamine sulphate showed the largest effects in an early phase of the disease 27. 
table 1.1. Most studied risk factors for incident knee oa (selected from 18).
risk factor number of papers number of patients pooled odds ratio
(95% Ci)
Bmi
overweight
obesity
23
17
639,526
346,788
2.18 (1.86 – 2.55)
2.63 (2.28 – 3.05)
previous knee injury 16 16,746 3.86 (2.61 – 5.70)
Gender 8 10,353 1.84 (1.32 – 2.55)
heberden’s nodes 8 6,109 1.49 (1.05 – 2.10) 
age 15 -* -*
*although all included studies reported a higher risk for knee oa at higher age, authors were not able to 
pool the results due to the different categorization of age-groups and ranges 18.
12 Chapter 1
in the absence of an adequate response, glucosamine prescription is advocated to be 
discontinued and stronger medication, as non-steroidal anti-inflammatory drugs, and 
possibly intra-articular injections can be considered. Ultimately, joint replacement 
surgery could be considered, if relief of symptoms stays out 25. in the Netherlands, most 
of the recommended treatment options, except for joint replacement, are provided in 
primary care.
despite the fact that discussed treatment options provide relief of knee oa symptoms 
for most patients when appropriately administered, at best disease processes are slowed 
down. evidence for true disease-modifying treatment options is scarce. 
prevention of knee osteoarthritis
Given the lack of disease-modifying treatments, opportunities for primary prevention of 
knee oa should be considered. however, up to now, no studies on the prevention of oa 
in any joint are available. according to the society for Prevention Research, some basic 
principles guidelines should be considered when designing a preventive trial 28. among 
others, the society for Prevention Research states that preventive measures should 
be applied in an early stage, to those at high risk, and should avoid causing harm. The 
preventive intervention itself should target modifiable risk factors, should specify clear 
goals, allow flexible protocols to comply with the individual needs, be available in the 
local community, and should target the risk factors from a multidisciplinary approach.
out of the previously indicated most prevalent and strongest risk factors for incident 
knee oa, a high body weight is the only modifiable factor. from an observational cohort 
study with 40 years of follow-up, it has been calculated that if overweight and obese 
women would lose 5 kg body weight, the risk of developing knee oa would be reduced 
by more than 50% 29. despite the considerable effects of overweight and obesity on the 
development of knee oa and the intuitive beneficial effects of weight loss, the direct 
effects of weight loss on the incidence of knee oa have never been studied. 
The literature shows an array of therapies for weight loss in overweight and obese 
individuals 30. Compliance to the weight loss therapy is a major challenge when con-
ducting a weight loss intervention. a combination of dietary and lifestyle interventions 
is suggested to be the most optimal 30. Target of a weight loss intervention for over-
weight and obese individuals should be losing 5 kg or 5% body weight. losing such 
amount of weight can be defined as clinically relevant, since it has been associated with 
health benefits, such as improvement of cardiovascular risk factors and reduced risk of 
diabetes Mellitus type 2 30-31.
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furthermore, glucosamine sulphate could also be considered as treatment option 
meeting the criteria of the society for Prevention Research for a preventive measure. 
although the evidence for the effectiveness of glucosamine sulphate is questionable, 
the effects are thought to be the greatest in an early stage of the disease and, more 
important, it is classified as having an excellent safety profile compared to placebo 26-27. 
Therefore, as recommended by the society for Prevention Research, it could be applied 
at an early stage of the disease and should cause no harm to the users 28.
based on the literature and with the guidelines of the society for Prevention Research 
in mind, the first ever preventive trial in oa was designed. The results of this trial are 
presented in this thesis. 
outline of this thesis
as indicated in the title and subtitle, the main focus of this thesis is on the effects of 
an excessive body weight on the development of knee oa and its role in the primary 
prevention of the disease. in Chapter 2, the biomechanical alterations in every day 
movements in obese individuals and their possible role in the development of knee 
oa are evaluated, after a systematic search of the literature. The interplay between a 
high body weight, alterations in the subchondral bone shape, and early signs of knee 
oa is assessed in Chapter 3. The central part of this thesis – the first ever preventive 
randomized controlled trial in oa research worldwide – is presented in Chapter 4. in 
this trial, the effects of a diet & exercise program and of glucosamine sulphate on the 
development on knee oa are evaluated in 407 middle-aged, overweight and obese 
women. Chapter 5 presents a detailed description of the results of the diet & exercise 
program. The true preventive effect of clinically relevant weight loss on the develop-
ment of knee oa, irrespectively of the applied interventions, is described in Chapter 
6. in Chapter 7, the safety effects of the glucosamine sulphate intervention on blood 
glucose levels are evaluated. The effects of knee malalignment and the interplay with 
body weight on the incidence of knee oa, within the for the trial selected population, is 
presented in Chapter 8. finally, in Chapter 9 the main findings of the previous chapters 
are discussed, together with the implications for further research on the development 
and prevention of knee oa.
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abstract
Background: obesity has been identified as a risk factor for osteoarthritis. for the 
weight-bearing joints, the combination of increased load and changed joint biome-
chanics could be regarded as underlying principle for this relation. This systematic 
review of the literature focused on the differences between obese and normal-weight 
subjects in biomechanics of the hip, knee and ankle joint during every day movements 
to summarize differences in joint load due to both higher body weight and differences 
in movement patterns.
methods: a systematic search, up to November 2010, was performed in the Pubmed 
and embase databases. 
results: This review showed that obese individuals adjust their movement strategy of 
every day movements. at self-selected speed, obese individuals walked slower, with 
shorter and wider steps, had longer stance duration and had a greater toe-out angle 
compared with normal-weight individuals. obese sit-to-stand movement was charac-
terized by less hip flexion and greater foot displacement.
Conclusions: obese individuals showed altered biomechanics during every day move-
ments. These altered biomechanics could be related to the initiation of osteoarthritis 
by a change in the load-bearing regions of the articular cartilage in the weight-bearing 
joints.
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introduction
obesity has been identified as a risk factor for the development of osteoarthritis (oa) 
1-2. apart from a proposed inflammatory component as shown in hand oa 3-4, for the 
weight-bearing joints an increase in joint load is often indicated as underlying principle 
for this relation 1,5-6.however, moderate levels of running did not increase the risk of oa 
in hips and knees and might even have a protective effect 7-8, healthy knee cartilage 
thickness was increased with an increased load on the knee during walking 8-9, and 
cadaveric studies showed that cartilage stiffness of hip, knee and ankle were correlated 
with joint loads during walking 6. This suggests that healthy cartilage can adapt to higher 
repetitive loads 9-10 and extra load on the weight-bearing joints caused by being obese 
alone cannot be linked to the development of oa 11. 
a study on weight loss and accompanied joint biomechanics showed a 1:4 ratio of 
loss of body weight to decrease of load on the knee joint 12. although these participants 
had radiologic signs of knee oa and joint biomechanics might therefore be altered com-
pared with non-oa subjects, these results show that higher body weight accounted only 
for a small part of total knee joint load 12. accompanied unfavourable joint biomechanics 
accounted for a greater part of the total knee joint load. The combination of increased 
load on the weight-bearing joints and changed biomechanics in obese individuals (o) 
may be a risk factor for the development of oa 13–17. for example during gait, malalign-
ment and hyperextension in the knee joint have been linked to development of oa in 
obese subjects 14-15,17 and in the ankle joint, altered kinematics may contribute to the 
degeneration of the tibiotalar cartilage 18-19. it has been suggested that changes in con-
tact position of the articular cartilage in the weight-bearing joints could be a factor in 
the degenerative changes 9-10. hence, it is suggested that differences in biomechanics in 
obese subjects during activities of daily living could lead to the onset of oa 14. 
in a theoretic overview in 2006, Wearing et al. 20 showed that there were differences 
in lower limb function between o and normal-weight individuals (NW). however, their 
overview was not based on a systematic search of the literature and conclusions were 
also based on studies that included subjects with oa. because oa influences lower limb 
biomechanics 21, these findings could be hampered by oa. The purpose of the present 
study was to give a systematic review of the present literature on the differences in the 
biomechanics of the hip, knee and ankle joints during every day movements between 
otherwise healthy obese and normal-weight subjects. in order to summarize alterations 
in load on the weight-bearing joints due to both higher body weight and differences in 
movement patterns.
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methods
a systematic search was performed in the Pubmed and embase databases up to 3 No-
vember 2010. search items included joints of interest, biomechanical items, every day 
movements and description of the population of interest. The complete search strategy 
is specified in the appendix.
studies had to meet the following inclusion criteria to be eligible for this systematic 
review: 
• Ten or more subjects (no case reports or very small studies).
• subjects had to be 19 years or older (to rule out the influence of growth on move-
ment patterns).
• subjects had to be free of degenerative rheumatic or neurological disease.
• description of joint angles and/or joint moments of weight-bearing joints during 
stance, walking, rising from a sitting position or climbing stairs.
• description of differences between obese versus normal-weight subjects.
• original research (no review, letter to the editor or comments).
No limitations were set on language, year of publication or publication status. after 
screening all abstracts on these criteria, all references of the eligible studies were ad-
ditionally screened. one review author (J. R.) extracted all data from the eligible studies. 
data were checked by a second author (s. b.). all data were derived from text, tables and 
figures of the eligible studies. No authors were contacted for additional information. for 
these observational studies, no validated risk of bias items exists. Therefore no quality 
assessment of the eligible studies was performed. 
Data presentation
The Preferred Reporting items for systematic Reviews and Meta-analyses (PRisMa) 
statement was used for data presentation throughout the systematic review 22. all 
biomechanical results are presented per joint. all presented moments are external joint 
moments. 
studies concerning gait differences between o and NW measured kinematic and 
kinetic variables during several different phases of gait. all study results were classified 
by the gait phases defined by Perry 23 and reduced to stance phase, because main focus 
of this review was on joint loads, which do not occur during swing phase (see figure 
2.1). Vismara et al. measured in both a horizontal treadmill position and a 15% inclined 
condition 24. since the objective was to describe biomechanics during activities of daily 
live, only data from the normal condition was used in the present study. 
for readability reasons, for kinematic and kinetic variables only significant differences 
between o and NW will be presented in the text. When measured in multiple studies, 
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average differences between o and NW will be presented with number of subjects per 
study taken in to account (all individual scores summed and divided by the total amount 
of subjects). because of the high number of variables measured in the eligible studies, 
an overview of all measured variables and the direction of the differences between both 
groups are presented in several tables in the appendix (see Tables a2.1–a2.7). in the text 
mentioned differences between o and NW were all statistically significant with P-values 
of <0.05.
results
The search strategy resulted in 1,516 unique potentially relevant articles. figure 2.2 
shows the flow diagram from all 1,516 potential articles to the 12 observational studies 
that were eligible for this systematic review. all 12 studies, with some of their study char-
acteristics, are listed in Table 2.1. Not all eligible studies had equal pre-defined criteria 
for o, but, as shown in Table 2.1, with a range of average body mass index from 33 to 42 
kg/m2 in o, obesity is well established among the eligible studies.
Gait
There were 10 eligible studies on kinematic and kinetic differences between obese and 
normal-weight subjects during walking. These studies can be divided in two groups. in 
figure 2.1. divisions of the gait cycle by Perry 23
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six studies, subjects walked at a self-selected speed 25–30. Whereas in the other four stud-
ies walking velocity was kept constant in both groups 24,31–33. This resulted in differences 
in outcomes and will therefore be discussed separately. 
Spatial and temporal kinematics
Walking at self-selected speed
studies reported a lower absolute walking speed of 0.3 ms-1 on average 25–28,30 and a 
lower walking speed relative to body height of 0.1 s-1 in o 29. absolute stride length 25,28,30, 
stride length relative to body height 26,29 and absolute step length 25 were respectively 
0.2 m, 0.1 mm-1 and 0.2 m smaller on average in o. step width was 0.1 m greater in o 
25,28. several studies reported no difference between o and NW on cadence 26,29, whereas 
spyropoulos et al. 28 reported that o walked at 13 steps per minute less than NW. Russell 
et al. also measured cadence and reported lower values for o, but these were not tested 
for significance 30. Relative to total cycle time, stance time was 3% greater on average in 
o 26,28-29. Two per cent greater double support time relative to total cycle time 26 and 2% 
smaller single limb support time relative to total cycle time 29 were found in o.
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Walking at standardized speed
browning and Kram 31 measured o and NW at six different walking velocities, starting at 
0.5 ms-1 up to 1.75 ms-1 with steps of 0.25 ms-1. deVita and hortobagyi 32, Messier et al. 33 
and Vismara et al. 24 measured all subjects at one standardized speed of 1.5 ms-1, 0.893 
ms-1 and 0.833 ms-1 respectively. Vismara et al. found 3 cm greater step length in o on 
the standardized walking velocity 24. however, deVita and hortobagyi did not found any 
difference on absolute step length step length 32, neither did browning and Kram 31 on 
absolute stride length at each walking velocity. besides, a longer stance time of 3% 31-32 
and a longer double support time, both relative to total gait cycle time, of 6% 24,31, and a 
greater step width of 0.1 m on average 24,31 were found in o (with exception of step width 
at 1.25 ms-1 where no difference was found).
Biomechanics
Walking at self-selected speed
The hip joint. spyropoulos et al. 28 reported 14° greater hip abduction in o on average 
during single limb support. Contrary, lai et al. 26 reported no significant difference at 
mid stance and reported 3° greater hip adduction on average at terminal stance and pre 
swing. No differences were found on hip joint moments between the two groups. 
The knee joint. lai et al. 26 reported 5° higher maximal knee adduction in o during 
stance phase. on absolute moment in the knee joint, segal et al. 27 reported significant 
higher peak adduction moment during weight acceptance phase in both obese groups 
(22 Nm higher in central obese and 11 Nm in lower obese) and during single limb sup-
port phase in central obese group (14 Nm). Contrary, Russell et al. reported no difference 
on absolute peak adduction moment between o and NW during the stance phase 30. 
Relative to body weight 27 and body weight and height 26, peak knee adduction moment 
was not significantly different between the groups.
The ankle joint. in the sagittal plane conflicting results were found. some studies 
reported no significant differences between o and NW 26,29, while spyropoulos et al. 28 
found significant higher dorsiflexion angles of 19° on average in o at loading response, 
mid stance, terminal stance, pre swing, maximal stance dorsiflexion and maximal stance 
plantar flexion. besides, on average 5° greater eversion at mid stance, terminal stance 
and pre swing 26 and 7° greater toe-out angle during the stance phase 25,29 were reported 
in o. Peak relative plantar flexor moment during stance was 0.1 Nm kgm-1 lower in o 26. 
Relative to body weight and velocity, Vismara et al. 29 reported no significant differences 
Changed biomechanics of the lower extremities in obese individuals 25
on peak plantar flexor moment between o and NW during terminal stance. lai et al. 26 
found 0.04 Nm kgm-1 higher peak inversion moment in o during stance.
Walking at standardized speed
The hip joint. No significant differences between o and NW in hip angles at mid stance 
31 and initial contact 24 were reported in the sagittal plane. Contrary, averaged over the 
entire stance phase, deVita and hortobagyi 32 reported a 5° greater hip extension angle 
in o. browning and Kram 31 reported a 47 Nm higher peak hip extension moment in o 
during stance phase at all speeds, with exception of 0.75 ms-1. deVita and hortobagyi 
32 averaged absolute hip extension moment over the entire stance phase and found no 
difference between o and NW. Relative to body weight browning and Kram 31 found no 
significant differences between o and NW at any speed.
The knee joint. in the sagittal plane, no significant differences in knee angles between 
o and NW at mid stance on all velocities 31 or on total range of motion 24 were reported. 
Contrary, Vismara et al. 24 reported 5° less flexion in o at initial contact at their stan-
dardized walking velocity. besides, 8° lower maximal and 4° average knee flexion were 
reported in o 32. on absolute peak knee extension moment, browning and Kram 31 re-
ported only significant differences between o and NW during stance phase at 1.75 ms-1, 
where o showed 47 Nm higher values. There were no significant differences between 
o and NW on peak knee extension moment relative to body weight on each walking 
velocity 31. Controversially, deVita and hortobagyi 32 reported a 0.5 Nmkg-1 lower peak 
knee extension moment in o during the stance phase at their standardized speed of 
1.5 ms-1. browning and Kram 31 calculated absolute peak knee adduction moment from 
the medio-lateral resultant of the ground reaction force and found significantly higher 
values in o at 0.75 ms-1, 1.25 ms-1 and 1.50 ms-1 (20 Nm on average).
The ankle joint. No significant differences were reported for plantar flexion at initial 
contact 24 and mid stance 24,31. Contrary, 5° lower plantar flexion in o was reported at 
terminal stance 24 and 7° greater plantar flexion in o at pre swing 32. besides, deVita and 
hortobagyi 32 reported 6° higher average plantar flexion during stance phase. Messier 
et al. 33 reported 8° greater ankle inversion in o at initial contact and 6° greater total 
eversion in o during stance phase. in the transverse plane, Messier et al. 33 reported 4° 
greater toe-out angle during stance phase in o. averaged over the stance phase, deVita 
and hortobagyi 32 found a 100 Nm greater ankle plantar flexion moment in o. browning 
and Kram 31 reported no significant differences on absolute peak ankle plantar flexion 
moment. a lower peak plantar flexion moment relative to body weight during stance 
phase was found in o at every walking speed; however, no data were given 31.
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sit-to-stand
from all eligible studies, there were two studies on biomechanical differences between 
obese and normal-weight subjects when rising from a chair 34-35. Galli et al. 34 included 
subjects with lower back pain in the obese group. This influenced the trial-by-trial 
outcomes of the obese group. authors concluded that fatigue did not influence the 
measurements in the first trial, but did in the last trial. Therefore, only results of the first 
trial are included in this review. besides this difference, studies had very similar methods 
and participant characteristics (see Table 2.1). by taking only the first trial results of the 
studies of Galli et al. 34, results of the studies were very consistent 34-35.
Biomechanics
studies found 22° less hip flexion on average 34-35 and 5 cm greater foot displacement 
in o 35. Galli et al. 34 found 7° greater dorsal flexion in o. sibella et al. 35 also measured 
plantar flexion angles, but did not analyse or present any data. 
both studies describe their kinetic data as moments relative to body weight and 
height; however, data were presented as Nmkg-1 instead of Nmkgm-1 or Nkg-1. because 
data were in the same range and were presented as Nmkg-1, it is assumed to be normal-
ized to body weight alone. The different movement strategies of o and NW led to a 0.3 
Nmkg-1 lower peak hip flexion moment and a 0.5 Nmkg-1 higher peak knee extension 
moment on average in o 34-35. both studies measured peak ankle flexion moment but did 
not analyse or present any data.
Discussion
The purpose of this study was to give a systematic review of the studies on biomechani-
cal differences of the lower limb between otherwise healthy o and NW during every 
day movements. Most of the eligible studies focussed on gait, but with considerable 
diversity in their measurements. The six eligible studies on gait at a self-selected velocity 
measured 99 different variables. of these, only 38 were measured in two or more studies 
and in 12 of the 38 variables conflicting results were found. summarizing all differences 
between o and NW that were confirmed in two or more studies, we can conclude that 
when walking freely, o had a lower absolute walking velocity of 0.3 ms-1 on average 
25–28,30, a smaller absolute stride length of 0.2 m 25,28,30. and 0.1 mm-1 relative to body 
height 26,29, a longer stance duration relative to total cycle time of 3% 26,28-29, a greater 
absolute step width of 0.1 m 25,28 and walked with 7° greater toe-out angle on average 
25,29 compared with NW. as the studies on gait at a standardized velocity confirm, part of 
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the differences between o and NW at a self-selected velocity were caused by the lower 
walking velocity of o rather than by obesity per se 20. however, because the purpose of 
the present study was describing differences in joint biomechanics during every day 
movements, focus will not be on the studies of gait at a standardized speed. because o 
and NW will not walk at equal velocities during every day movement.
in normal gait, it has been shown that lowering walking velocity led to lower peak 
relative joint flexion and extension moments in hip, knee and ankle 36 and lower peak 
absolute joint moments in hip and knee in the sagittal and coronal plane 37. besides that, 
greater toe-out angle has been associated with decreased knee adduction moment rela-
tive to body weight and height in normal gait, because it shifts the force vector closer to 
the knee joint 38. Therefore, some authors suggested that o lower their walking velocity 
to lower the load on their joints 26,28,31-32. in the present systematic review, relative joint 
moments were mostly equal between groups. so alterations in walking velocity and toe-
out angle in o were not large enough to lead to lower relative joint moments. however, 
with exception of relative knee joint moment in the coronal plane, none of the relative 
joint moments were measured in two or more studies.
although relative knee adduction moment was not higher in o compared with NW 
26-27, this variable has been associated with development of knee oa, especially in obese 
14-15. Relative knee adduction moment during gait and relative medial cartilage thickness 
are negatively correlated in obese, whereas in NW there is a positive correlation 14. equal 
knee adduction moments relative to body weight (and height) will lead to higher abso-
lute adduction moments in obese because their body weight is much higher. Therefore, 
the contradicting relation between the relative medial cartilage thickness and the 
relative adduction moment suggests that the absolute knee adduction moment in NW 
stays within levels wherein healthy cartilage can adapt to the repetitive loads. While in 
o, articular cartilage may not be able to respond to the higher level of absolute knee 
adduction moment during gait 14. The systemic inflammatory effect of the surplus fat 
tissue in o may play a role in this alteration of cartilage characteristics. hence, increased 
body weight and fat mass and accompanied higher absolute knee adduction moment 
during walking in o can lead to cartilage degeneration prior to oa signs in o 14. a lack of 
power in the study of Russell et al. 30 seemed to have kept results from the present study 
supporting this theory with uniform results.
The studies on sit-to-stand movement showed similar results; higher loads on the 
knee joint and lower loads on the hip joint in o 34-35. Unfortunately, none of the studies 
measured biomechanical variables in the coronal or transverse plane. Therefore, it is not 
possible to give a good analysis of the total loads on the weight-bearing joints during 
the sit-to-stand movement.
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all results of the eligible studies in the present systematic review have to be seen 
in perspective to the limitations of their measurements. There are known instrumental 
issues concerning human movement analysis 39 and, especially in obese subjects, soft 
tissue artefacts are a major source of error 40. even in NW, soft tissue artefacts are around 
4° to 5°. Most differences in joint angles found among the eligible studies, especially ab-/
adduction and rotational angles, have a similar magnitude, troubling the interpretation 
of the results 40.
The systematic review has its limitations as well. first, no quality assessment of eligible 
studies has been performed because no validated risk of bias items exist. a frequently 
indicated item at risk of bias is blinding of outcome assessors. however, it seems unlikely 
that blinding could influence study results in the eligible studies, because all joint angles 
and moments were calculated digitally. on the other hand, not assessing the quality of 
the eligible studies could have led to possible ignorance of confounding influences on 
the study results. for example, age differed greatly between the o and NW in all sit-to-
stand studies 34-35 and some studies on gait 26,32-33. however, it is suggested that there is 
no evidence that biomechanics are affected by age in these ranges 32. second, because 
of the relative small number of eligible studies per activity of daily live, results were not 
subdivided by method characteristics that might have influenced the outcomes. such 
as walking surface (overground vs. treadmill) or footwear (barefoot vs. shoes). When 
taken into account, these factors might diminish found differences between o and NW 
or could lead non-significant differences between both groups into significance when 
results were divided by these factors.
although the present study was based on a systematic search of the literature, it did 
not cover all aspects of obese biomechanics. factors not taken in to account, that do 
have influence on obese biomechanics, include lower maximal muscle strength relative 
to body weight 20, significant reduced joint range of motion 41 and foot pressure patterns 
42.
despite these limitations and despite the heterogeneity of the eligible studies regard-
ing subject characteristics, measurement equipment and study design, still several 
distinct differences between o and NW were found. The results from this systematic 
review confirmed that o altered their movement strategies during every day walking, 
walking at a standardized speed and sit-to-stand movement. during freely walking, 
o lowered their walking speed and increased their toe-out angle. in theory to lower 
loads on their joints in the sagittal and coronal plane, but with that they introduce a 
rotational malalignment. This rotation could lead to cartilage degeneration in the af-
fected joints because of a shift of the contact area towards infrequently loaded regions 
of the cartilage that, at some point, can no longer adapt to the altered loading 9. Neutral-
izing toe-out angle in o to counteract the rotational malalignment does not seem to 
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be an advantageous intervention, because of an increase in the knee adduction joint 
moment, that already seemed to be above acceptable ranges 14. Whether alterations in 
sit-to-stand movement among o could be associated to cartilage degeneration remains 
unclear, because only sagittal analyses were available. it cannot be ruled out that there 
are more biomechanical differences between o and NW during every day movements, 
but more consistent, high quality research, with more equality among measured vari-
ables, is needed. More sophisticated movement analysis systems with higher precision, 
for instance biplane radiography 43, should be considered in future studies to analyse 
the difference in movement patterns between o and NW in more detail. by combining 
movement analyses with magnetic resonance imaging techniques, cartilage properties 
associated to the development of oa, such as volume, thickness and defects, could 
be studied in relation to the differences in movement patterns between o and NW, to 
confirm the role of adjusted biomechanics in the development of oa. of course, these 
studies should have a longitudinal design, contrary to the cross-sectional design of all 
eligible studies in the present study.
overall, although the current literature is not comprehensive, the eligible studies are 
very heterogeneous, and remarks can be made on the precision of the measurements, it 
can be concluded that o alter their movement strategies of every day movements. There 
are indications that these alterations could be associated to the osteoarthritic process 
of cartilage degeneration.
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abstract
Background: in the knee joint, bMi is associated with bone shape. also, both bMi and 
bone shape are related to early signs of knee osteoarthritis (oa). in theory, there could 
be a causal effect of bMi on bone shape, which in turn leads to early oa signs (media-
tion). on the other hand, aspects of bone shape might only be related to incident oa in 
the presence of a high bMi (moderation). The objective of this study is to explore these 
relationships.
methods: Using 2d statistical shape Models, shapes of both the femur and tibia were 
analysed in 397 non-oa (K&l-grade 0), middle-aged females. The mediating role of 
femur and tibia shape features on the relation between bMi and early signs of knee oa 
(as seen on MRi) and the moderating role of bMi on the relation between shape features 
and these early oa signs were tested.
results: bMi was indicated as moderator on the relation between one femur and 7 
tibial modes and the presence of cartilage defects and bone marrow lesions. only one 
tibial mode, representing knee flexion angle, showed a mediator effect on the relation 
between bMi and the presence of cartilage defects.
Conclusions: Certain tibial shape characteristics play an initial role in the develop-
ment of knee oa, among subjects with a high bMi. besides, greater extension of the 
knee joint, as a result of a high bMi, seems to be a protective mechanism on the pres-
ence of cartilage defects.
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introduction
development of osteoarthritis (oa) is known to be a multifactorial process 1. in the 
knee joint, obesity is known to play a major role in the pathogenesis of the disease 2. 
The presence and development of bone marrow lesions (bMls) and cartilage defects 
in the tibiofemoral joint are associated to high body mass index (bMi) and are seen as 
early structural changes leading to knee oa 3-5. besides the negative systemic effects of 
surplus fatty tissue, subjects with a high bMi suffer from altered load patterns on the 
weight-bearing joints, due to a higher body weight and adjusted biomechanics of every 
day movements which could lead to oa 6.
altered loads on the knee joint as seen in people with a high bMi, which are higher 
and are accompanied by changed kinematics, could lead to changes in bone shape. 
for instance, in both oa and non-oa individuals, relative knee adduction moment and 
bMi were positively correlated to tibial plateau area 7-9. hypothetically, a greater tibia 
plateau will keep stresses in the joint within limits, because higher loads are distributed 
over a greater surface 10. still, a larger tibia plateau has been associated with increased 
tibiofemoral cartilage defects 7, 11. Possibly since the tibia plateau does not increase 
proportionally with increase in body size 12. furthermore, the fact that biomechanical 
factors, as the relative knee adduction moment, were among the best predictors of 
distribution of bone mineral density in the proximal tibia 13, supports the notion that 
altered knee joint loads can influence bone characteristics. high local bone mineral den-
sity has been linked to the presence of bMls, which suggests that these alterations of 
bone characteristics can indeed play an initial role in the development of knee oa 7-8, 11.
The above demonstrates that in the knee joint, bMi is associated with changes in 
bone shape and that both factors are related to early signs of knee oa. it is however 
unclear how these factors influence one another. Certain bone shape features might 
only be related to cartilage defects and bMls in subjects with a high bMi. in that case, 
bMi could be regarded as a moderator of the relation between bone shape and early oa 
signs 14. alternatively, there could be a causal effect of bMi on bone shape, which in turn 
might lead to bMls and cartilage defects and eventually oa. if so, bone shape could be 
regarded as mediator in the association between bMi and early oa signs 14. by exploring 
these associations, we hope to provide further information on the factors involved in 
the development of knee oa, which might be used for identifying subjects at risk and 
designing new interventions in order to prevent the disease.
Using statistical shape Models (ssM) 15, association between femoral bone shape 
features and incident oa features in the hip joint have been established (e.g. 16-17). also 
in the knee joint, ssM has been used to demonstrate altered knee shape in women with 
oa 18. in the present study, we used ssM to analyse the shape of both the distal femur 
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and proximal tibia in a population of non-oa, middle-aged females. We will explore a) 
the moderating role of bMi on the association between femur and tibia shape features 
and the presence of cartilage defects and bMls in the knee as seen on Magnetic Reso-
nance imaging (MRi) and b) the mediating role of femur and tibia shape features on the 
association between bMi and the presence of cartilage defects and bMls. 
materials and methods
population 
in this study we used data from the Rotterdam study. This is a prospective population-
based study of subjects of 45 years and over, aiming to investigate determinants of 
cardiovascular, neuro-degenerative, locomotor and ophthalmologic diseases in the 
general elderly population. in total 14,926 persons were included 19. at baseline, all 
subjects were examined. examination consisted of an interview, physical examination 
focussing on possible causes of diseases in the elderly and an X-ray of both knees. These 
examinations were repeated every 3-4 years. since incidence of knee osteoarthritis is 
higher in women, all women (aged 45-60 years) of the Rs-iii sub cohort underwent ad-
ditional MRi of both knees at their baseline visit 19. all women that had MRi and X-rays 
of the knees available at the time of this study were selected for the present study. The 
Medical ethical Committee of the erasmus Medical Centre approved the present study 
and all subjects gave written informed consent.
measurements
all radiographs of the knees were weight-bearing antero-posterior radiographs taken at 
70 KV, a focus of 1.8 mm2, and focus-to-film distance of 120 cm, using high Resolution 
G 35x43 cm film (fujifilm Medical systems, stamford, CT). Radiographs of the extended 
knees were obtained with the patella in central position. a multi-sequence MRi proto-
col in a sagittal plane on a 1.5-T MRi scanner (General electric healthcare, Milwaukee, 
Wisconsin) was performed. all participants were scanned with an 8-channel cardiac 
coil, so two knees could be scanned at once, just by re-localizing. The multi-sequence 
protocol contained: a fast spin echo (fse) proton density T2 weighted sequence (TR/Te 
4900/11/90, flip angle of 90-180, slice thickness 3.2mm, field of view 15 cm), a fse T2 
weighted fatsat sequence (TR/Te 6800/80, flip angle 90-180, slice thickness 3.2 mm, field 
of view 15cm), a spoiled gradient echo sequence (TR/Te 20.9/2.3, with fat saturation, flip 
angle 35, slice thickness 3.2 (1.6)mm, field of view 15 cm) and a fiesta C-T1/T2 weighted 
sequence (TR/Te 5.7/1.7, no fat saturation, flip angle 35, slice thickness 1.6 mm, field of 
view 15 cm).
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Data
body height and weight were used for calculation of bMi and date of birth to calculate 
age at time of this study. Two trained readers (ds and bMdK) who were blinded for clini-
cal data scored all radiographs using Kellgren and lawrence (K&l) scale 20. Reproduc-
ibility was checked using kappa statistics after scoring a random sample of all X-rays 
twice. Knee alignment was assessed on the X-rays by digitally determining the angle 
between the line connecting the midpoint between the tibial spines with the midpoint 
of the femur approximately 10 cm. proximal of the knee joint and the line connecting 
the midpoint between the tibial spines with the midpoint of the tibia 10 cm. distal of the 
knee joint 21-22. 
Using freely available software (active shape Models toolkit, Manchester University, 
Manchester, UK developed by T.f. Cootes), a statistical shape model of the tibia and 
femur was constructed on the radiographs (see figure 3.1). after all contour points were 
applied to the radiographs (46 on the femur, including cartilage area on the medial 
condyle, and 51 on the tibia), the program overlays all contours using the mathematical 
centre (left knees were mirrored onto the right). The contours are corrected for size and 
rotation to obtain an optimal fit. Through Principal Component analysis, independent 
modes of shape variation in femur and tibia were produced. each mode is expressed 
figure 3.1. applied shape models using active shape Models (frontal view of a right knee).
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numerically, where 0 is the mean shape and negative and positive values represent the 
deviation from this mean, in either direction. We selected the number of modes such 
that 95% of the shape variation in the study population was described.
all MRis were assessed by a trained reader (ds) using the Knee osteoarthritis scoring 
system (Koss) 23. from this semi-quantative scoring system, diffuse and focal cartilage 
defect scores (on fse proton density T2 sequence) and bMl score (on fse fatsat se-
quence) of medial and lateral femur condyle and medial and lateral part of the tibia 
plateau were selected to evaluate early signs of oa. for both cartilage defect scores, 
depth of the defect and the surface extend were scored on a scale from 0 to 3 (absent, 
minimal, moderate and severe). These scores were combined into one dichotomous 
score (absent/present), with cartilage defects being scored as absent if both scores were 
0. Present was scored if both scores were 1 or higher. bMls were also scored on a scale 
from 0 to 3 and recoded into absent/present (0 / ≥1).
statistics
all analyses were done using a selection of the data. because the aim of this study was to 
investigate moderator and mediator effects on early oa signs, only subjects with a K&l 
score of zero in both knees were selected. Mode values were normalized to zero mean 
and unit standard deviation.
To test whether certain joint shape features are only related to the presence of early oa 
signs in the presence of a high bMi (moderation), the independent relations of bMi, mode 
values and the interaction between the two variables to the presence of all cartilage 
defects and bMls (for femoral modes, only femoral cartilage defects and bMls scored in 
the femur were tested. for tibial modes, only the early oa signs scored on the tibia were 
used) were determined using Generalized estimating equations (Gee), which takes the 
correlation between both knees within subjects into account, controlled for continuous 
measures of age and alignment angle (see figure 3.2a). a moderator effect is present if 
the interaction term explains a significant amount of variance in the dependant variable 
14. if a significant moderator effect was found, the relation between the corresponding 
mode values and the early oa signs was determined using Gee, controlled for bMi, age 
and alignment angle, in subgroups based on bMi (bMi < 27 kg/m2 and bMi ≥ 27 kg/m2). 
odds ratios will be tested on significant differences between these subgroups 24.
further, we tested whether bone shape has a mediating role on the effect of bMi on 
early oa signs. a mediating role is present if the indirect path from bMi, via bone shape 
to early oa signs (path a x b, see figure 3.2b) is significant, as indicated by the sobel-test 
25. The sobel operator was calculated based on results of Gee, with age and alignment 
angle (for a) and age, alignment angle and bMi (for b) as covariates. a significant media-
tion effect can be further classified into three subtypes using the decision tree by Zhao 
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et al. 26. depending on the direct path c (figure 3.2b), a mediation effect is ‘indirect-only’ 
(direct path c is not significant), ‘complementary’ (direct path c is significant and has the 
same sign as the mediation effect) or ‘competitive’ (direct path c is significant but its sign 
is opposite to that of the mediation effect).
although the number of statistical tests would require a lower significance threshold, 
due to the exploratory intentions of the present study, a p-value < 0.01 was considered 
statistically significant in all tests. all statistical tests were performed using sPss 17.0 
(Chicago, il).
results
Characteristics of the women from the total sub cohort that underwent additional MRi 
(N = 891) and the population selected for the present study (N = 397) were not signifi-
cantly different (age 53.8 ± 3.8 year, bMi 27.0 ± 4.8 kg/m2 vs. 53.8 ± 3.9 year, 26.4 ± 4.6 
kg/m2 respectively). The interrater reliability for scoring radiological oa on the X-rays 
was good (κ = 0.62). Presence of the early oa signs, as seen on MRi, is given in Table 3.1. 
Bmi as moderator on the relation between shape features and early oa signs
Table 3.2 presents all statistically significant mode x bMi interaction terms. in total one 
femur mode (out of 19 femur modes) and seven tibial modes (out of 28) showed a sta-
tistically significant interaction term on the presence of several early oa signs. for these 
modes, subgroup analysis showed that only three tibial modes (modes 8, 12 and 15) 
had significant odds ratios in the subjects with bMi ≥ 27 kg/m2. These odds ratios were 
significantly different from odds ratios in subjects with a bMi < 27 kg/m2 (p = 0.001 for 
all mode values).
Tibial mode 8 represents variation in size of the lateral tibial spine, with concurring 
variation in both depth of the proximal rim of the medial plateau and width of the lateral 
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figure 3.2. illustration of the moderator (panel a) and mediator (panel b) design.
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table 3.1. Count of bone marrow lesion and cartilage defect scores.
right left
absent present absent present
femur
Medial condyle bMls 353 41 (10%) 348 49 (12%)
lateral condyle bMls 378 16 (4%) 379 18 (5%)
Medial condyle Cds 368 28 (7%) 369 26 (7%)
lateral condyle Cds 382 14 (4%) 381 14 (4%)
tibia
Medial plateau bMls 381 13 (3%) 391 6 (2%)
lateral plateau bMls 382 12 (3%) 388 9 (2%)
Medial plateau Cds 375 21 (5%) 381 14 (4%)
lateral plateau Cds 389 7 (2%) 391 4 (1%)
bMl: bone marrow lesion; Cd: cartilage defect.
table 3.2. significant results for Gee of mode x bMi interaction term on presence of early oa signs (left) 
and accompanied subgroup analysis (right) for Gee of mode values on presence of early oa signs.
  mode x Bmi to presence ofa: p-value
relation of mode to presence of early oa signsb
Bmi < 27 Bmi ≥ 27
  odds ratioc 95%-Ci odds ratioc 95%-Ci
femur    
mode 11 lateral Cds 0.008 0.99 0.69 – 1.40 1.12 0.65 – 1.93
tibia  
mode 8 lateral Cds 0.002 1.85 1.09 – 3.15 12.52d 4.40 – 35.66
mode 12 lateral Cds 0.005 1.11 0.73 – 1.69 17.70 d 3.63 – 86.31
mode 13 lateral Cds 0.001 1.43 0.94 – 2.18 0.38 0.10 – 1.52
mode 15 medial bMls 0.002 1.31 0.80 – 2.15 0.43 d 0.28 – 0.68
mode 19 medial bMls 0.002 1.26 0.70 – 2.28 0.49 0.22 – 1.10
mode 25 lateral Cds 0.001 1.56 0.68 – 3.60 0.04 0.00 – 0.51
mode 26 lateral Cds < 0.001 1.86 0.87 – 3.98 0.45 0.09 – 2.23
Cd: cartilage defect; bMl: bone marrow lesion; 95%-Ci: 95% confidence interval; a adjusted for mode 
score, bMi, age and alignment angle; b adjusted for bMi, age and alignment angle; c odds ratio based on 
z-scores of the mode values; d odds ratio significantly different between groups (p = 0.001). bold 95%-Ci 
represent statistically significant odds ratio (p < 0.01).
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proximal tibia. lateral cartilage defects were associated to a large tibial spine and a deep 
rim in subjects with a bMi ≥ 27 kg/m2. Tibial mode 12 seems to represent variation in size 
of the lateral tibial spine with concurring variation in the inclination medial plateau. in 
MODE 8-4 SD +4 SD
MODE 12-4 SD +4 SD
MODE 15-4 SD +4 SD
figure 3.3. Modes with moderator effect on presence of early oa signs (+/- 4 sd; in order to illustrate 
relatively small differences within modes properly). a) Tibial mode 8, represents variation in size of the 
lateral tibial spine, with concurring variation in depth of the proximal rim of the medial plateau and width 
of the lateral proximal tibia. b) Tibial mode 12, representing forward rotation of medial tibia plateau in low 
mode values. C) Tibial mode 15, representing medial spiking, lowering of the medial anterior ridge of the 
tibia plateau and a less concave transition from the shaft to the plateau in higher values.
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subjects with a bMi ≥ 27 kg/m2, lateral cartilage defects were associated to a large tibial 
spine and a flat medial plateau. Tibial mode 15 appears to represent variation in size of 
the medial tibial spine. bMls on the medial side were associated to a relatively small 
medial tibial spine in subjects with a bMi ≥ 27 kg/m2 (see figure 3.3).
mode values as mediator between Bmi and presence of early oa signs
for all mode values and all cartilage defect and bMl scores, the indirect effect of bMi on 
the presence of early oa signs through the mode values was determined (relation a x 
b, see Methods and figure 3.2b). only the relationship between bMi and the presence 
of lateral cartilage defects through tibial mode 0 was significantly different from zero (p 
= 0.001). The direct relation between bMi and the presence of lateral cartilage defects 
was not significant (p = 0.934). based on the decision tree of Zhao et al., ‘indirect-only’ 
mediation is established for these mode values and it is unlikely there are other omit-
ted mediators 26. Tibial mode 0 values seemed to represent a difference in knee flexion 
angle, with higher values representing greater knee flexion (figure 3.4).
Discussion
in this study, we found significant moderator effects of bMi on the relation between 
several femur and tibia shape features and the presence of bMls and cartilage defects in 
middle-aged women free of radiographic signs of knee oa. besides, a significant media-
tor effect of tibia shape features was found in the relation between bMi and presence of 
lateral cartilage defects among these women. 
Presence of bMls in this study (in 29% of the subjects) was within ranges found in 
other studies of healthy, non-oa subjects. in these studies, presence of bMls ranged 
-2 SD +2 SDmeanMODE 0
figure 3.4. Tibial mode 0, representing greater knee flexion in higher mode values
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from 13% to 61% of the subjects, probably due to differences in subject characteristics, 
definitions and the presence of knee oa 4, 27-30. Presence of cartilage defects in this study 
was lower than reported in other healthy middle-aged subjects 11. in the present study, 
cartilage defects were found in 21% of the subjects. literature reports ranges from 28% 
to 71% for healthy, non-symptomatic subjects 11. however, since radiological oa scores 
were not always an exclusion criteria in these studies, these populations included sub-
jects with K&l score ≥ 2, whereas in the present study K&l score was limited to 0 in both 
knees. Therefore, the results give a good insight in factors related purely to the early 
signs of knee oa and hence, to possible initiation of the disease.
Bmi as moderator on the relation between shape features and early oa signs
in the femur and the tibia, several interaction terms (mode value x bMi) showed signifi-
cant associations to the presence of either bMls or cartilage defects. only for three tibial 
modes, a significant difference in odds ratio was found between subjects with a bMi < 
27 kg/m2 and those with a bMi ≥ 27 kg/m2 (Table 3.2). The bMi cut-point of 27 kg/m2 was 
chosen since beyond this point a clear increase in oa incidence is found 31. interestingly, 
all three tibial modes showing an association with early oa signs in subjects with a bMi 
≥ 27 kg/m2 showed a variation in tibial spine size. This association has not been studied 
excessively. studies that did examine the role of height and pointedness of the tibial 
spines showed an association with presence of several oa features for high, pointed 
spines 32-33. as in the present study, these studies showed an association between varia-
tion in tibial spine size and cartilage pathologies on the contra lateral side 32-33. The exact 
mechanism behind this association is unclear. some authors suggest the variation in 
shape of the tibial spines to be osteophytosis and hence part of the disease process 
32-34, while other emphasize that the tibial spines are connected to the meniscus and 
the anterior cruciate ligament, suggesting that tensile forces on these structures might 
induce shape alterations 33, 35. since a high bMi is associated to both high biomechanical 
loads and systemic inflammation 2, both theories might underlie the associations found 
in subjects with a bMi ≥ 27 kg/m2 in the present study, and have to be studied in more 
detail.
mode values as mediator between Bmi and presence of early oa signs
only tibial mode 0 had a mediator effect (in this case ‘indirect-only’) on the relation 
between bMi and the presence of lateral cartilage defects. a higher bMi was associated 
to greater extension of the knee joint (see figure 3.4), which in turn was associated to 
less cartilage defects on the lateral compartment of the femur. interestingly, our results 
thus indicate an indirect protective role of bMi on lateral cartilage defects. although 
a systematic review on kinematic differences between normal-weight and obese indi-
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viduals 6 did not find differences in knee extension angle, several studies suggested an 
association between hyperextension of the knee and less oa-related features 36-37. data 
from the present study supports this and hence, greater knee extension might function 
as a protective mechanism in individuals with a high bMi in order to prevent cartilage 
damage.
a drawback of our study is that data are limited due to the two dimensional basis of 
the shape assessment. Thus, it is not always easy to determine whether the found pro-
jected shape features are due to true variation in shape of the bones or due to positional 
variation. Given the cross-sectional design, the defects seen on MRi are only assumed to 
be precursors of knee oa. The true development of knee oa could not be studied.
in conclusion, certain tibia shape characteristics, mainly of the tibial spines, appear 
to play an initial role in the development of knee oa, but only in subjects with a high 
bMi. further, a greater extension of the knee joint, due to a high bMi, appears to be a 
protective mechanism and prevent cartilage defects.
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abstract
Background: The present study shows the results of the first ever preventive random-
ized controlled trial in osteoarthritis (oa) worldwide. 
methods: in a 2x2 factorial design, the effects of a diet and exercise program and of 
glucosamine sulphate (double blind and placebo-controlled) on the incidence of knee 
oa after 2.5 years were evaluated in a high-risk group of 407 middle-aged women with 
a bMi ≥ 27 kg/m2 without signs of knee oa at baseline (isRCTN 42823086). Primary 
outcome measure was the incidence of knee oa, defined as incidence of either Kellgren 
& lawrence grade ≥ 2, joint space narrowing of ≥ 1.0 mm or clinical knee oa according 
to the combined clinical and radiographic aCR criteria. 
results: only 10% of all subjects were lost to follow-up after 2.5 years. in total, 17% of 
all knees showed incident knee oa at follow-up. intention To Treat analyses showed a 
significant interaction effect between the two interventions. accounting for this interac-
tion, no significant main effects of either intervention were found, but both interven-
tions showed trends towards reduced knee oa incidence. These effects were neutralized 
in subjects receiving both the diet and exercise program and glucosamine. 
Conclusions: hampered by the unexpected interaction between the two interventions, 
no significant main effects of the diet and exercise program and of glucosamine sul-
phate were found on incident knee oa in middle-aged women with a bMi ≥ 27 kg/m2 
over 2.5 years. however, positive trends for the two separate interventions were found 
and should be further explored.
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introduction
over the last decades, numerous longitudinal studies on risk factors for onset and pro-
gression of osteoarthritis (oa) of the knee, hip and hands have been performed 1-2. These 
studies have led to the identification of a wide variety of modifiable and non-modifiable 
risk factors; mainly focusing on knee oa. With this accumulated knowledge, first steps 
towards primary prevention should be considered 3-4.
The strongest and most prevalent risk factors for incidence of knee oa are overweight 
or obesity, higher age, female sex, and a history of knee injury 5-6. after the age of 50, inci-
dence increases markedly and incidence levels among women exceed those of men 7. a 
meta-analysis on the effect of overweight and obesity on the onset of knee oa showed 
odds ratios (oRs) ranging from 2.1 up to 4.3 compared to normal weight 5.
altogether, women over the age of 50 who are overweight or obese and free of knee 
oa form a high-risk group for the development of knee oa in subsequent years. several 
studies indicate that weight loss in overweight or obese individuals could prevent knee 
oa 2,8-9. in an observational cohort, it was calculated that if women with a baseline 
body mass index (bMi) ≥ 25 kg/m2 would reduce their bMi with 2 units (~ 5 kg), they 
would have a substantially reduced risk for developing knee oa (oR = 0.41) 9. from the 
framingham study it was estimated that the incidence rate of knee oa would decrease 
by 33% if bMi in obese women (≥ 29 kg/m2) would be reduced to 25 – 28.9 kg/m2 (over-
weight) or if women with overweight would reduce their weight to normal (bMi < 25 kg/
m2) 8. The direct effects of weight reduction (primary prevention) on subsequent knee 
oa development have never been studied so far.
Glucosamine has been studied for the treatment of patients with established oa 10, 
but it has never tested for its preventive effects. literature shows the largest effects of 
glucosamine over placebo when used in an early phase of the disease 11 and especially 
in the knee joint 12. since all forms of oral glucosamine have shown to produce no side 
effects over placebo, even after long-term use 13, investigation of the preventive effect 
of glucosamine on incident knee oa seems worthwhile. 
The objective of the present study was to evaluate the effect of a tailored diet and 
exercise program and of oral crystalline glucosamine sulphate (double blind and 
placebo-controlled) in a 2x2 factorial design on incidence of knee oa in overweight 
females between 50 and 60 years, free of radiological and clinical knee oa at baseline, 
over a 2.5 year follow-up period.
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methods
The PRoof study (PRrevention of knee osteoarthritis in overweight females, isRCTN 
42823086) was funded by ZonMw, The Netherlands organisation for health Research 
and development. The study was approved by the Medical ethics Committee of erasmus 
University Medical Centre. The manuscript has been written according to the CoNsoRT 
statement guidelines 14.
study sample
fifty general practitioners (GPs) in the region of Rotterdam, The Netherlands, sent study 
information and a reply-card to all registered women between 50 and 60 years without 
major co-morbidities. interested women with a reported bMi ≥ 27 kg/m2 were contacted 
by phone to check all inclusion criteria. besides age and bMi-related inclusion criteria, 
subjects had to be free of knee oa according to the aCR-criteria 15, not under treatment 
for knee complaints, free of MRi contraindications, free of rheumatic diseases, not using 
walking-aids, master the dutch language and not using oral glucosamine for the last 6 
months. all women eligible and willing to participate were invited for baseline measure-
ments (July 2006 – May 2009).
physical examination
body weight, body height, waist circumference, skin folds, and blood pressure were re-
corded. both knees were examined for pain upon pressure at the joint margins, warmth, 
crepitations, and laxity of the ligaments, and both hands for heberden’s nodes. all physi-
cal examinations were performed at baseline and after 2.5 years follow-up.
radiography
semi-flexed posterior-anterior knee radiographs were taken at baseline and follow-up 
according to the MTP protocol 16. a trained researcher, blinded for clinical outcomes, 
scored all radiographs (baseline and follow-up images at once with known sequence) us-
ing the Kellgren & lawrence (K&l) criteria 17. a random subset of 20% of the radiographs 
was scored by a second blinded researcher to determine inter-observer variability. Mini-
mal joint space width was measured by visual reading with the use of a digital ruler for 
each tibiofemoral compartment 18, using the average score of two researchers blinded 
for clinical outcomes and baseline measurements. scores with a difference between 
both readers ≥ 2.0 mm were re-evaluated during a consensus meeting. Medial knee 
alignment angle was assessed by digitally determining the angle between the line from 
the centre of the tibial spines through the centre of the femoral shaft at approximately 
10 cm from the joint margin and the matching line through the tibia 19.
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Questionnaires
at baseline and every 6 months, participants filled in questions on the number of days 
with knee pain, activity level (sQUash 20), co-interventions, quality of life (euroQol 21), 
medical consumption, and nutritional habits. at baseline, 12 months and 30 months, 
knee complaints, Koos questionnaire 22, menopausal status, and co-morbidities were 
additionally assessed. WoMaC pain and function scores were calculated from the Koos 
questionnaire.
randomization
after informed consent procedure and all baseline measurements, subjects were ran-
domized according to a consecutive case number. for the diet and exercise program, 
subjects were randomized 1:1, using block randomisation with block size 20. a research 
assistant, not involved in the trial, provided a sealed envelope that was opened by the 
subject in the presence of the researcher. allocation to glucosamine or placebo was also 
done one-on-one using a blocked randomization list with block size 20. however, this 
intervention was double-blinded (see below).
home visits
every 6 months, all participants were visited at home. at this visit, participant´s well-
being was discussed, body weight was measured, the questionnaire was checked for 
missing data, the participant was provided with a new batch of study drugs, compliance 
to the study drug was scored by the participant, and the remainder of the previous 
batch was retrieved for an objective compliance calculation.
Diet and exercise program (Dep)
a detailed description of the deP is given elsewhere 23. in short, subjects randomized to 
the intervention group were referred to a dietician and were invited to attend physical 
exercise classes. Using Motivational interviewing techniques 24, the dietician set goals 
regarding nutritional habits and physical activity patterns in agreement with the par-
ticipant. Thereafter a tailor made strategy was determined. additionally, subjects were 
invited to join twenty weekly physical exercise classes (12 to 15 participants) of one 
hour, supervised by a physical therapist. a variation of low impact sports and exercises 
were offered in order to regain pleasure in physical activity and find activities for long-
term continuation. The control group was not offered an intervention, neither were they 
actively discouraged to undertake any form of weight reduction on their own.
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Crystalline glucosamine sulphate versus placebo (Gsvp)
all study drugs were provided in identical packaging by Rottapharm Madaus. subjects 
and research staff were blinded for allocation throughout the whole study. Rottapharm 
Madaus was not involved in study design, data collection, or statistical analyses. subjects 
were asked to consume one sachet of 1500 mg of the study drug (powder) a day for the 
total follow-up period of 2.5 years. 
outcome measures
Predefined primary outcome measure was the difference between the intervention/glu-
cosamine and control/placebo group on the incidence of knee oa, defined as incidence 
of either K&l ≥ 2, joint space narrowing (JsN) of ≥ 1.0 mm or knee oa according to the 
combined clinical and radiographic aCR-criteria 15. secondary outcome measures were 
the differences between groups in quality of life, WoMaC pain and WoMaC function 
scores, actual weight loss, occurrence of oa MRi features, and increase in bone and 
cartilage degeneration markers. since MRi scores and biomarkers will only be available 
in the course of 2013, these outcomes will not be presented here. 
sample size
The study was powered to show an incidence reduction from 20% in the deP control 
group/placebo group to 10% in the deP intervention/glucosamine group. These num-
bers were based on a twelve year follow-up study with an incidence of K&l ≥ 2 of 39.1% 
25. in the age range of 45 to 49 years, this number was 1.6 fold higher, suggesting an 
incidence of 13% over 2.5 years. The primary outcome measure combined incidence of 
K&l grade ≥ 2, aCR criteria and JsN. since there is only moderate overlap between these 
measures 26, a 20% incidence in the control group seemed reasonable. No interaction 
between the interventions was assumed. based on rates in our previous 2-year oa trial 
27, we accounted for 10% lost to follow-up. Therefore, two groups of 200 subjects would 
be appropriate (one-sided testing, alpha = 0.05, beta = 0.80).
analyses
intention To Treat (iTT) analyses on all available data of all knees of all randomized par-
ticipants served as primary analyses. first, the univariate association between known 
prognostic variables (age, K&l grade (≥1 vs. 0), varus alignment (<178° versus ≥178°)28, 
mild knee symptoms, bMi, a history of knee injury, heberden´s nodes, and postmeno-
pausal status) and the primary outcome measure was determined using Generalized 
estimating equations (Gee), with the association between two knees within one person 
taken into account. Variables with a p-value < 0.2 were analysed multivariate. Variables 
with a p-value <0.05 in the multivariate model were adopted as confounders. second, 
Prevention of knee oa in overweight females 57
the interaction between both interventions was determined using Gee, adjusted for the 
confounding variables. Third, the effects of deP and GsvP were determined using Gee, 
adjusted for the confounding variables and, if prompted, the interaction between both 
interventions.
for the Per Protocol (PP) analyses, the latter two iTT analyses were rerun, between 
those subjects compliant to deP (≥ 6 dietary consultations and ≥ 7 attended physical 
exercise classes) and those randomized to the deP control group and in those compliant 
to GsvP (≥ 75% of the study taken). all analyses were performed using PasW statistics 
version 17.0 (sPss inc., Chicago, il). 
available secondary outcomes were analysed using a linear mixed model estimated 
by restricted maximum likelihood (ReMl) to test effects of both interventions and their 
interaction over the follow-up period (sas 9.2, sas institute inc., Cary, NC). a p-value < 
0.05 was defined as statistically significant for all analyses. Randomization code for GsvP 
was broken after all analyses were completed.
results
in total, 6691 women were contacted by fifty GPs. eventually, 407 women were invited 
for baseline measurements and were randomised. figure 4.1 shows the complete flow-
chart. Mean age at baseline was 55.7 ± 3.2 years and mean bMi was 32.4 ± 4.3 kg/m2 
(see Table 4.1). after 2.5 years, forty-one women (10.1%) were lost to follow-up. of these, 
thirty-six women were unwilling to continue their participation; two women withdrew 
because of side effects; one woman was unattainable; two women died in the course of 
the study. one woman died shortly after study ending (all deaths not related to study 
drugs). 
Joint space narrowing (JsN; iCC 0.5 – 0.8) was found medially in 5% and laterally in 6% 
of all knees. incidence of K&l-grade ≥ 2 was found in 4% of all knees (kappa 0.6). six per 
cent of all knees showed incident oa according to the aCR-criteria. Combined into the 
primary outcome measure, 135 knees (17%) showed incident knee oa after 2.5 years.
bMi, K&l grade (≥1 vs. 0), varus alignment, mild symptoms, and a knee injury in the 
past were univariately associated with the primary outcome. Multivariate, only K&l 
grade was associated with the primary outcome. 
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50 general practitioners contacted all women between 50 
and 60 years registered at their practice (6691 women) 
3094 women (46%) returned the reply‐
card to the research institute
1358 women (44%) 
were not interested in 
participating 
847 women (49%) were 
excluded because BMI, 
based on reported body 
weight and height, was 
< 27.0 kg/m2 
889 women (51%) with 
BMI ≥ 27.0 kg/m2 were 
send additional 
information  
After screening on all in‐ and exclusion criteria by phone, 
407 women (46%) were eligible and were invited for 
baseline measurements 
DEP + 
Placebo  
(N = 101) 
DEP + 
Glucosamine  
(N = 102) 
Control + 
Placebo  
(N = 102) 
Control + 
Glucosamine 
(N = 102) 
8 women 
lost to 
follow‐up 
after 2.5 
years 
(1 died, 7 
unwilling) 
9 women lost 
to follow‐up 
after 2.5 
years 
(1 un‐
attainable, 8 
unwilling) 
10 women 
lost to follow‐
up after 2.5 
years 
(2 side‐
effects, 8 
unwilling) 
14 women 
lost to 
follow‐up 
after 2.5 
years  
(1 died, 13 
unwilling) 
1736 women (56%) 
were interested in 
participating 
Randomization
figure 4.1. flow-chart of participants in the PRoof study.
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intention to treat analyses
The iTT analyses on the main effects of the two interventions and their interaction 
showed a significant statistical interaction (p = 0.04). hence, the effects of one inter-
vention depended on the allocation to either groups of the other intervention and the 
four groups had to be analysed separately. in none of the four groups, the number of 
subjects was high enough to reach the numbers required for statistical analyses, as in-
dicated by the sample size calculations, due to the unexpected interaction between the 
interventions. The power was increased by analysing on knee level instead of subject 
level, taken the association between two knees within a person into account, the power 
was increased. still, the number of knees was around 10% short of the number needed. 
table 4.1. distribution and mean (± st. dev) of prognostic variables and the primary outcome among the 
randomized intervention arms.
 
Diet & exercise program
Control group intervention group
placebo Glucosamine placebo Glucosamine
Baseline characteristics        
N - subjects 102 102 101 102
   age (yr.) 55.7 ± 3.3 55.7 ± 3.1 55.7 ± 3.2 55.7 ± 3.1
   bMi (kg/m2) 32.6 ± 4.3 32.4 ± 4.6 32.3 ± 4.5 32.1 ± 3.7
   heberden’s nodes        
     uni-lateral 15% 16% 12% 12%
     bi-lateral 10% 14% 20% 9%
   Postmenopausal status 70% 68% 66% 67%
   euroQol (0-1)* 0.90 ± 0.12 0.88 ± 0.13 0.88 ± 0.14 0.90 ± 0.12
   WoMaC (0-100)**
     pain 5.1 ± 8.5 7.1 ± 11.7 8.1 ± 13.3 6.6 ± 11.4
     function 5.3 ± 8.7 7.1 ± 12.2 7.7 ± 12.2 5.9 ± 10.4
N – knees 204 204 202 204
   K&l
     grade 0 53% 47% 53% 50%
     grade ≥ 1 46% 53% 46% 50%
   Minimal JsW
      medial (mm) 4.4 ± 0.8 4.4 ± 0.8 4.4 ± 0.8 4.4 ± 0.9
      lateral (mm) 5.9 ± 1.1 5.8 ± 0.9 5.8 ± 1.1 6.1 ± 1.2
   Varus alignment 46% 38% 38% 37%
   Mild symptoms 29% 30% 36% 27%
   history of knee injury 14% 12% 10% 13%
* higher scores represent higher quality of life. **higher scores represent more pain/worse function. JsW: 
joint space width
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Given the opposite effects of deP within the GsvP groups, and vice versa, iTT and PP 
analyses were performed two-sided, using a p-level < 0.05. Table 4.2 shows the oRs from 
the iTT analyses for the four groups. The reduced adjusted oRs for deP (0.69 [0.39 – 
1.21]) and GsvP (0.59 [0.31 – 1.12]) did not reach statistical significance.
Diet and exercise program
The effects of deP on body weight, fat percentage, and bMi have been reported exten-
sively elsewhere 23. in short, 28% of the 203 women randomized to deP were compliant 
to the intervention. Compliant women had a mean weight reduction of 1.4 ± 5.2 kg 
after 30 months versus 0.0 ± 6.7 kg in the control group. at 6 and 12 months, the num-
ber of participants fulfilling the predefined target of 5 kg or 5% weight reduction was 
significantly higher in the intervention group than in the control group (14% vs. 6% at 6 
months, p = 0.01 and 17% vs. 10% at 12 months, p = 0.04). eventually, 63 women (15%) 
met this target at 30 months. 
PP analyses comparing those women compliant to deP to those randomized to the 
deP control group also showed a significant interaction with GsvP (p = 0.01). incidence 
of knee oa was found in 19%, 13%, 9% and 23% of the knees of subjects randomized to 
the deP control group with placebo and glucosamine, respectively and subjects compli-
table 4.2. odds ratios from intention To Treat analyses for the four randomized groups on incidence of 
knee oa.
n
(knees)
incident 
knee oa
or
(unadjusted)
95% Ci or
(adjusted)*
95% Ci
deP control group / placebo 204 19% 1 (reference) 1 (reference)
deP control group / glucosamine 204 13% 0.610 0.628 – 1.135 0.591 0.313 – 1.118
deP intervention group / placebo 202 15% 0.695 0.396 – 1.213 0.685 0.389 – 1.208
deP intervention group / glucosamine 204 20% 1.010 0.579 – 1.763 0.972 0.553 – 1.710
* adjusted for baseline Kl grade (0 vs. ≥ 1). deP: diet and exercise program, oR: odds ratio, Ci: confidence 
interval.
table 4.3. odds ratios from Per Protocol analyses on incidence of knee oa.
n
(knees)
incident 
knee oa
or
(unadjusted)
95% Ci or
(adjusted)*
95% Ci
deP control group / placebo 204 19% 1 (reference) 1 (reference)
deP control group / glucosamine 204 13% 0.610 0.328 – 1.135 0.590 0.310 – 1.122
Compliant to deP / placebo 58 9% 0.341 0.109 – 1.063 0.349 0.110 – 1.105
Compliant to deP / glucosamine 56 23% 1.220 0.567 – 2.628 1.277 0.594 – 2.747
* adjusted for baseline Kl grade (0 vs. ≥ 1). deP: diet and exercise program, oR: odds ratio, Ci: confidence 
interval
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ant to deP with placebo and glucosamine, respectively. accompanying oRs are given in 
Table 4.3. 
oral glucosamine sulphate versus placebo
during the follow-up period, a total of 291 adverse events (aes) were reported by a total 
of 118 women, equally divided between glucosamine and placebo group (Chi2 test: p = 
0.23). all reported serious aes (26 by 25 women) were classified as not related to study 
drug and also equally divided between groups (Chi2 test: p = 0.26). after study ending, 
17% of the women in the placebo group and 15% of the women in the glucosamine 
group were convinced they had received glucosamine. The majority of all women (52% 
in the placebo group and 46% in the glucosamine group) were convinced they received 
placebo (Chi2 test: p = 0.24). None of the involved researchers and none of the partici-
pants were unblinded during the trial. in total, 250 women were compliant to GsvP (66% 
in the placebo group, 57% in glucosamine group). 
PP analyses showed no interaction between deP and GsvP (p = 0.17). incidence of 
knee oa occurred in 20% of the knees of the women compliant to the placebo and in 
21% of the knees of women compliant to glucosamine (adjusted oR 0.99 [0.61 – 1.63]).
secondary outcome measures
secondary outcome measures are represented in figures a4.1-a4.4 in the appendix. 
There was only a statistically significant difference between the deP intervention and 
control group on actual weight loss (p = 0.04). detailed analyses showed a significant 
difference in weight loss at 6 months (β = 1.79, p < 0.01) and 12 months (β = 1.39, p = 
0.01). also in PP analyses, only the effect of deP on actual weight loss was statistically 
significant in favour of the deP intervention group (p = 0.01), with statistically significant 
differences in weight loss at 6 months (β = 3.08, p < 0.01), 12 months (β = 2.86, p < 0.01), 
18 months (β = 1.98, p = 0.02), and 24 months (β = 1.79, p = 0.04).
Discussion
This study presents the first ever preventive randomized trial on knee oa worldwide. 
Given the medical and economic burden of the disease and all knowledge obtained 
in the numerous of studies on knee oa carried out in the last decades, evaluation of 
preventive interventions should be the next step. The diet and exercise program and 
the glucosamine sulphate intervention showed no significant main effects on the inci-
dence of knee oa over the 2.5 years follow-up period. however, due to the unexpected 
significant interaction between both interventions, these analyses were slightly under-
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powered. The fact that the interaction between the two interventions became stronger 
in subjects compliant to deP indicates a true interaction between deP and GsvP. 
This preventive randomised trial focused on subjects with high risk of developing 
knee oa and used a combined outcome measure to make a trial in such a slowly pro-
gressing disease feasible over a relative short time period of 2.5 years. This combination 
of radiographic and clinical measures of knee oa into the primary outcome measure 
improves the ability to determine the preventive effects of the studied interventions 3, 
although one misses the detailed insight in the development of the disease. explorative 
evaluation of the separate items confirmed the pattern found in the combined primary 
outcome measure, even within the scores of JsN of both individual blinded scorers. This 
suggests that the effects of deP and GsvP in this trial were similar for the clinical and 
radiographic features of knee oa. 
although we found no significant main effects of deP and GsvP on primary and 
secondary outcomes after 2.5 years, the statistical interaction of deP with GsvP did 
show several interesting results. in the iTT analyses, the effect of glucosamine sulphate 
over placebo was opposite in both groups of deP and vice versa. Where glucosamine 
sulphate reduced oa incidence numbers in the group not undergoing deP (adjusted 
oR 0.59 [0.31 – 1.12]), oa incidence was increased in the glucosamine sulphate group 
within the deP intervention group (adjusted oR 1.44 [0.83 – 2.48]). on the other hand, 
deP reduced the incidence numbers within the placebo group (adjusted oR 0.69 [0.39 
– 1.21]), but showed an increased oR within the glucosamine sulphate group (adjusted 
oR 1.63 [0.89 – 3.01]). only in those subjects compliant to deP, not GsvP, the effects were 
magnified (adjusted oR 0.35 [0.11 – 1.10] within placebo group and adjusted oR 2.17 
[0.95 – 4.96] within the glucosamine sulphate group). although tested in subjects with 
established knee oa, results from Messier et al.29 might give some indication for the 
mechanism behind this interaction. Messier and co-workers found that after a 6 months 
exercise period, subjects randomized to a combination of glucosamine/chondroitin 
decreased in knee flexion strength, whereas subjects receiving placebo significantly 
improved their strength. also balance was better in the placebo group after 6 months 
29. These results suggest that glucosamine might interfere with processes of repair and 
growth after physical exercise. on the other hand, a 12 week training program combined 
with glucosamine sulphate did not show a difference in knee extension strength over 
the placebo group in knee oa patients 30. The more sensitive and explorative measures 
of the MRi and biomarkers, which are being assessed within the present study, might 
provide more detailed information on the underlying mechanism for the interaction 
between deP and GsvP. 
for implementation reasons, a very pragmatic design was chosen for deP. Nevertheless, 
the intervention had a significant effect on the actual weight loss during the first year of 
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follow-up. activity levels were higher in the deP intervention group throughout the total 
follow-up period. however, due to large variation in activity levels within the groups, the 
difference did not reach statistical significance. Thus, despite the relatively low compli-
ance figures, similar to other physical exercise and diet interventions in overweight and 
obese individuals 31, the current deP succeeded in a low level change in lifestyle of the 
subjects randomized to the intervention group, also in the iTT population. Contrary to 
daily practice, the control group in the current trial formed a relatively active control 
group. Nearly 90% of all subjects stated to have a preference for the deP intervention 
group at baseline. for ethical reasons, the deP control group was not actively refrained 
from any interventions on weight loss. after 2.5 years, 18% of all women randomized to 
the deP control group fulfilled the criterion of losing 5 kg or 5% of baseline body weight. 
Therefore, the effects of deP found on incident knee oa may have been underestimated.
in conclusion, the primary analyses showed no significant main effects of deP or GsvP 
on incidence of knee oa over 2.5 years. These analyses, however, were hampered by an 
unexpected significant interaction between the two interventions. The current trial pro-
vides many new insights in the possibilities for prevention of knee oa within a high-risk 
group of middle-aged, overweight women. The low dropout rate of 10% strengthens 
results of this first attempt to prevent oa in subject at high risk. The trends towards 
preventive effects of the two interventions separately and their interaction needs fur-
ther elaboration. a longer follow-up period and more sensitive outcome measures (e.g. 
MRi data) will provide a better insight in the development of knee oa and in the exact 
preventive effects of the applied interventions and their interaction.
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abstract
Background: Weight loss interventions have been studied extensively, but method-
ological limitations negatively affecting applicability in everyday clinical practice are a 
very common problem in these studies. despite the fact that obesity is treated mostly 
in a primary care setting, studies that investigate weight loss interventions in a primary 
care setting are scarce. our objective was to assess the effectiveness of a tailor made 
weight loss intervention in achieving a clinically significant weight loss in overweight 
(bMi ≥ 27 kg/m²) women aged 50 – 60 years in a primary care setting.
methods: as part of a randomised controlled trial on the effects of a tailor made weight 
loss intervention and oral glucosamine sulphate on the incidence of osteoarthritis of the 
knee in 407 overweight women aged 50 – 60 years, we analysed the effectiveness of the 
weight loss intervention in achieving clinically relevant weight loss.
results: at baseline, the mean body weight for all participants was 88.7 ± 13.2 kg, and 
the mean bMi was 32.4 ± 4.3 kg/m². The percentage of participants that lost ≥ 5 kg or 
5% of their baseline body weight was 14.8% versus 6.3% (p=0.012) at six months for 
the intervention group and the control group, respectively. at twelve months, this was 
18.7% versus 14.9% (p=0.027).  Mean weight gain at six months was -0.9 kg versus 0.9 
kg (p<0.001) for the intervention group and the control group, respectively. at twelve 
months, this was -0.6 kg versus 0.6 kg (p=0.01). at 30 months of follow-up, no significant 
differences were found between both groups.
Conclusions: This weight loss intervention, which, at short notice, is easily applicable 
in everyday clinical practice, is effective in achieving clinically significant weight loss 
in overweight women aged 50 – 60 over a 12 month period. long-term weight loss 
maintenance however, occurred only marginally. Magnitude of the effect is comparable 
to that achieved in many other, more intensive weight loss interventions.
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introduction
Numerous studies have investigated the health benefits of weight loss in obese indi-
viduals 1-3. a systematic review of long-term weight loss interventions reported that, 
besides surgical interventions, dietary and lifestyle therapy as well as drug therapy have 
the potential to provide modest weight loss and may improve cardiovascular risk factors 
4. however, drop-out rates were as high as 31-64% and only two of the 44 eligible studies 
presented intention to treat results 1. The other 42 studies based their conclusions on 
per protocol results, which lead to overestimation of the effects and hence, makes the 
results less applicable in everyday clinical practice 4. besides, because of high drop-out 
rates, the majority of the studies based their outcomes only on ‘study-completers’, or 
used methods such as ‘last observation carried forward’ or ‘baseline observation carried 
forward’ methods. This may overestimate the total weight loss because study completers 
may have lost more weight than participants who quit the intervention earlier 4. because 
of these limitations, these studies have shown that particular interventions, when com-
pleted, have the potential to result in clinically relevant weight loss, but have failed to 
investigate whether an intervention would be applicable in everyday clinical practice 4. 
in this past year, there have been some trials published reporting on weight loss 
interventions in a primary care setting. a weight loss intervention study by Wadden et 
al. 5 for example, included counselling with pharmacotherapy, while the study by appel 
et al. 6  tested an intervention which was delivered by care providers other than primary 
care providers. The latter solely played a supporting role.
The majority of weight loss trials conducted in the last few decades used a pre-defined 
scheme of dieting, exercise or psychological treatment to apply to all participants, re-
gardless of their age, sex, baseline body mass index (bMi), etc. 7. however, a systematic 
review reported that the most effective way to promote weight loss in large groups of 
overweight and obese individuals is to offer a ‘tailor made’ intervention with diet and 
exercise. This could reduce the high drop-out rates 8. 
Motivational interviewing, a method of consulting patients based on self determi-
nation Theory, claims to be effective especially in promoting long-term weight loss 
maintenance 9. Motivational interviewing is a technique developed to change people’s 
behaviour by manipulating there intrinsic motivational patterns 10. a systematic review 
clearly stated motivational interviewing as being superior in lowering bMi compared to 
traditional methods of consulting 10. 
The purpose of the present study was to analyse whether a tailor made weight loss 
intervention with diet and exercise, based on motivational interviewing, would be ef-
fective in achieving ≥ 5 kg or 5% of baseline body weight in a group of overweight 
women in a primary care setting. several studies found this amount of weight loss to 
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be associated with health benefits, including improvement of cardiovascular risk factors 
and reduced risk of incident diabetes and hypertension 1-3. douketis et al. reported that 
this amount of weight loss improves lipid levels and glycaemic and blood pressure con-
trol, especially in people with cardiovascular risk factors 4. our expectation was that by 
offering a tailor made intervention, instead of dictating the participants on the quantity 
and quality of their diet and exercises, our drop-out rates would be much lower than in 
comparable studies.
methods
proof study
The intervention we studied was part of a randomised controlled trial that investigated 
the preventive effect of a weight reduction program and oral glucosamine sulphate 
versus placebo on the development of knee osteoarthritis, in a 2x2 factorial design in 
overweight women, called the PRoof study (isRCTN 42823086; Chapter 4) 11. This trial 
was approved by the local Medical ethical Committee of erasmus University Rotterdam 
and all participants provided written informed consent. The PRoof study was open 
labelled for the tailor made intervention to reduce weight, and double blinded for the 
intervention with crystalline glucosamine sulphate (1:1 block randomization within 
both interventions, using block size 20). for the present study, all data was derived from 
the complete dataset of the PRoof study. only the data concerning the tailor made 
intervention to reduce body weight was used in the present study.
recruitment
a detailed description of the recruitment and measurements of the PRoof study can be 
found elsewhere (Chapter 4) 11. in short, 50 general practitioners recruited participants, 
by sending an information letter to all women between 50 and 60 years registered at 
their practice. all interested women with a self-reported bMi ≥ 27 kg/m2 received ad-
ditional information by mail. subsequently these women were checked for inclusion 
criteria by phone. inclusion criteria were: female gender, age 50 to 60 years, overweight 
(bMi ≥ 27 kg/m2), free of knee osteoarthritis according to the aCR criteria 12, free of 
contraindications to MRi, free of rheumatic diseases, and not using oral glucosamine 
during the past six months. Thereafter all eligible women were invited to the research 
centre for physical examination and X-rays as well as MRi scans of both knees. exclu-
sion criteria were: already consulted a physician, a physical therapist or an alternative 
health provider for knee pain possibly indicating osteoarthritis of the knee, presence of 
radiologic signs indicating knee osteoarthritis (Kellgren-lawrence index of 2 or more), 
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not being able to communicate in the dutch language, presence of severely disabling 
co-morbidity. figure 5.1 shows the study selection process.
 
50 general practitioners contacted all women between 50 
and 60 years registered at their practice (6691 women) 
3094 women (46%) returned the reply‐
card to the research institute
1358 women (44%) 
were not interested in 
participating 
847 women (49%) were 
excluded because BMI, 
based on reported body 
weight and height, was 
< 27.0 kg/m2 
889 women (51%) with 
BMI ≥ 27.0 kg/m2 were 
send additional 
information  
After screening on all in‐ and exclusion criteria by phone, 
407 women (46%) were eligible and were invited for 
baseline measurements 
Intervention 
group  
(N = 203) 
Control 
group  
(N = 204) 
17 women lost to 
follow‐up after 2.5 years 
(1 unattainable, 1 died, 
15 unwilling) 
24 women lost to 
follow‐up after 2.5 years
(2 side‐effects, 1 died, 
21 unwilling) 
1736 women (56%) 
were interested in 
participating 
Randomization
figure 5.1. study selection process
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intervention
The relevant intervention consists of an individual tailor made intervention to reduce 
weight, which has been constructed in cooperation with the dutch society of dieticians. 
as said, literature suggests the focus of any weight loss intervention should be on chang-
ing food patterns and habits in physical activity. The health Council of the Netherlands 
also emphasises the importance of these components 13. 
To make the intervention easily applicable in everyday clinical practice, all participants 
were given the opportunity to visit a dietician and a physical therapist nearby their 
home address. all dieticians were trained in Motivational interviewing 10. at baseline, the 
participant discussed nutritional habits and physical activity patterns with a dietician. 
based on the goal setting theory of strecher 14 and the specific implement technique 
15, they agreed on the intentions. subsequently, the dietician composed the individual 
tailor made strategy to accomplish these goals. Primarily, a tailor made advice was given 
for a low fat or a low calorie diet, or both, as well as for physical activity. during the first 
month the participant had an appointment with the dietician once in every two weeks; 
during the consecutive period the frequency of appointments was determined in dia-
logue by the dietician and the participant. These appointments were used to evaluate 
the plan, and if indicated, to adjust the plan. The total duration of these sessions was 
limited to a total of four hours per year. No limit was set on the total period during which 
they were under treatment.
besides, the participants in the intervention group were given the opportunity to 
participate in physical activity classes. in these classes (groups of 12-16 persons) they 
tried a broad range of different low-intensive sport activities under the supervision of 
a physical therapist, such as Nordic walking, volleyball, bowling, salsa dancing, tai chi, 
softball, belly dance, modern dance. The aim of these lessons was to regain pleasure in 
physical activity and to find an activity which they could maintain for themselves for 
long-term continuation. Twenty group activities, one lesson of one hour weekly, were 
spread over a period of half a year. because participants in every group were recruited 
per general practice and lived in the same neighbourhood, continuation of activities 
together was stimulated in case they were interested. both the dietician appointments 
and the physical activity lessons were free of cost to the participants in the intervention 
group.
The participants in the control group have not received this active (i.e. initiated by the 
research group) intervention to reduce body weight, but were free to undertake any 
actions to lose weight at their own initiative.
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physical examination
at baseline and after two and a half years of follow-up, physical examination was per-
formed at the research centre to measure body weight, body height, blood pressure, 
abdominal circumference and skin folds. fat percentage was calculated using the fol-
lowing formula: body fat percentage = (0.730 * bMi) + (0.548 * triceps skin fold) + (0.270 
* age) – 5.9. according to lean et al., this is the most reliable method of assessing body 
fat percentage based on simple anthropometric measurements in women 16. skin folds 
were measured using The harpenden skinfold Caliper hsK-bi. bMi was calculated as 
body weight in kilograms divided by the height in meters squared. additionally, serum 
samples were taken to measure serum hba1c and total cholesterol.
Questionnaire
at baseline, the participants filled out a questionnaire to record characteristics such 
as smoking status, educational level, co morbidity, menopausal status, quality of life, 
social participation, physical activity level and nutritional habits. every sixth month the 
participant was visited by the research assistant to fill out a shorter questionnaire to 
determine compliance to the interventions, physical activity level, nutritional habits, 
co-interventions, medical consumption and quality of life. in addition, body weight was 
measured during these visits.
Quality of life was measured using the eQ-5d euroQol questionnaire, which has 
been thoroughly validated 17. Physical activity level was measured using the validated 
sQUash questionnaire 18-19. intensity scores of ainsworth were used to calculate the 
activity score of the participants 20-22. To calculate the total activity score, each physical 
activity in ainsworth’s compendium received an intensity score ranging from 1 to 9 18. 
These intensity scores were based on the Metabolic equivalent Tasks (MeT’s), which are 
the ratios of a person’s metabolic rate while performing the activity and their metabolic 
rate while seated and resting 20-21. Total activity scores were calculated by multiplying 
total minutes of activity per week and the intensity score. The sum of all activity scores 
formed the total score 19. Nutritional habits were assessed with a validated questionnaire 
23, which was extended to meet our study requirements. 
assessment of compliance to the intervention
dieticians kept record of participant’s body weight and gave them two scores each visit; 
one to indicate to what extent they had reached their set goals concerning physical 
activity, the other to indicate to what extent they had reached their set goals concerning 
nutritional habits. Physical therapists solely recorded presence of participants during 
the physical activity classes.
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statistical analyses
analysis was performed using sPss PasW statistics version 17.0 (sPss inc., Chicago, il). 
baseline characteristics were presented using descriptive statistics as mean ± standard 
deviation (sd). body weight data was presented as mean ± standard error of the mean. 
The primary objective was to assess the number of participants that lost ≥ 5 kg or 5% of 
their baseline body weight. secondary objectives were to evaluate differences between 
the intervention and the control group in fat percentage, bMi, quality of life, physical 
activity level and nutritional habits. all results presented are intention-to-treat results.
The relationship between assignment to the intervention group and chance of suc-
cess, which was defined as losing ≥ 5 kg or 5% of baseline body weight, was calculated 
using Generalized estimating equations (Gee), taking into account the correlation of re-
peated measurements within one participant. This analysis is the most reliable, because 
it does not require imputation and, moreover, it does not take only the completers into 
account, but all measurements of the complete dataset. furthermore, this analysis is 
widely recommended in literature 24-25. all covariates, which included physical activity 
level, nutritional habits and quality of life, were tested for being mediators of the inter-
vention effect using sobel’s test 26-27. also, following the recommendations by Kraemer 
et al. 28, all baseline characteristics were tested for being moderators of the intervention 
effect, using the Gee analysis.
Group differences at set times were analysed using 2-tailed independent t-tests for 
scale variables, and 2-tailed chi-squared tests for categorical variables. for categorical 
variables, significance was calculated with fisher’s exact test. for each outcome multiple 
linear or logistic regression models were conducted to identify what the intervention 
effect on each outcome was. also, logistic regression was used to determine which vari-
ables were correlated with the primary outcome (≥ 5 kg or 5% of baseline body weight 
reduction). in all analyses, a 5% significance level for testing was used.
since data were derived from a RCT on the preventive effects of a diet and exercise 
program on the development of knee osteoarthritis, the corresponding power calcula-
tion was done on incidence figures, rather than on weight loss. in retrospect, we calcu-
lated a power of more than 80% to detect a significant difference between both groups 
in losing ≥ 5 kg or 5% of their baseline body weight.
results
participants
of the 6691 women who were contacted by their general practitioners, 3094 women 
(46%) returned the reply-card to the research institute, of which 1736 women (56% of 
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the repliers) were interested in participating. 847 women (49% of interested women) 
were excluded because calculated bMi, based on reported body weight and height, was 
below 27.0 kg/m2. 889 women (51% of interested women) with bMi of 27.0 kg/m2 or 
higher were sent additional study information. after screening on all inclusion criteria 
by phone, 407 women (46%) were eligible and were invited for baseline measurements 
and randomised to either the intervention or the control group. of these participants, 
70% were postmenopausal at baseline, 93% were of european or North-american 
table 5.1. baseline characteristics
Control group intervention group
mean standard 
Deviation
n % mean standard 
Deviation
n %
age, year 55.7 3.2 55.7 3.2
body weight, kg 89.2 13.6 88.2 12.9
body Mass index, kg/m² 32.5 4.5 32.2 4.1
fat %* 44 5.5 44 5.1
abdominal circumference, cm 106 10 105 9
approximate body weight 1 year ago, kg 87 15 86 15
approximate body weight around 40th year, kg 76 12 74 14
smoking status Non-smoker 77% 87%
smoker  23%   13% 
education level low 35% 32%
Mid-low   45%   51% 
Mid-high   17%   16% 
high   3%   2% 
Co morbidity** 34% 35%
Premenopausal 29% 31%
Quality of life (dutch euroQol eQ-5d) 
Range: 0-1
0.89 0.13 0.89 0.13
social participation*** 9.00 2.18 9.10 2.06
ethnicity european/North american
south american
african
asian
other
93%
1%
1%
1%
5%
94%
1%
1%
2%
2%
Physical activity (sQUash score) 7094 3817 6525 3608
blood hba1c, % 5.8 0.7 5.8 0.8
blood total cholesterol, mmol/l 6.1 1.2 6.0 1.1
snacks consumed per week**** 10.0 0.8 9.4 0.8
* Calculated with formula by lean et al. 16. ** defined as ≥1 condition currently under treatment. *** 
defined as hours per week spent on paid/voluntary/household work or studying. **** defined as food 
consumed between or after main meals of the day, such as cookies, chips, chocolate, etc.
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origin. Mean age was 55.7 (sd=3.2) and mean baseline bMi was 32.36 (sd=4.29). Table 
5.1 shows all baseline characteristics. There were no significant differences between the 
intervention group and the control group. 
participation rates
since no pre-defined scheme of dieting or exercising was presented, but instead partici-
pants decided together with the dietician on their diet, exercise pattern and goals, the 
participation rates varied widely. of the 203 participants randomised to the interven-
tion, 181(89.2%) went at least once to the dietician. 50.8% of the participants had 6 
appointments or more. The mean period between the first and the last visit was 36.3 
weeks (sd=31.4). 50.8% of the participants were less than half a year under treatment 
by a dietician, and 22.0% was under treatment for more than a year. Mean weight loss 
from first to last consult recorded by the dieticians was 1.89 kg (sd=3.93). of these 203 
participants, 79% attended at least one physical activity lesson. 57% of the participants 
attended 7 classes or more. Mean attended lessons were 8 (sd 6).
Weight loss
after randomisation, body weight was recorded at 6 months for 371 participants (91.1%), 
at 12 months for 368 participants (90.4%) and at 30 months for 361 participants (88.7%). 
at 6 months, mean change (± standard error (se)) from baseline in body weight was 0.9 
± 0.3 kg in the control group, and -0.9 ± 0.3 kg in the intervention group (p<0.001). at 
12 months, the mean body weight change was 0.6 ± 0.4 in the control group, and -0.6 
± 0.4 in the intervention group (p=0.014). at 18, 24 and at 30 months, there were no 
significant differences between both groups. figure 5.2 shows all weight change data.
primary objective
Table 5.2 shows the percentages of participants who lost body weight or retained their 
baseline body weight, and the percentages of participants who lost ≥ 5 kg or 5% of 
their baseline body weight. at 6 months, significantly more people in the intervention 
group lost weight or retained their baseline body weight (58.2% vs. 37.4%, p<0.001) 
and there was a higher percentage of people in the intervention group who lost ≥ 5 kg 
or 5% of their baseline body weight (14.8% vs. 6.3%, p=0.012). also at 12 months, both 
the percentage of participants who lost weight or retained their baseline body weight 
(51.9% vs. 39.2%, p=0.016), and the percentage of participants who lost ≥ 5 kg or 5% of 
their baseline body weight (19.7% vs. 11.0%, p=0.027) was significantly higher in the 
intervention group. at 18, 24 and at 30 months, there were no significant differences 
for both outcomes. The overall intervention effect on the primary outcome of losing 
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figure 5.2. Mean body weight change (95% Ci) compared to baseline body weight according to 
randomized groups (blue line: control group, green line: intervention group).
table 5.2. Results of primary objective and figures on weight loss 
Criterion all intervention group Control group p-value
no. of participants (%)
≤ baseline body weight
6 months 178/371 (48) 110/189 (58) 68/182 (37) <0.001
1 year 168/368 (46) 97/187 (52) 71/181 (39) 0.02
2.5 year 169/361 (47) 95/184 (52) 74/177 (42) 0.07
lost ≥ 5 kg or 5% of baseline body weight
6 months 40/371 (10.8) 28/189 (14.8) 12/182 (6.3) 0.012
1 year 55/368 (14.9) 35/187 (18.7) 20/181 (11.0) 0.027
2.5 year 63/361 (17.5) 27/184 (14.7) 36/177 (20.3) 0.10
figures presented as: number of participants who fulfilled the criterion/total participants at that time 
(percentage of total). exact significance calculated with Chi-squared tests and fisher’s exact test.
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≥ 5 kg or 5% of baseline body weight, taking into account all measurements, was not 
significant (oR 1.12, 95% Ci 0.70-1.80).
secondary objectives
secondary objectives were to evaluate differences between the intervention and the 
control group in fat percentage, bMi, quality of life, physical activity level, the percent-
age of participants who measure up to the dutch Physical activity Guideline 29 and 
nutritional habits.
in the overall study population, fat percentage declined from 43.5% to 42.6% re-
spectively (p<0.001) from baseline to 2.5 years of follow-up. There was no significant 
difference between both groups in decline in fat percentage. for bMi, the same pattern 
is found as in body weight change; at 6 months, bMi change in the intervention group 
was -0.3 against 0.3 in the control group (p<0.001) and at 12 months, bMi change was 
-0.2 against 0.3, respectively (p=0.007). With logistic regression analysis, we identified 
baseline bMi to be a positive predictor of the chance of losing ≥ 5 kg or 5% of baseline 
body weight (oR 1.08; 95% Ci 1.02 – 1.15), although no interaction of this effect and 
the intervention effect was found. There were no significant differences between both 
groups in quality of life at any of the time points. at 6 months the change in physical ac-
tivity compared to baseline, measured with the sQUash questionnaire, was significantly 
higher in the intervention group. Change of score was 117.3 (1.8% of baseline score) 
in the intervention group against -682.7 (9.6% of baseline score) in the control group 
(p=0.03). The percentage of participants who complied with the dutch Physical activ-
ity Guideline, was higher at 6 months in the intervention group (58.5% against 46.1% 
in the control group, p=0.019); not at 12 and 30 months. Regarding nutritional habits, 
solely the amount of consumed snacks differed between the two groups. snacks were 
table 5.3. differences between both groups at set times for primary and secondary outcome measures.
6 months 12 months 2.5 years
Percentage of participants losing ≥ 5 kg or 5% of baseline body weight 8.5%* 7.7% -5.6%
body weight change, kg -1.8*** -1.3* -0.5
Change in fat percentage n.m. n.m. 0.2
Change in body mass index, kg/m² -0.1*** -0.2** -0.4
Change in quality of life, dutch euroQol eQ-5d n.m. n.m. 0.2%
Change in physical activity, sQUash score 800* 600 392
Participants that comply to dutch Physical activity Guideline 12%* -2% -0.3%
snacks eaten per week, no. -1.1* -0.5 -0.2
figures represent the difference between the intervention group and the control group for the given 
measures at the indicated time points (compared to baseline). *P<0.05. **P<0.01. ***P<0.001. n.m.: not 
measured.
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defined as food, other than fruit, consumed between or after the three main meals of 
the day, such as cookies, chips, chocolate, etc. The amount of snacks consumed at 6 
months was significantly lower in the intervention group. Participants in the interven-
tion group consumed on average 7.0 snacks per week, against 8.1 in the control group 
(p=0.034). The other secondary objective measurements at other measurement times in 
the follow-up showed no significant differences between both groups. Change in serum 
hba1c and total cholesterol also showed no significant difference between both groups. 
No significant differences were found at 2.5 years of follow-up. Table 5.3 summarizes the 
results of primary and secondary objectives. 
None of the covariates were identified as being mediators of the intervention effect. in 
addition, the Gee analysis showed that none of the baseline characteristics were identi-
fied as being moderators of the intervention effect on weight loss. also, it was found that 
after controlling for various covariates, the odds of losing 5 kg or 5% of baseline weight 
was not affected by any of the covariates, such as age, smoking status, educational level 
or ethnicity.
Discussion
in this effectiveness study, a tailor made intervention to reduce body weight was proven 
to be effective on short-term. after 6 months, the percentage of participants who lost ≥ 
5 kg or 5% or more of their baseline body weight was twice as large in the intervention 
group compared to the control group. This amount of weight loss has been associated 
with improvement in cardiovascular risk factors by numerous studies 1-4. in addition, 
mean weight loss, reduction in bMi, increase in physical activity and reduction in snacks 
consumed per week was significantly greater in the intervention group at 6 months. 
at 12 months, the difference between both groups in the primary objective slightly 
declined. still, the weight loss and reduction in bMi were significantly greater in the 
intervention group at this point. The intervention proved to have no long term effect; 
after 2.5 years of follow-up, no significant differences between both groups were found. 
in contrast to other weight loss intervention studies, we did not dictate the partici-
pants how and to what extent they should exercise and diet. instead, we offered them 
the possibility of attending physical activity lessons and dietician appointments, in or-
der to reach, in dialogue, an individual tailor made scheme 4. This approach was chosen 
to minimize the drop-out rates, in order to obtain results which are more applicable 
to everyday clinical practice than results from many other weight loss intervention 
studies 4. our drop-out rates of 9.4% at one year of follow-up and 11.1% at 2.5 years of 
follow-up were considerably lower than the mean drop-out rates of many comparable 
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intervention studies 4. it is a very pragmatic approach, much more accessible and easier 
to prescribe to large groups than most weight loss interventions with stricter diet and 
exercise schemes 4. Moreover, this approach was recommended in literature as being 
superior to more traditional methods 8. The inevitable consequence of this method is 
that the duration of the intervention itself, the dietician appointments and physical 
activity lessons, is subject to great variation. in our study, we have seen that only 22% of 
the participants were under treatment by a dietician for more than a year. furthermore, 
51% of the participants quit seeing a dietician within half a year from baseline. Results in 
primary and secondary objectives reflected this pattern; the largest intervention effect 
is seen at 6 months of follow-up, at 12 months of follow-up there is still a small interven-
tion effect observable, but after this intervention effects are levelled out. Weight loss 
only seems to occur during the intervention, despite the fact this intervention was 
designed to promote long-term weight loss maintenance. 
one of the reasons that may have caused underestimation of the intervention effect is 
the fact that in our control group also a substantial amount of weight loss has occurred. 
This could have been caused by the recruiting process. since the participants were re-
cruited for participation in the PRoof study, the participants who were randomised to 
the control group had already received information regarding the increased risk of knee 
arthritis, due to their overweight. This information could have motivated a substantial 
proportion of the people randomised to the control group to lose weight at their own 
initiative. another explanation as to why weight loss maintenance has occurred in such 
small rates is the limitation imposed on dieting by insurance companies. Just four hours 
per year was reimbursed. Participants who wished to visit the dietician for more than 
four hours in one year, had to pay for these visits themselves. also, in this intervention 
the participants were offered a maximum of 20 physical activity lessons, assuming 
this would be enough to stimulate the participants to continue physical activities 
themselves after seizure of the lessons. a final factor that could have contributed to an 
underestimation of the intervention effect is the mean baseline body weight and bMi of 
our participants. We have identified baseline bMi to be a positive predictor of the chance 
of losing ≥ 5 kg or 5% of baseline body weight. The higher the baseline bMi is, the higher 
the chance of success is, an effect also found in many other studies 30. in comparison to 
other weight loss studies, the baseline bMi and baseline body weight of our participants 
is relatively low 4. 
Very few trials were designed to test the effectiveness of weight loss interventions, 
rather than the efficacy 4. The facilities used in the present trial are already available in 
everyday clinical practice. besides, few trials were conducted in a primary care setting 
31. Moreover, most studies dictated a very restrictive diet and exercise scheme, whereas 
our study let the participants decide on their scheme themselves 4. Nevertheless, the 
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amount of weight loss occurred in the first year of follow-up in our pragmatic weight 
reduction intervention was similar to the amount of weight loss achieved in many ef-
ficacy studies 4. 
This trial has several limitations. firstly, the participants got the opportunity to attend 
only 20 exercise lessons for free. secondly, due to the inclusion criteria of the PRoof 
study, the results are only applicable to women aged 50 – 60, without knee complaints. 
Thirdly, the well-established relationship between weight loss and improvement of car-
diovascular risk factors was not confirmed in our study. literature suggests a follow-up 
time of at least four years to examine any effect on these factors 4. Therefore effects might 
be found, when prolonging follow-up. The fact that both the dietician appointments 
and the physical activity lessons were free of cost to the participants in the intervention 
group could have caused an overestimation of the intervention effect. however, during 
the trial, insurance covered the costs for the dietician appointments, also for the partici-
pants in the control group, in case they decided to visit a dietician on their own initiative.
since the objective of this study was not to show superiority of our intervention to 
traditional predefined interventions, but to assess the effectiveness of the intervention 
in itself, we did not compare our tailor made weight loss intervention to a traditional 
pre-defined intervention. Therefore, from this study, it cannot be determined whether 
this intervention is more effective in achieving clinically significant weight loss than a 
traditional intervention.
several strengths of this trial are the low drop-out rates, the design which makes this 
intervention easily applicable in everyday clinical practice, the intention-to-treat data, 
which make a much more valid estimate of the intervention effect in everyday clini-
cal practice than per protocol analyses and, finally, our design including motivational 
interviewing as a basis for promoting adherence, as has been recommended 8,30. 
in conclusion, despite the fact that the diet and exercise schemes in our study are 
less restrictive than in most weight loss interventions, our tailor made intervention to 
reduce body weight is effective to induce clinically significant weight loss in one year 
in an amount which is comparable to that achieved in most other weight loss trials 4. 
This effect is not overestimated, since our drop-out rates were relatively low, and we 
conducted an intention-to-treat analysis. since the facilities for this intervention are 
already accessible and it is easy to prescribe to large groups, this intervention could 
be a realistic option to implement in primary care. in future research, long-term weight 
loss maintenance, which has occurred marginally in our study, might be achieved by 
prolonging the intervention or follow-up time, offering more physical activity lessons 
and dieting consults, and by designing a more representative control group. also, the 
use of electronically delivered interventions, such as internet and telephone counselling 
could help to increase participation rates 32. additional studies are needed to provide 
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general practitioners with an effective tool to achieve especially long-term weight loss 
maintenance in overweight women.
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abstract
Background: The present study evaluates the effect of a clinically relevant weight loss 
on the incidence of knee osteoarthritis (oa) in middle-aged, overweight and obese 
women, without clinical and radiological knee oa at baseline. 
methods: a total of 353 women (87%) with follow-up data available were selected from 
the PRoof study (isRCTN 42823086). all radiographs were scored for K&l grades and 
minimal joint space width was digitally measured in the medial and lateral tibiofemoral 
compartment. incidence of knee oa was compared between women that reached the 
weight loss target of 5 kg or 5% of body weight after 30 months and those that did not 
reach this target. The predefined primary outcome measure was the incidence of knee 
oa, defined as onset of K&l ≥ 2 or the onset of clinical knee oa (according to the aCR 
criteria), or joint space narrowing (JsN) ≥ 1.0 mm in the medial or lateral compartment. 
Using Generalized estimating equations, incidence of knee oa according to the primary 
outcome, and for all items separately, was compared between both groups (adjusted 
for randomized groups of the initial trial, K&l grade and bMi at baseline, and a history 
of knee injury). 
results: The weight loss group had a significant lower incidence of knee oa accord-
ing to the primary outcome measure (15% vs. 20%; oR 0.5, 95% Ci 0.3 – 0.9) and for 
incidence of K&l ≥ 2 (3% vs. 6%; oR 0.3, 95% Ci: 0.1 – 0.9). Moreover, the weight loss also 
positively affected several health measures. There was no significant effect of weight 
loss on incidence of clinical oa according to the aCR criteria (5% vs. 7%; oR 0.4, 95% Ci 
0.1 – 1.3) or on either medial (5% vs. 6%; oR 0.7, 95% Ci 0.3 – 1.7) or lateral JsN (6% vs. 
7%; oR 0.7, 95% Ci 0.3 – 1.7). 
Conclusions: a reduction ≥ 5 kg or 5% of body weight over a 30 month period reduces 
the risk for the onset of radiographic knee oa in middle-aged, overweight and obese 
women. due to the slow progress of the disease, a longer follow-up period will be 
necessary before the number of prevented cases of knee oa by substantial weight loss 
becomes clinically relevant.
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introduction
The worldwide prevalence of obesity nearly doubled between 1980 and 2008 1. accord-
ing to the most recent estimations by the World health organization, 35% of all adults 
are overweight (bMi ≥ 25 kg/m2) and more than 12% is obese (bMi ≥ 30 kg/m2) 1. a 
high bMi is a strong risk factor for the onset of knee osteoarthritis (oa) 2-3 and has been 
associated with the incidence of both clinical 4-5 and structural features 6-10 of knee oa. 
Given the high medical costs, morbidity and disability associated with knee oa, there is 
an increasing need for preventive measures.
in trials among subjects with and without established knee oa, weight loss was shown 
to have advantageous structure modifying, systemic and clinical effects 11-14. in a system-
atic review on the effects of weight loss on knee oa patients, a weight loss of at least 5% 
body weight was indicated for symptomatic relief 15. losing ≥ 5 kg or 5% body weight 
has also been indicated as minimal weight loss for a positive and clinically relevant ef-
fect on the cardiovascular risk profile, including significant reduction of blood pressure 
and improved glucose tolerance 16. in subjects without knee oa but with overweight or 
obesity, and hence at high risk for developing knee oa, the preventive effect of such a 
clinically relevant weight reduction has never been studied. in the framingham study it 
has been estimated that substantial weight loss (± 5 kg) could reduce the onset of knee 
oa in overweight and obese subjects 17-18. 
Recently, the first ever preventive trial in oa research worldwide, the PRoof study 
(PRevention of knee osteoarthritis in overweight females; Chapter 4) 19, was under-
taken. in this randomized clinical trial among middle-aged women with a bMi ≥ 27 kg/
m2 without knee oa at baseline, the effects of a diet and exercise program on incidence 
of knee oa over 2.5 years was studied. The diet and exercise program did show favour-
able effects on body weight figures in the intervention group during the first year of 
the intervention and indications of a preventive effect among subjects compliant to the 
intervention were found (Chapter 4) 19. The objective of the diet and exercise interven-
tion was a structural weight reduction of 5 kg or 5% of baseline body weight. 
The primary objective of the present study is to evaluate the effects of a clinically rel-
evant reduction in body weight (≥ 5 kg or 5%), irrespective of the original interventions, 
on the incidence of clinical and radiological knee oa after 2.5 years in middle-aged 
overweight and obese women. 
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methods
for this study we used data from the PRoof study (isRCTN 42823086). a full description 
of the study protocol can be found elsewhere (Chapter 4) 19.  in short, this 2.5 year follow-
up study aimed to evaluate the preventive effect of a diet and exercise program and oral 
glucosamine sulphate (double-blind, placebo controlled) on the onset of knee oa in a 
2x2 factorial design. study protocol was approved by the Medical ethical Committee of 
erasmus MC.
fifty general practitioners in the area of Rotterdam, the Netherlands, contacted all 
women aged between 50 and 60 years registered at their practice. all women that 
returned the reply-card, reported a bMi ≥ 27 kg/m2, and were interested in participation, 
were sent additional information. one week later, inclusion criteria were screened by 
phone. inclusion criteria were: age between 50 and 60 years, bMi ≥ 27 kg/m2, no knee 
oa according to the aCR criteria (clinical + radiographic) 20, no contra-indications for 
MRi, no rheumatic diseases, not using a walking aid, not under treatment for knee com-
plaints, mastering the dutch language, and not using oral glucosamine during the past 
6 months. all women eligible and willing to participate were invited to visit the research 
institute for informed consent procedure and baseline measurements.
at baseline, body weight and height, waist circumference, and blood pressure were 
measured. skin folds of the triceps were measured and used to calculate fat percentage 
using the formula by lean et al 21, that was defined as the most reliable method based 
on simple anthropometric measurements in women (fat percentage = [0.73xbMi] + 
[0.548*triceps skin fold] + [0.27xage] - 5.9). a blood sample was taken to assess total 
blood cholesterol and hba1c concentration and heberden’s nodes on both hands were 
assessed. a standardized semi-flexed Pa radiograph of both knees was taken according 
to the MTP protocol 22. all subjects filled in a questionnaire that included questions on 
knee complaints, number of days with knee pain, past knee injuries, and postmeno-
pausal status. all measurements were repeated after 2.5 years of follow-up. 
all tibiofemoral compartments of all knees were scored for knee oa by a researcher 
blinded for clinical outcomes (baseline and follow-up images at once with known 
sequence), using Kellgren & lawrence (K&l) criteria 23. Minimal joint space width was 
measured digitally on each radiograph in each tibiofemoral compartment by two 
blinded researchers independently, according to the method of lequence 24. scores 
with a difference between both readers ≥ 2.0 mm were re-evaluated by both readers at 
a consensus meeting. Joint space narrowing (JsN) was calculated for each tibiofemoral 
compartment by substracting the mean score of both assessors at baseline from the 
mean score at follow-up.
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for the analyses, all subjects with the primary outcome measure and follow-up data 
on body weight available were selected. baseline characteristics were tested for signifi-
cant difference between Wl and N-Wl group using independent t-test (linear measures) 
and Chi2 test (dichotomous measures). Using Generalized estimating equations (Gee), 
which takes into account the association between knees within subjects, incidence of 
knee oa in subjects that reached the weight loss (Wl) target of 5 kg or 5% body weight 
reduction at 2.5 years was compared to subjects that did not fulfil the target (N-Wl). 
The predefined primary outcome measure was the incidence of knee oa, defined 
as incidence of either K&l ≥ 2 or aCR criteria or JsN ≥1.0 mm in the medial or lateral 
tibiofemoral compartment. additionally, differences between Wl and N-Wl were also 
tested for the separate items of the primary outcome measure. all Gee analyses were 
adjusted for the randomized groups of the initial PRoof study, K&l grade at baseline (0 
vs. ≥ 1) ; since it was shown to be related to the incidence of knee oa (Chapter 4) 19, and 
those factors that were significantly different between Wl and N-Wl groups at baseline. 
Results from these analyses were presented in odds ratios (oRs) with 95% confidence 
intervals (Ci). baseline differences between Wl and N-Wl groups were tested using 
student’s t-tests for continuous variables and Pearson Chi-square test for categorical 
variables. To evaluate the magnitude of the changes in clinical outcomes after a weight 
reduction of 5 kg or 5% body weight, changes over the 2.5 year follow-up period on 
total cholesterol, hba1c level, fat percentage, waist circumference and blood pressure 
between Wl and N-Wl were assessed using student’s t-tests. all statistical analyses were 
performed using performed using sPss 20.0 (Chicago, il) with a p-value < 0.05 regarded 
as statistically significant.
results
after 2.5 years, the primary outcome measure and follow-up data on body weight was 
available for 353 women (87 %). from these women, 61 subjects (17%) fulfilled the 
weight loss target of 5 kg or 5% body weight. baseline characteristics of both groups are 
presented in Table 6.1. at baseline, the mean bMi (p = 0.01) and the number of knees 
with an injury in the past (p = 0.01) were significantly higher in the Wl group. hence, 
the analyses were additionally adjusted for these variables. The weight change in the 
Wl group over the 2.5 years of follow-up was -9.9 ± 5.7 kg on average, ranging from -4.2 
kg to -24.7 kg. in the N-Wl group, subjects gained 1.8 ± 4.0 kg on average, ranging from 
-4.8 to +21.2 kg. Mean change in bMi was -3.6 kg/m2 in the Wl group and +0.7 kg/m2 in 
the N-Wl group. 
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table 6.1. baseline characteristics (mean ± st.dev.).
non weight loss group Weight loss group p-values
N – subjects 292 61
age (yr.) 55.8 ± 3.2 55.5 ± 3.2 0.42
bMi (kg/m2) 32.0 ± 4.1 33.4 ± 4.3 <0.01
Postmenopausal status (yes) 69% 73% 0.33
heberden’s nodes (in ≥ 1 finger) 28% 25% 0.58
assigned to diet and exercise group* 53% 43% 0.04
assigned to glucosamine group* 52% 44% 0.14
N – knees 584 122
K&l grade 0 52% 43%
0.11
K&l grade ≥ 1 48% 57%
history of knee injury (yes) 12% 21% 0.01
Mild oa symptoms (yes) 31% 33% 0.75
Varus alignment (yes) 39% 43% 0.36
*Randomized groups in the original PRoof study.
table 6.2. incidence of knee oa for weight loss and non-weight loss groups.
outcome Group incidence odds ratio** 95 % Ci
Knee oa* Wl group 18/122 (15%) 0.50 0.27 – 0.91
(primary outcome measure) N-Wl group 117/584 (20%) 1
K&l ≥ 2 Wl group 3/118 (3%) 0.28 0.09 – 0.89
N-Wl group 33/545 (6 %) 1
aCR criteria Wl group 6/122 (5%) 0.39 0.09 – 1.30
N-Wl group 41/584 (7 %) 1
Medial JsN Wl group 6/122 (5%) 0.65 0.26 – 1.67
N-Wl group 34/583 (6%) 1
lateral JsN Wl group 7/122 (6%) 0.73 0.32 – 1.68
N-Wl group 40/583 (7%) 1
Wl group: weight loss group (≥ 5 kg or 5% weight loss). N-Wl group: non weight loss group (<5 kg or 
5% weight loss). K&l: Kellgren & lawrence criteria. JsN: joint space narrowing (≥1.0 mm). *defined as 
incidence of K&l ≥ 2 or the aCR criteria or JsN ≥1.0 mm. **analyses adjusted for randomized groups of 
PRoof study, K&l grade and bMi at baseline, and past injury. N-Wl group served as reference group.
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incidence figures of knee oa according to the primary outcome and the separate 
items and corresponding oRs for the Wl group relative to the N-Wl group are presented 
in Table 6.2. incidence according to the primary outcome measure was 20% in N-Wl and 
15% in the Wl group (oR 0.50; 95% Ci 0.27 – 0.91). also the difference in incidence of K& 
l ≥ 2 between N-Wl (6%) and the Wl-group (3%) showed to be statistically significant 
(oR 0.28; 95% Ci 0.09 – 0.89).
subjects in the Wl group had a significant reduction of hba1c level, fat percentage, 
waist circumference and systolic and diastolic blood pressure over the 2.5 year follow-up 
compared to subjects in the N-Wl group (see Table 6.3).
Discussion
for the first time, the true preventive effect of weight reduction on incident knee oa 
in a high risk group of middle-aged women with a bMi ≥ 27 kg/m2 has been studied. 
The present study shows that a clinically relevant weight reduction of 5 kg or 5% body 
weight or more leads to significantly less incident cases of knee oa in overweight and 
obese women.
The PRoof study used a combined outcome measure of radiographic and clinical 
knee oa features in order to make a preventive randomized trial feasible over a relative 
short follow-up time (Chapter 4) 19. in the N-Wl group, 6% of all knees had incident ra-
diographic knee oa (K&l ≥ 2) over the follow-up period. This annual incidence of 2.4% is 
table 6.3. baseline and 2.5 year follow-up values for several health measures (mean ± st.dev).
health measure Group Baseline follow-up mean difference p-value
hba1c (mmol/mol) Wl group 40.4 ± 9.2 39.4 ± 8.3 -1.4 ± 3.6 0.03
N-Wl group 39.5 ± 8.6 39.8 ± 7.3 0.4 ± 6.1
Total cholesterol (mmol/l) Wl group 6.0 ± 1.2 5.9 ± 1.4 -0.0 ± 1.5 0.73
N-Wl group 6.1 ± 1.1 5.9 ± 1.1 -0.1 ± 0.9
fat percentage Wl group 44.6 ± 5.2 39.9 ± 4.7 -4.7 ± 3.5 <0.01
N-Wl group 43.2 ± 4.9 43.1 ± 4.6 -0.1 ± 3.4
Waist circumference (cm) Wl group 108 ± 10 101 ± 11 -7.3 ± 6.7 <0.01
N-Wl group 105 ± 9 107 ± 10 1.5 ± 5.5
blood pressure (systolic) Wl group 146 ± 24 141 ± 20 -5.3 ± 23 0.04
N-Wl group 146 ± 21 146 ± 21 0.2 ± 18
blood pressure (diastolic) Wl group 95 ± 11 87 ± 11 -7.9 ± 11 <0.01
N-Wl group 93 ± 12 91 ± 12 -2.8 ± 10
Wl: weight loss. N-Wl: non weight loss. P-values are significance level of differences in mean delta’s 
between both groups.
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at the high end of the range found in population based cohorts using the same criterion, 
such as the framingham study (2% in women) 25, the Rotterdam study (1.4% in men and 
women with a bMi > 27.5 kg/m2), the Chingford Women’s study (2.3% in women aged 
45-64) 26, and the Road study (3.6% in women aged 50-59) 27. only the latter reported 
higher incidence numbers than in our study, but these were calculated on a subject level 
rather than knee level. on a subject level, an annual incidence of 4% was found in the 
N-Wl group. incidence of clinical knee oa (clinical + radiographic) found in the present 
study (2.8% in N-Wl group) was higher than numbers reported in other studies (1% in 
women of the framingham study 25 and 0.3% in middle-aged women 28). This might be 
explained by the fact that our study was conducted in overweight and obese subjects, 
who are at higher risk for the onset of knee oa than normal weight individuals 2-3.
There is an obvious overlap between incidence of JsN and incidence of K&l ≥ 2, given 
the fact that JsN is part of the definition of K&l ≥ 2. Nevertheless, we did not find a 
similar association between weight loss and incident JsN like we found for the incidence 
of K&l ≥ 2. in additional, K&l ≥ 2 requires definite osteophytes in the tibiofemoral joint. 
Previously, surplus fat mass has been linked to osteophyte formation, possibly through 
circulating leptin levels 29. since circulating leptin level decrease after weight loss 29, it 
could be supposed that a clinically relevant weight loss would lead to less osteophyte 
formation. This hypothesis is supported by our results.  None of the knees of the women 
that reached clinically relevant weight loss showed incidence of a definite osteophyte, 
versus 3 % of all knees of the women that did not reach this amount of weight loss (p < 
0.05). less osteophyte formation could explain why we did find an effect of weight loss 
on incidence of K&l ≥ 2, which was not found for JsN.
at baseline, the Wl group had a significantly higher bMi and reported a higher num-
ber of knees with a history of knee injury. The first was to be expected since a high 
bMi is a predictor for greater weight loss 30-31. Probably, the higher prevalence of knees 
with a history of injury in the Wl group was also linked through bMi; baseline bMi was 
significantly higher in subjects with a previously injured knee than in subjects without 
and a history of injury showed to have a non-significant effect on all outcome measures 
when adjusted for bMi at baseline (data not shown). Perhaps the former injury led to a 
less active lifestyle and hence, a higher body weight.
besides effects on the onset of knee oa, the substantial weight loss also positively 
affected several health measures, such as blood glucose level, fat percentage, waist 
circumference and blood pressure. Positive alterations in these features have been 
linked to lower risk of diabetes mellitus type 2, cardiovascular morbidity and mortality 
32. however, the magnitude of the changes found was not high enough to reduce the 
10-year risk of fatal cardiovascular disease 32. Maintenance of the body weight in the Wl 
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group over a prolonged period will possibly lead to greater reductions in these health 
measures.
in conclusion, a reduction ≥ 5 kg or 5% of body weight over a 30 month period reduces 
the risk for the onset of (radiographic) knee oa in middle-aged, overweight and obese 
women. also, several health measures were positively altered after this substantial 
weight loss. due to the slow progress of the disease, a longer follow-up period will be 
necessary before the number of prevented cases of knee oa by substantial weight loss 
becomes clinically relevant.
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abstract
Background: in a recent systematic review, negative effects of prolonged glucosamine 
usage on glucose metabolism were more likely among subjects with impaired insulin 
resistance or glucose tolerance. despite this, glucosamine is recommended for the 
management of osteoarthritis (oa) in international guidelines and is freely available 
over the counter. The objective of the present study was to evaluate the effect of a 2.5 
years, placebo controlled intervention with oral crystalline glucosamine sulphate on 
hba1c levels in middle-aged women with a bMi ≥ 27 and therefore at increased risk for 
impaired glucose tolerance. 
methods: data from the PRoof study were used. in total, 407 women between 50 and 
60 years, with a bMi ≥ 27 kg/m2, without clinical and radiographic knee oa at baseline 
were randomized over oral crystalline glucosamine sulphate or placebo. at baseline, 
1 year, and 2.5 years, hba1c level was determined in all subjects. Using restricted 
maximum likelihood methods, the effect of glucosamine on hba1c level throughout 
the follow-up period was determined in all subjects. Thereafter, analyses were rerun for 
subjects with and without elevated hba1c level (≥ 42 mmol/mol) at baseline. finally, the 
risk of attaining an elevated level of hba1c after 2.5 years was determined.
results: only 10.1% of the subjects were lost to follow-up after 2.5 years. The glucos-
amine intervention had a non-significant effect on mean hba1c level over 2.5 years, 
when analysed among all subjects (p = 0.94), and in subjects with a normal (p = 0.60) 
or elevated (p = 0.82) hba1c level at baseline. however, compared to placebo, subjects 
randomized to glucosamine sulphate had an odds ratio of 2.81 (1.12 – 7.04) for attaining 
an elevated hba1c level at follow-up. 
Conclusions: a 2.5 year oral glucosamine sulphate intervention did not affect mean 
hba1c levels in overweight and obese females, but did lead to significant more women 
being at ‘high risk for developing diabetes’.
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introduction
despite limited and conflicting evidence, oral glucosamine is a widely used treatment 
for osteoarthritis (oa). Very likely, two factors that stimulate the use of glucosamine are 
the recommendations for glucosamine use for the management of oa in international 
guidelines 1-2 and the safety over placebo as reported in several clinical trials 3-4. how-
ever, there is some evidence that prolonged use of glucosamine might negatively affect 
the glucose metabolism, especially among subjects with impaired glucose tolerance 5-6. 
since one of the greatest risk factors for oa, a high body mass index (bMi), is also linked 
to impaired glucose tolerance 7, studies on the effects of glucosamine use on glucose 
metabolism in subjects with impaired glucose tolerance have been undertaken. in a 
recent systematic review, dostrovsky and co-workers 5 showed that indeed studies that 
included subjects with impaired insulin resistance or glucose tolerance were more likely 
to detect an effect of glucosamine on glucose metabolism than those excluding these 
subjects. however, they conclude that the included studies were small, of short duration 
and had a large heterogeneity. Unfortunately, most recent large clinical trials could not 
be included in the systematic review since most did not report on measures of glucose 
metabolism 5.
in the recently completed PRoof study on the preventive effects of a diet and exercise 
program and of oral glucosamine sulphate on knee oa (Chapter 4) 8, 407 middle-aged 
women with a bMi ≥ 27 kg/m2 were randomized over a daily dosage of 1500 mg of either 
crystalline glucosamine sulphate or placebo, for a 2.5 year follow-up period. for inclu-
sion, subjects were not screened on glucose tolerance, but glucose metabolism was 
measured using haemoglobin a1c (hba1c) levels; making the evaluation of prolonged 
glucosamine usage on glucose metabolism in subject with and without impaired glu-
cose tolerance possible.
elevated hba1c levels reflect long-term hyperglycaemia over the preceding two to 
three months 9-10. for non-diabetes individuals with increased bMi, normal hba1c level 
is set as < 42 mmol/mol 10. in clinical trials, hba1c is the most common measure of gly-
caemic control 11 and quite recently, elevated hba1c levels (≥ 42 mmol/mol) were set as 
diagnostic criterion for diabetes 12.
The first objective of the present study was to evaluate the effect of a 2.5 year placebo 
controlled intervention with glucosamine sulphate on hba1c levels in middle-aged 
women with a bMi ≥ 27 kg/m2 and therefore at increased risk for impaired glucose toler-
ance. secondly, the intervention effect on hba1c level within subjects with and those 
without elevated hba1c level at baseline was determined. finally, the risk of attaining an 
elevated level of hba1c after 2.5 years for subjects randomized to glucosamine sulphate 
was determined.
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methods
The PRoof study (isRCTN 42823086) was designed to evaluate the effects of a diet 
& exercise program and of oral glucosamine sulphate in 2x2 factorial design on the 
incidence of knee oa in middle-aged overweight females, free of radiographic and 
clinical knee oa at baseline. a full description of the trial design can be found elsewhere 
(Chapter 4) 8. in short, 50 general practitioners in the area of Rotterdam, the Netherlands, 
contacted all women between 50 and 60 years of age registered at their practice. out 
of 6.691 women contacted, a total of 407 were interested, fulfilled the inclusion criteria 
and were randomized. study protocol was approved by the Medical ethical Committee 
of the erasmus MC.
at the baseline visit, all subjects signed the informed consent. body weight, body 
height and waist circumference were measured, a blood sample was drawn for analysis 
of hba1c level (mmol/mol), and physical activity was scored by the subjects by filling 
in the sQUash questionnaire 13. after the baseline measurements, all subjects were 
randomized over either placebo or crystalline glucosamine sulphate (1:1 at subject level, 
using blocked randomization with block size 20). subjects received study drugs for the 
first 7 months and were instructed to solve and consume one sachet (1500 mg) every 
day. after 6 months, all subjects were home visited to renew the study drug. at the home 
visit after 12 months, a new blood sample was drawn for hba1c determination. after 
2.5 years, all baseline measurements were repeated at the research lab. all study drugs 
were provided by Rottapharm Madaus, in identical packaging. subjects and research 
staff were blinded for allocation throughout the whole study. Rottapharm Madaus was 
not involved in study preparations, data collection, or statistical analyses.
The effect of the glucosamine sulphate, compared to placebo, on hba1c level over 
the follow-up period was determined using linear mixed models for repeated measure-
ments. Thereafter, the analyses were rerun in subjects with (≥ 42 mmol/mol) and in 
subjects without elevated hba1c level at baseline (< 42 mmol/mol). all analyses were 
adjusted for possible confounders (age, bMi, sQUash at baseline and change over 30 
months, change in waist circumference, and season of baseline measurement 14) and 
the randomized groups of the diet & exercise program. The risk of attaining an elevated 
level of hba1c after 2.5 years (≥ 42 mmol/mol) was tested in all subjects using logistic 
regression, additionally adjusted for having an elevated level of hba1c at baseline. all 
analyses were performed using sPss PasW 20 (sPss inc., Chicago, il) and with a p-value 
< 0.05 set as statistically significant.
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results
from the initial 407 randomized women, only forty-one women (10.1%) were lost to 
follow-up during the study. Most drop-outs were unwilling to continue participation. 
only two withdrew because of side effects (Chapter 4) 8. over the total follow-up period, 
a total of 250 women (61%) reached the pre-specified target of ≥ 75% of study drugs 
consumption. Mean study drug consumption throughout the entire study was 72%.
The study population consisted of ninety-five per cent Caucasian women. other base-
line characteristics of all participants are given in Table 7.1. hba1c levels were available 
for 94% of all subjects at baseline, 82% after 1 year and 85% after 2.5 years. Mean hba1c 
level for subjects in the placebo group was 39.6 ± 6.9 mmol/mol after 1 year and 39.7 ± 
7.6 mmol/mol after 2.5 years. in the glucosamine group, mean hba1c level was 39.9 ± 
7.4 mmol/mol after 1 year and 39.8 ± 7.2 mmol/mol after 2.5 years. Table 7.2 shows the 
mean hba1c levels throughout the follow-up period, for subjects with and without an 
elevated hba1c level at baseline. in total, 18% of the subjects had a baseline hba1c level 
≥ 42 mmol/mol.
table 7.1. baseline characteristics (mean ± st.dev or percentage)
all
(n = 407)
placebo
(n = 203)
Glucosamine
(n = 204)
bMi (kg/m2) 32.4 ± 4.3 32.5 ± 4.4 32.3 ± 4.1
age (yr.) 55.7 ± 3.2 55.7 ± 3.2 55.7 ± 3.1
Current smoker (% ) 18% 15% 21%
systolic blood pressure (mm hg) 146 ± 22 146 ± 20 147 ± 23
diastolic blood pressure (mm hg) 94 ± 12 93 ± 11 94 ± 12
Total cholesterol  (mmol/l) 6.0 ± 1.1 5.9 ± 1.1 6.1 ± 1.1
hba1c (mmol/mol) 39.7 ± 8.6 39.8 ± 8.2 39.6 ± 9.1
elevated hba1c* (%) 18% 21% 16%
* hba1c level ≥ 42 mmol/mol.
table 7.2. hba1c levels during follow-up for subjects with normal and elevated hba1c level at baseline.
normal baseline hba1c
(< 42 mmol/mol)
elevated baseline hba1c
(≥ 42 mmol/mol)
placebo Glucosamine placebo Glucosamine
Baseline
N (%*) 150 (74%) 156 (76%) 43 (21%) 32 (16%)
hba1c (mmol/mol) 36.7 ± 2.9 37.1 ± 2.8 50.6 ± 11.1 51.6 ± 16.8
1 year
N (%*) 124 (66%) 129 (63%) 34 (17%) 39 (19%)
hba1c (mmol/mol) 37.2 ± 2.8 37.8 ± 3.0 48.1 ± 9.9 48.9 ± 12.9
2.5 years
N (%*) 131 (71%) 136 (66%) 30 (15%) 37 (18%)
hba1c (mmol/mol) 37.3 ± 2.8 37.8 ± 3.7 48.6 ± 12.5 50.2 ± 11.8
*Percentage of subjects that were randomized to placebo/glucosamine sulphate.
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The glucosamine intervention had a non-significant effect on mean hba1c level over 
2.5 years when analysed among all subjects (p = 0.94), and in subjects with a normal (p 
= 0.60) or elevated (p = 0.82) hba1c level at baseline. logistic regression analysis in all 
subjects showed a significant odds ratio of 2.81 (1.12 – 7.04) for glucosamine over pla-
cebo on an elevated hba1c level after 2.5 years, in the adjusted analyses. The interaction 
between the glucosamine intervention and an elevated level of hba1c at baseline on 
attaining an elevated hba1c level at follow-up was not statistically significant (p = 0.43), 
thus the effect was equal for subjects with and without elevated hba1c level at baseline.
Discussion
The present study presents hba1c levels in overweight and obese women during a 2.5 
year placebo controlled intervention using oral glucosamine sulphate. There was no 
effect of glucosamine over placebo on mean hba1c level throughout the follow-up 
period. also within subject with an elevated hba1c level at baseline, no effect of the 
intervention was found on mean hba1c level. We did find a significantly increased risk 
of glucosamine use on attaining an hba1c level ≥ 42 mmol/mol after 2.5 years.
subjects with an hba1c level ≥ 42 mmol/mol have a high risk of developing diabetes 
10. besides, a high hba1c level has a strong predictive value for diabetes complications 9. 
This makes concerns about a possible effect of long-term glucosamine usage on hba1c 
levels a reasonable subject of debate. dostrovsky and co-workers were able to evaluate 
the effects of multiple dosages of glucosamine on glucose metabolism in a total of 172 
subjects out of seven trials 5. due to large heterogeneity, no quantitative analysis could 
be done. out of the systematic review, three of the eligible studies evaluated the glu-
cose metabolism by using hba1c levels 11, 15-16. Mean hba1c levels found in the present 
study were within the range found in these studies. None of the trials found an effect of 
glucosamine usage on mean hba1c levels 11, 15-16. even not in subjects with diagnosed 
diabetes Mellitus Type 2 11. 
all studies that evaluated the effect of glucosamine usage on hba1c levels 11, 15-16, 
including ours, had a reasonable variation within their measurements, troubling the 
comparison of average hba1c levels. We therefore, contrary to the previous studies, 
analysed the effect of the glucosamine intervention on attaining an elevated hba1c 
level after 2.5 years. in subjects randomized to glucosamine sulphate, an oR of 2.81 was 
found for becoming at risk for developing diabetes compared to placebo. although the 
progression to diabetes is rather a continuum rather than a threshold 10, these results do 
suggest that taking glucosamine sulphate for 2.5 years does negatively influence the 
glucose metabolism in middle-aged, overweight females. however, since the present 
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study was not designed to evaluate the effects of long-term glucosamine use on glucose 
metabolism and since attaining an elevated level of hba1c at follow-up does not mean 
that diabetes will develop per se 10, these results need to be confirmed in other studies. 
such studies should, beside hba1c levels, take other diabetes risk factors into account 
as well, in order to make a proper risk profile 9-10 and be able to make final remarks about 
the effect of long-term glucosamine use on glucose metabolism. 
in conclusion, the present study showed that in middle-aged women with a bMi ≥ 
27 kg/m2, a 2.5 year glucosamine sulphate intervention did not affect mean hba1c 
levels compared to placebo. however, a significant oR of 2.81 was found for attaining 
an hba1c level that is internationally marked as ‘high risk for developing diabetes’ for 
glucosamine sulphate over placebo. This is an important finding since at this moment 
the safety profile of glucosamine is considered to contain no notable side effects and is 
even available over the counter.
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abstract
Background: Knee malalignment is shown to be a modifiable factor. it is unsure whether 
it is a risk factor for incident knee osteoarthritis. Present study investigates the associa-
tions between malalignment and incidence of knee oa over a 2.5 year period, within 
351 middle-aged overweight women (bMi ≥ 27 km/m2), free of clinical and radiological 
knee oa at baseline.
methods: Using Generalized estimating equations, associations between valgus and 
varus alignment (compared to neutrally aligned knees) and the incidence of radio-
graphic knee oa (K&l ≥ 2), clinical knee oa (aCR criteria), and medial and lateral joint 
space narrowing (≥ 1.0 mm) was studied. secondary, the interaction between varus and 
valgus alignment and bMi on the separate incidence measures was tested.
results: Varus aligned knees had a significantly increased risk for the development of 
radiographic knee oa (odds ratio 2.8, 95% Ci: 1.3 – 5.9). a significant interaction between 
varus alignment and bMi was found for medial joint space narrowing. among obese 
subjects (bMi ≥ 30 km/m2), an increased odds ratio for varus aligned knees on medial 
joint space narrowing was found (2.6, 95% Ci: 1.1 – 6.3).
Conclusions: Current data suggest that varus alignment might be a target for the pre-
vention of knee oa in middle-aged overweight and obese women.
Malalignment; a possible target for the prevention of knee oa 115
introduction
To reduce medical costs, morbidity, and disability caused by knee osteoarthritis (oa) 
through primary prevention, identification of modifiable risk factors is necessary. exces-
sive body weight has been proposed as a modifiable risk factor for the incidence of knee 
oa 1. The preventive effect of a diet and exercise program on incidence of knee oa in 
middle-aged women was recently assessed in a large RCT (Chapter 4) 2. Whether ma-
lalignment could be regarded as modifiable risk factors for knee oa is subject of debate 
3-4. Malalignment leads to changes in load distribution in the knee joint. Varus alignment 
leads to higher loads on the medial part of the tibiofemoral joint, while valgus alignment 
shifts knee load towards the lateral compartment. With the use of wedged insoles 5-8, 
increased sole stiffness 6, or braces 8-9, the shift in knee joint load can partly be opposed, 
also in joints free of oa. so malalignment can be regarded as a modifiable factor. 
it is unsure whether malalignment is a risk factor for development of knee oa or a 
risk factor for progression of knee oa. studies among healthy subjects showed contra-
dicting results on the relationship between malalignment and incident knee oa 4, 10-12. 
besides, malalignment did not lead to greater cartilage volume reduction 13, and was not 
associated with chondral defect scores 13 or joint space narrowing 14. however, all these 
studies were among healthy people with mainly normal body weight. brouwer et al. 15 
showed that in overweight and especially obese individuals, malalignment significantly 
increased the risk on development of knee oa (odds ratio 2.0 for varus alignment in 
subjects with bMi ≥ 25 and <30 km/m2 and 3.3 and 5.1 for valgus and varus alignment 
in subjects with bMi ≥ 30 km/m2). in subjects with a normal body weight, no association 
between malalignment and incident knee oa was found. it is therefore suggested that 
malalignment can be a risk factor for initiation of knee oa in combination with a high 
bMi. 
brouwer et al. 15 based their results on a large cohort study. however, in order to 
confirm that malalignment can be a target for the prevention of knee oa, the effect of 
malalignment should be confirmed in a target population of subjects at high risk of de-
veloping knee oa. The PRoof study (PRevention of knee osteoarthritis in overweight 
females; Chapter 4 2) offers such a high risk group. hence, the first objective of the cur-
rent study was to evaluate the effect of varus and valgus alignment on the onset of knee 
oa over a 2.5 year follow-up period in a high risk group of middle-aged overweight and 
obese females. The second objective was to evaluate a possible interaction between 
malalignment and bMi (overweight vs. obese) on the incidence of knee oa within the 
given population.
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methods
for this study we used data from the PRoof study (isRCTN 42823086). a description of 
the study protocol can be found elsewhere (Chapter 4) 2, 16. in short, this 2.5 year follow-
up study aimed to evaluate the preventive effect of a diet and exercise program and oral 
glucosamine sulphate (double-blind, placebo controlled) on the initiation of knee oa in 
a 2x2 factorial design. study protocol was approved by the Medical ethical Committee 
of the erasmus MC.
participants
The PRoof study was conducted among a group of subjects without clinical and radio-
logical knee oa, with a high risk of developing knee oa; women with a bMi ≥ 27.0 km/
m2 and between 50 and 60 years of age. in the region of Rotterdam, The Netherlands, 50 
general practitioners sent an information letter about the study, with a reply-card, to all 
women between 50 and 60, without major comorbidities, registered at their practice. a 
total of 6.691 women were contacted. additional information about the study was sent 
to all women who returned the reply-card, indicated they were interested in participat-
ing and had a bMi ≥ 27 kg/m2 (as calculated by the body weight and body length as filled 
in on the reply-card). after several days, all women were contacted by phone to check 
on all inclusion criteria. besides criteria on age and bMi, subjects had to be free of knee 
oa according to the aCR criteria 17, free of contraindications to MRi, free of rheumatic 
diseases, not using a walking aid, not under treatment for knee complaints, master the 
dutch language, and not using oral glucosamine during the past 6 months. all women 
eligible and willing to participate were invited to visit the research institute to sign the 
informed consent and undergo physical examination and radiographs of both knees. 
measurements
at baseline, body weight and height were measured and a standardized semi-flexed Pa 
radiograph of both knees was taken according to the MTP protocol 18. The width of a 
horizontal beam, centred at the tibiofemoral joint space, was adjusted to fit both knees 
on a single image. all subjects filled in a questionnaire that included questions on knee 
complaints, number of days with knee pain. all measurements were repeated after 2.5 
years of follow-up.
Data
Measured body height and weight were used for calculation of bMi and date of birth to 
calculate age. a researcher blinded for clinical outcomes scored all radiographs (baseline 
and follow-up images at once) using the Kellgren & lawrence (K&l) criteria 19. Minimal 
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joint space width was measured digitally in each tibiofemoral compartment, of both 
knees, by two blinded researchers individually, according to the method of lequence 20. 
Minimal joint space width of each compartment was defined as the mean score of both 
assessors. scores with a difference between both readers ≥ 2.0 mm were re-evaluated by 
both readers at a consensus meeting. Medial anatomical knee alignment angle was as-
sessed by digitally determining the angle between the line from the centre of the tibial 
spines through the centre of the femoral shaft at approximately 10 cm from the joint 
margin and the line from centre of the tibial spines through the centre of the tibial shaft 
at approximately 10 cm from the joint margin, since it highly correlates to the mechani-
cal axis of the knee and is well assessable on the knee radiographs 21. anatomical knee 
alignment angles were corrected for offset with mechanical knee alignment angle (4⁰) 
and categorized. anatomical knee alignment angles between 182 and 184 were defined 
as normal, >184 as valgus alignment and <182 as varus alignment 15. Reproducibility of 
K&l grading and anatomical knee alignment assessment was checked after scoring a 
random sample of 20% of all radiographs twice by a second blinded reader.
statistical analyses
The primary outcome measure of the PRoof study was the incidence of knee oa, 
defined as incidence of radiographic knee oa (K&l ≥ 2), clinical knee oa (clinical 
and radiographic aCR criteria 17), or medial or lateral joint space narrowing ≥ 1.0 mm 
(Chapter 4) 2. Using Generalized estimating equations (Gee), which takes into account 
the correlation between two knees within subjects, the relation between varus/valgus 
alignment and the onset of knee oa according to the primary outcome measure and 
for all three items separately was determined. Neutrally aligned knees constituted as 
reference group in all analyses. To study possible different effects within subgroups of 
bMi, the interaction between malalignment and bMi was also studied, by adding bMi at 
baseline and the interaction term between malalignment and bMi at baseline to the Gee 
in a separate analysis. The associations between malalignment and incident knee oa 
were determined for overweight (bMi < 30 kg/m2) and obese (bMi ≥ 30 kg/m2) women 
separately, for the outcome measures that showed a significant interaction with bMi. all 
analyses were adjusted for K&l grade at baseline (as in the original trial; Chapter 4 2) and 
the randomized groups of both interventions of the PRoof study. a p value < 0.05 was 
considered as statistically significant. all statistical tests were performed using sPss 20.0 
(Chicago, il) and were presented as odds ratio (oR) with corresponding 95% confidence 
intervals (Cis).
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results
both knees from all 351 subjects with baseline knee alignment data and incidence mea-
sures at follow-up available were selected (86% of all subjects of the PRoof study). bMi 
at baseline was significantly lower (32.3 ± 4.1 vs. 33.1 ± 5.0 kg/m2; p = 0.05) and medial 
joint space width significantly higher (4.8 ± 0.8 vs. 4.6 ± 0.7 mm; p = 0.01) in the selected 
subjects compared to those with incomplete data.
Valgus alignment was found in 13% and varus alignment in 40% of all knees. baseline 
characteristics are given in Table 8.1. at baseline, the percentage of K&l grade ≥ 1 and 
the mean lateral minimal joint space width were significantly higher in the varus aligned 
knees. The mean medial minimal joint space width was significantly lower in the varus 
aligned knees. Tests for reproducibility showed moderate agreement for K&l grade 
(kappa 0.6), and good agreement for alignment (kappa 0.7) and minimal joint space 
width (kappa 0.7).
for the primary outcome measure, no significant effects of varus (23% incidence) 
or valgus alignment (21% incidence) were found, compared to neutral aligned knees 
(16% incidence). a significant interaction with bMi was found (p < 0.01) for the pri-
mary outcome measure. Within obese, a significantly increased oR was found for varus 
aligned knees (incidence 26% vs. 15% in neutral aligned knees; oR 1.8, 95% Ci 1.1 – 3.1). 
Radiographic knee oa (K&l ≥ 2) was found in 9% of all varus knees and 6% of all valgus 
knees at follow-up. in neutrally aligned knees, only 3% incidence of radiographic knee 
oa was found. only varus aligned knees had a significant oR (2.8, 95% Ci 1.3 – 5.9) for 
the incidence of radiographic knee oa at follow-up. No significant interaction between 
incidence of radiographic knee oa and bMi was found. Varus aligned knees had a higher 
incidence of clinical knee oa (8%) compared to valgus (3%) and neutral aligned knees 
(6%), but these differences did not reach statistical significance. No interaction between 
table 8.1. baseline characteristics.
all
(n = 702)
neutrally aligned 
knees (n = 334)
varus aligned knees 
(n = 279)
valgus aligned 
knees (n = 89)
age (yr.) 55.7 ± 3.2 56.0 ± 3.1 55.5 ± 3.3 55.5 ± 3.2
bMi (kg/m2) 32.3 ± 4.1 32.2 ± 3.8 32.3 ± 4.5 32.3 ± 4.3
K&l grade ≥ 1 50 % 46% 56% 44%
Mild symptoms (yes) 31% 31% 32% 30%
history of knee injury (yes) 14% 12% 15% 18%
Minimal medial JsW (mm) 4.8 ± 0.8 4.9 ± 0.7 4.6 ± 0.9 5.0 ± 0.8
Minimal lateral JsW (mm) 6.2 ± 1.1 6.1 ± 1.0 6.4 ± 1.1 5.8 ± 1.0
all values are calculated on knee level. Neutral: medial anatomical knee angles 182˚ - 184˚. Varus: medial 
anatomical knee angles <182˚. Valgus: medial anatomical knee angles >184˚. JsW: joint space width. 
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malalignment and bMi was found for the onset of clinical knee oa. Malalignment had 
no significant effect on the incidence of medial or lateral joint space narrowing. only 
for varus alignment and medial joint space narrowing, a significant interaction with bMi 
was found (p < 0.01). Varus aligned knees were significantly associated with medial joint 
space narrowing (incidence 9% vs. 4% in neutral aligned knees; oR 2.6, 95% Ci 1.1 – 6.3). 
see Table 8.2 for full details.
Discussion
since knee malalignment is a modifiable factor and related to knee loading, its role in 
the onset of knee oa is important in the search for modifiable risk factors for the disease. 
our study shows that among middle-aged women, free of knee clinical and radiographic 
knee oa at baseline, varus alignment is associated with a significant increase in the inci-
dence of radiographic knee oa, compared to neutrally aligned knees. in obese subjects, 
varus alignment also showed a significant increase in medial joint space narrowing. 
Contrary to previous studies, our population was recruited for a preventive trial in a 
clinical setting. This makes results highly representative for a possible target population 
selected for a preventive intervention; for instance by counter acting the malalignment.
in the present study, knee alignment was measured on short-limb radiographs. This 
is a validated measurement of static knee alignment 21, especially in large studies with 
a wide variety of alignment angles 22. definitions of malalignment on the other hand 
are less undisputed. for comparison, we used definitions of varus and valgus alignment 
by brouwer et al. 15. Probably due to a higher baseline bMi in our study, knee alignment 
was shifted towards varus alignment (see figure 8.1). data from Niu et al. confirm that 
a shift towards varus alignment is seen in obese non-oa subjects 23. The applied offset 
correction of 4° in the present study is within ranges of suggested correction from ana-
tomical to mechanical axis of 3 to 6 degrees 21-22, 24-26. Nevertheless, alignment measured 
on radiographs is a static representation of knee alignment and does not fully represent 
dynamic loads on the tibiofemoral joint 23, 27.
Malalignment can partly be opposed by non-surgical interventions. although mainly 
studied in subjects with knee oa 28-29, bracing also has shown to be effective in reducing 
peak knee adduction moment and angular impulse during walking in healthy subjects 
with varus aligned knees 9. also, full-length wedged insoles have been proven to alter 
knee joint load in healthy subjects 7. Whether these interventions have a preventive 
effect on the development of knee oa has never been studied. before designing such 
a trial, efficacy and effectiveness of both interventions should be determined in the 
target population, since conflicting results have been found in different populations 28-29. 
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in a direct comparison of the biomechanical effects of valgus knee brace and lateral 
wedged insoles in a study among subjects with knee oa, Jones et al. 8 showed that 
both interventions reduced medial knee joint load. however, the effects of the wedged 
insoles were significantly greater than the knee brace. Moreover, and very important 
when administering a preventive intervention, all participants preferred the wedged 
insole intervention over the knee brace at the end of the trial. since adherence to the 
intervention will be an important issue when prescribing an active measure to healthy 
subjects in order to prevent future disease, subjects’ preferences will be very important.
The association between varus alignment and obesity on the one hand and the inci-
dence of knee oa on the other hand, as found in the present study, might be mediated by 
meniscal extrusion. since both varus alignment and obesity are associated with a higher 
prevalence of meniscal extrusion 30-31. in subjects with K&l grade < 2 at baseline, Madan-
sharma and co-workers 32 showed that subjects with meniscal extrusion had higher 
rates of joint space narrowing over the subsequent two years. other studies also showed 
associations between meniscal extrusion and knee oa features 30-31. Whether interven-
tions like braces or wedged insoles can counteract the initiated processes by the existing 
meniscal extrusion and, over time delay or prevent knee oa has never been studied. 
figure 8.1. histogram of medial anatomical knee angles.
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The combined knee oa outcome measure was adopted from the original PRoof 
study. in order to make a preventive randomized trial feasible over a relative short 
follow-up time, the incidence of radiographic knee oa, clinical knee oa and joint space 
narrowing were combined into one measure. hence, the present results are based on 
secondary analyses. a longer follow-up duration and more sensitive measures (e.g. MRi) 
would provide more detailed information about the association between malalignment 
and incidence of knee oa.
in conclusion, our study showed a significant association between varus alignment 
and incidence of radiographic knee oa after 2.5 years in middle-aged women. among 
obese women, varus aligned knees also had a significant increased risk for joint space 
narrowing. Contrary to previous studies on the association between malalignment and 
incidence of knee oa that focused mainly on large cohorts, this study shows that, within 
a relatively easy obtainable population, varus alignment is a risk factor for incident knee 
oa. since varus alignment is a modifiable factor, results from the present study suggest 
that varus alignment might be a target for the prevention of knee oa in middle-aged 
obese women.
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excessive body weight is one of the strongest and most prevalent risk factors for the 
development of knee osteoarthritis (oa). The worldwide prevalence of obesity has 
nearly doubled between 1980 and 2008 and is still rising. The World health organization 
estimates 35% of all adults to be overweight and more than 12% to be obese 1. Given the 
burden for patients and the high medical costs associated with knee oa, this shows the 
importance of full understanding of the role of overweight and obesity in the develop-
ment of the disease.
main findings
This thesis focuses on the development and prevention of knee oa and the role of 
overweight and obesity on these two domains. in Chapter 2, we saw that with only 12 
eligible studies, relative little research has been done on the biomechanical differences 
between normal-weight and obese individuals during every day movements; despite 
the fact that the mechanical effects of excessive body weight have long been regarded 
as the main factor in the development of knee oa in overweight and obese individuals. 
This systematic review shows that obese individuals alter their movement strategies 
during every day movements and provides indications on how these alterations might 
be involved in the onset of knee oa.
The explorative analyses in Chapter 3 show that, in women free of radiological signs 
of knee oa, alterations in the shape of the femur and tibia are present across the whole 
range of the body mass index (bMi). however, in subjects with a bMi ≥ 27 kg/m2, certain 
shape variations in the tibia are related to early signs of knee oa, as seen on magnetic 
resonance imaging (MRi). on the other hand, also a causal path from a high bMi to knee 
joint shape alterations, leading to early signs of knee oa, was suggested from the shape 
models. These data add to the knowledge of the association between a high body weight 
and the development of knee oa, but still no conclusive evidence for the mechanism 
behind this association is provided.
The core data of this thesis are derived from the first ever preventive trial in oa research; 
the PRoof study. Two interventions, a diet & exercise program and oral glucosamine 
sulphate, were tested for their preventive effects on knee oa in a high risk group of 
overweight and obese, middle-aged women. both interventions showed non-significant 
trends towards a preventive effect, but these analyses are hampered by the unexpected 
interaction between the two interventions (Chapter 4). The diet & exercise intervention 
is analysed in more detail in Chapter 5. despite the low compliance, the intervention 
resulted in clinically relevant weight loss in the intervention group within the first year. 
When the clinically relevant weight loss was present after 2.5 years, regardless of the 
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allocation to the diet & exercise program or the control group, significant preventive 
effects were found on the incidence of knee oa (Chapter 6). a longer follow-up period 
is needed to see whether the number of prevented cases of knee oa after such weight 
loss can become clinically relevant.
despite the fact that oral glucosamine sulphate is generally regarded as a safe supple-
ment, Chapter 7 shows that this opinion might have to be reconsidered for overweight 
and obese individuals. subjects randomized to the active treatment had increased risk 
of becoming at ‘high risk for developing diabetes’ compared to the placebo group.
Chapter 8 shows that in the high-risk group selected for the PRoof study, varus align-
ment of the knee joint also puts subjects at increased risk for developing knee oa over a 
relatively short time and that this effect is even stronger in those with a bMi ≥ 30 kg/m2 
compared to those with a bMi between 27 and 30 kg/m2, for several outcome measures. 
Development of knee osteoarthritis
for decades, the negative effects of a high bMi on the incidence of knee oa are known. 
increased loading of the knee joint due to the excessive body weight has long been 
regarded as the main factor behind this association. The possible inflammatory aspects 
involved in the onset of knee oa are only recognised in recent years. 
Biomechanics
The results of the systematic review presented in Chapter 2 give some indications of the 
biomechanical aspects of obesity in relation to the development of knee oa. however, 
there is a methodological drawback in the included studies. all eligible studies used 
surface markers which suffer from relative large measurement errors due to movement 
of the skin relative to the bone, especially with large subcutaneous fat mass, as in obese. 
Compared to bone embedded markers, the average rotational error of surface markers 
ranged between 2.4° and 4.4° and the translational error between 3.3 and 13.0 mm during 
the stance phase in walking normal-weight individuals 2. for evaluation of the flexion/
extension patterns, these measurement errors might be within acceptable limits, but for 
exo-/endorotation and ab-/adduction patterns, such errors form a substantial propor-
tion of the total range of movement in these directions. Given the small magnitude of 
the translational movements within the knee joint, more sophisticated measurement 
techniques are required to study the effects of obesity on knee joint biomechanics and 
reveal (or rule out) how biomechanical alterations are linked to the aetiology of knee oa. 
fortunately, high-speed biplane radiography and comparable techniques are optimized 
for clinical research. With measurements errors of only 0.6° and 0.5 mm on average 3, 
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these techniques should provide valid data on knee biomechanics in obese individuals 
in future studies.
an important structure in the weight-bearing capacity and stability of the knee 
joint are the menisci. in contrast to conventional radiographs, menisci can nowadays 
be visualized and assessed on pathologies with the use of MRi. in recent years, it was 
shown that meniscal extrusion is an independent risk factor for the development of 
knee oa 4. it is very well possible that meniscal extrusion is the factor behind the as-
sociation between malalignment and increased knee oa development, as was indicated 
in Chapter 8. since both malalignment and obesity are associated to meniscal extrusion 
4-5, meniscal extrusion might be the mediating biomechanical factor in the relationship 
between obesity, malalignment and incident knee oa. Preliminary data from the MRi 
acquisition of the PRoof study give some support for this hypothesis; almost half of 
all knees showed extrusion (≥ 2.0 mm) of the body of the medial or lateral meniscus at 
baseline. This will probably be a factor in the subsequent development of knee oa, but 
the exact aetiology within the development of knee oa is unknown. further studies 
should be undertaken to work out the exact role of meniscal extrusion in the oa process 
and to formally test the mediating effect of meniscal extrusion in the association be-
tween obesity and the development of knee oa and for the association of malalignment 
and knee oa.
Throughout this thesis, as in the fast majority of the current literature, bMi is regarded 
as a valid surrogate measure of body fat. even though it does not discriminate between 
muscle mass and fat mass, which are inversely related to knee oa. for instance, lower 
M. Quadriceps strength, which is equivalent to lower muscle mass, was associated to 
incident knee oa, lower cartilage volume, and a decrease of cartilage volume over time, 
while the same holds for a higher body fat measures 6-7. for example, interestingly, thigh 
total fat and thigh subcutaneous fat measures were significantly associated with com-
pressive knee forces, anterior-posterior shear forces and patellofemoral compressive 
forces during walking in oa patients, adjusted for bMi 8. Unfortunately, this has never 
been studied in a high-risk non-oa population, but it shows that local fat masses are 
associated to increased loading of the knee joint independent of bMi. so, more precise 
measures of body fat distribution and muscle mass seem favourable over bMi when 
studying the association between body weight and knee oa development.
inflammation
besides the biomechanical aspects of overweight and obesity, recent focus has been di-
rected to the systemic effects of surplus fat mass on oa development. since obesity was 
also shown to increase the risk for oa in non-weight-bearing joints, biomechanical fac-
tors alone are thought to be insufficient to fully explain the relation between obesity and 
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knee oa development 9. in a recent review article, issa and co-workers neatly describe 
the inflammatory aspects of adipose tissue and its possible role in the development of 
knee oa 10. adipose tissue excretes a decent amount of pro-inflammatory cytokines, 
often called adipokines. Many of these adipokines have been shown to mediate syno-
vial tissue inflammation and induce cartilage degradation. besides, cartilage subject to 
mechanical load also activates signalling pathways that promote tissue homeostasis 
by balancing the production of anabolic growth factors and catabolic cytokines and 
pro-inflammatory mediators. With increased loading due to overweight and obesity, 
pro-inflammatory mediators are highly expressed and will unfavourably disbalance the 
homeostasis, which eventually leads to tissue breakdown. on the other hand, inflam-
matory processes are also presumed to cause pain sensitization. This increases the 
degree and duration of pain after a stimulus 11. so besides the structural aspect of knee 
oa, surplus fat mass may also affect the sensation of pain disadvantageously through 
inflammatory processes, causing en aggravating complaints related to knee oa. 
These inflammatory processes associated with overweight and obesity are only recog-
nized over the last years, but are now generally accepted despite the fact that they are 
not fully understood and not all details of the process are available yet. 
Most likely, the alterations in shape of the femur and tibia shown in Chapter 3 are 
partly caused by inflammatory processes. several upregulated factors in overweight and 
obese individuals are also known to stimulate bone remodelling by osteophyte forma-
tion 12-13. so possibly, due to the low grade chronic inflammation associated with surplus 
fat mass in overweight and obese individuals, alterations of the shape of the femur and 
tibia take place. as shown in Chapter 3, several of the alterations to the tibia might play 
a role in the development on knee oa, since they are associated to early oa signs as 
seen on MRi. also the biomechanical alterations found in obese individuals shown in 
Chapter 2 might have an underlying inflammatory aspect. inflammation and effusion 
of the knee joint often co-exist 14. Recently, effusion of the knee joint was shown to alter 
gait biomechanics 15. again, this was only measured in knee oa patients. hereby the 
biomechanical effects are possibly greater that in non-oa subjects, since inflammatory 
processes are more active in oa knees, but it would be very interesting to study the 
presence and effects of knee joint effusion in overweight and obese individuals and the 
accompanied effects on joint biomechanics.
altogether, a better understanding in the inflammatory processes expressed in over-
weight and obese individuals and their involvement in the development in knee oa 
will be necessary to fully understand the increased risk for knee oa development in 
overweight and obese individuals.
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prevention of knee osteoarthritis
after decades of studies on the aetiology, risk factors and progression of knee oa, the 
time was right to take the next step in oa research and, for the first time, focus on the 
prevention of the disease.
the proof study
besides the presented and discussed results in Chapters 4 – 8, the PRoof study holds 
some value information on the preventive possibilities within a high-risk group of over-
weight and obese, middle-aged women. for instance, despite the fact that all women 
were free of clinical knee oa (according to the aCR criteria) and thus could not experi-
ence any direct beneficial effects of the offered interventions, most were willing to stay 
in the trial over relative long period of 2.5 years, as shown by the lost to follow-up figure 
of only 10%. besides, also without a possible direct advantageous effect, compliance to 
the glucosamine and placebo was relatively high. a systematic review on medication 
adherence in a wide variety of complaints across 569 studies revealed an overall average 
of 75%, ranging from 5 to 100% 16. With an average compliance to the supplements of 
72% in the PRoof study, compliance can be considered as very good given the lack of 
complaints at baseline and the relative long follow-up period. Unfortunately, compli-
ance to the diet & exercise program lagged behind. We will discuss this issue elsewhere 
in this chapter. despite the latter, the overall conclusion of the PRoof study is that a 
high-risk group of overweight and obese, middle-aged women is highly suitable for the 
long-term evaluation of preventive measures in knee oa.
at baseline, the inclusion of the knees in the PRoof study was not limited to K&l 
grade 0, even though it was suggested that knees with ‘doubtful oa’ at radiographs 
(equivalent to K&l grade 1) will probably have early oa and true prevention can thus 
not be established 17. however, limiting included knees to those with K&l grade 0 in 
this high-risk group of subjects would probably have led to inclusion of many knees 
unsusceptible to the oa process 18. data from the PRoof study did show that indeed 
knees with K&l grade 1 at baseline probably already have an early form of oa. one 
in five knees with K&l grade 1 at baseline showed incident knee oa according to the 
primary outcome measure, while only one in ten knees with K&l grade 0 did so. for 
incidence of K&l grade 2 after 2.5 years of follow-up, baseline K&l grade 1 even had a 
four-time higher incidence compared to the knees with K&l grade 0 (8% vs. 2%). despite 
the higher incidence rates of the knees with radiologic signs of knee oa, it seemed that, 
also within these knees, the preventive measure had their effect; within the knees show-
ing incident knee oa, the proportions of baseline K&l grades 0 and 1 did vary between 
randomized groups. This suggests that both stages of the disease can be prevented. 
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however, present incidence rates will require a longer follow-up to test this statement 
statistically.
Compared to other oa studies, the cut-off for incidence of joint space narrowing (JsN) 
of ≥ 1.0 mm was fairly conservative. When designing the PRoof study, it was assumed 
that a lower cut-off would not be clinically relevant given the healthy status at baseline 
of the included knees. We now can reflect on this assumption. indeed, the overlap be-
tween the number of knees with incident JsN and the number of knees with incident 
oa according to the other two items of the primary outcome measure drops with 31% 
to 50% when the cut-off is set at ≥ 0.5 mm, as common in other studies where it is 
used to define progression among subjects with already evident knee oa. as known, the 
overlap between JsN, K&l ≥ 2 and the aCR criteria is only modest 19, but this substantial 
drop in overlap seems to segregate the items of the primary outcome measure into 
measures of a completely different stage and aspects of the disease. one could highly 
question the clinical relevance of such measures.
Diet & exercise program
designing a weight loss intervention for overweight and obese individuals is a complex 
matter. When designing the PRoof study, a simple and pragmatic intervention was put 
together that met the criteria for a successful weight loss program; a tailor made design 
and the use of Motivational interviewing. as described in Chapter 5, these two features 
were indicated as superior to other designs for long-term weight loss. Given the strong 
preference of the subjects at baseline for the intervention group over the control group 
(nearly 90% stated to have a preference for the active group) and the overall compli-
ance figure of only 28%, one could argue that the diet & exercise program was not very 
successful. however, perhaps the offered interventions (diet counselling and physical 
activity classes) were not diverse enough. With 51% compliance to the dietician and 
57% to the physical exercise classes, both interventions separately were reasonably well 
conducted by the participants. The combination of these two interventions did not seem 
to be a great success for the fast majority of the subjects in the intervention group, given 
the compliance figure. based on the results of the PRoof study, it is possible to think 
of other intervention strategies that might be effective and could be combined with 
either the diet & exercise program and/or the diet counselling; for instance education. 
at baseline, subjects were asked to rate their general health status on a visual analogue 
scale from 0 to 100, where 100 was the best possible and 0 the worst possible health 
status. despite a mean bMi over 32 kg/m2, 66% of the subjects being obese, and almost 
one out of four having severe obesity (bMi ≥ 35 kg/m2), 89% of all subjects rated their 
general health status to be 70 or higher and even 69% as 80 or higher. it seems that 
this population of middle-aged women should be educated on the negative effects of 
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overweight and obesity on general health, in order to make them aware of the urge of 
weight loss. Without this knowledge, it is not so surprising that compliance figure remain 
below the level one would expect given the body weight figures within this population. 
besides, incorporating family members into the interventions would probably increase 
compliance figures. social support is a known key factor for lifestyle changes and, most 
of the time, households share unhealthy lifestyles 20. 
Glucosamine sulphate
despite numerous studies, the mechanism of action and the effectiveness of glucos-
amine in oa is still subject of debate. Results presented in Chapter 4 will not settle the 
discussion. The interaction with the diet & exercise program and the effects of glucos-
amine on the hba1c level (Chapter 7) will possible even provoke new discussions. as 
stated, there are some hypotheses on the mechanism of action of the found interaction 
(Chapter 4). however, most of the studies that provide such hypotheses did not study 
the biochemical mechanisms associated with this interaction, but only provide indirect 
indications 21-22. Given the strong interaction found in the PRoof study, the biochemical 
mechanisms involved in physical exercise and glucosamine synthesis should receive 
further attention.
in previous studies it was suggested that glucosamine sulphate would be most ef-
fective in an early stage of the disease 23. overall, glucosamine sulphate is thought not 
to rebuild damaged cartilage, but would slow down cartilage degradation processes 24. 
The items of the primary outcome measure involving articular cartilage (K&l ≥ 2 and 
JsN ≥ 1.0 mm) required relative large reductions in articular cartilage before they are 
marked as incident and are therefore relatively insensitive. despite this, a substantial, 
but not statistically significant, reduction in odds ratio for incident knee oa was found 
in the glucosamine sulphate group. Possibly, the more sensitive data of the MRi acquisi-
tion will provide further insight in the preventive effects of glucosamine sulphate over 
placebo. Moreover, since the MRi acquisition covers multiple tissue pathologies in the 
knee joint that are known to be involved in the oa process, such as cartilage defects, 
hoffa synovitis, synovial effusion, and bone marrow lesions, the effects of glucosamine 
sulphate on cartilage maintenance and as anti-inflammatory factor can be evaluated.  
Clinical implications
The PRoof study is the first ever trial on the prevention of oa worldwide. future preven-
tive studies should learn from results presented throughout this thesis, such as issues on 
the inclusion of subjects, subject’s compliance to the interventions, choice of outcome 
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measures, and incidence figures. for the design of the PRoof study, some assumptions 
were made. one such assumption, that there would be no interaction between the diet 
& exercise program and the glucosamine intervention, proved to be wrong and had ma-
jor consequences for the direct clinical implications of the trial. due to the unexpected 
interaction, the power of the trial was insufficient. Therefore, no firm statements on the 
effectiveness of the studied interventions can be given. however, given the indications 
for a possible preventive effect within the subjects compliant to the diet & exercise 
program (Chapter 4) and the effects of substantial weight loss on incidence figures and 
certain health measures (Chapter 6), the current thesis will provide general practitioners 
with more evidence to inform and convince overweight or obese middle-aged women 
of the need for weight loss. Until further details on the effectiveness of glucosamine 
sulphate are studied, there is no need to preventively prescribe glucosamine sulphate to 
overweight or obese middle-aged women. especially considering the number of (mild) 
side effects associated with the studied supplements (glucosamine and placebo, Chap-
ter 4) and the possible negative effects of glucosamine sulphate on the blood glucose 
levels after 2.5 years (Chapter 7).
future studies
some future studies are already mentioned throughout this chapter and are thus not 
reconsidered here (e.g. highly accurate movement analyses within obese, the role of 
meniscal extrusion, body composition rather than bMi as measure of joint load, the 
inflammatory aspects of surplus fat mass on radiological and clinical oa development). 
however, there are some remarks left on future studies that deserve attention. 
With the extensive knowledge on the development of oa and given the positive 
results of the PRoof study on the feasibility of a preventive trial in a high-risk popula-
tion, at least for the knee and hip joint, future preventive trials should be considered. To 
gather a more detailed insight in the development of knee oa and on the preventive 
effects of the studied interventions within the PRoof study, MRi data (baseline and 
follow-up) and inflammatory and metabolic markers from urine and serum samples will 
be studied at short notice.
With better (higher magnetic field) and new MRi techniques (e.g. dGeMRiC, T1rho, 
and T2 mapping) becoming available for scientific research, visualization of knee joint 
pathologies improves, well before oa has developed in a patient. eventually, these tech-
niques can help identifying pathologies which are important in the development of knee 
oa. after identification, the exact mechanisms causing the pathologies and its timing in 
the subsequent knee oa development should be studied. hereafter, new preventive 
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measures can be developed and hopefully more individuals can be retained from the 
pain, disability, and costs associated with knee oa. in order to optimize the treatment 
(both preventive and symptomatic) of knee oa, MRi has another important role in future 
studies. in the traditional radiographic definitions of knee oa, the patellofemoral joint 
is completely neglected. only in the aCR-criteria, crepitus of the patella is considered. 
No wonder that scores of knee pain and function in subjects with and without radiologi-
cal knee oa do not correlate too well with radiological features of knee oa. obviously, 
individuals rating their knee complaint will include the patellofemoral joint, while the 
radiological assessment only focusses on the tibiofemoral joint. With the use of MRi, 
that can visualize the whole knee joint, the role of patellofemoral pathologies in the 
development of both clinical and radiological knee oa should be unravelled. Treatment 
of a patient with or at high risk for knee oa should involve both the tibiofemoral and 
patellofemoral joint. We therefore also have to examine the preventive effects of the 
interventions evaluated in the PRoof study on the patellofemoral joint and explore the 
role of the presence and development of abnormalities in the patellofemoral joint on 
the development of knee complaints.
as indicated earlier, the content of the weight loss intervention should be optimized 
further to increase compliance and weight loss figures. beside the already proposed 
additions of education and the involvement of family members, some other interesting 
elements have been reported after designing the diet & exercise intervention of the 
PRoof study. Wluka and co-workers 25 recently listed a couple; telephone consultation 
resulted in 3 to 5 kg weight loss over 6 months. additionally, mobile text messages, mail, 
and internet-based programs showed positive results and gain more popularity. 
in subjects without knee oa, increased joint load due to regular moderate physical ac-
tivity is known to have positive effects on joint health, as long as injuries are prevented. 
however, the mechanism behind the positive effects is unknown and hence, the content 
of the physical exercise classes as incorporated in the PRoof study was optimized based 
on assumptions rather than on knowledge. it is known that muscle contractions pro-
voke a strong anti-inflammatory response 26, but it is unknown whether this temporary 
effect plays a role in the oa process. Without knowledge on the mechanism of action, 
it is hardly possible to optimize physical exercise interventions for future studies on the 
prevention of knee oa. 
other populations could also be considered for future preventive studies on knee oa. 
although not so highly prevalent on a population level, knee injuries form a very strong 
risk factor for subsequent knee oa development. after knee joint injury, increased load 
on the joint, either by a high bMi or provoked by high impact sports, is known to induce 
fast development of knee oa 27. as soon as the exact aetiology of post-traumatic knee oa 
development is unravelled (studies are underway, e.g. after aCl rupture 28), preventive 
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measures could be designed and tested. of course, it would be even better to prevent 
the actual knee injury to occur. since effective training protocols exist for the prevention 
of knee injuries within athletes (especially for girls/women) of high-risk contact sports 
(e.g. 29-30), more attention should be paid to the implementation of these protocols. 
finally, as indicated in Chapter 8, malalignment might be regarded as a modifiable risk 
factor for knee oa, especially in obese subjects. future studies should be undertaken to 
confirm effects of insoles or braces on knee malalignment within obese subjects free of 
knee oa, in order to make a new preventive trial in oa possible.
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appendix to Chapter 2
specification of used search strategy. 
(foot oR knee oR hip oR ankle oR “lower extremity” oR “lower limb*”) aNd (biomec* oR 
mechanic* oR kinemat* oR kinetic* oR dynamic* oR force* oR moment* oR torque* 
oR power* oR load* oR *strength oR angle*) aNd (gait oR *walking oR sit-to-stand oR 
*stairs oR standing oR stance oR locomotion oR rising oR movement oR activity oR 
exercise oR physical oR posture) aNd (overweight oR obes* oR “body mass index” oR 
bMi). limits: human, all adult, title/abstract 
limiting the search strategy to title/abstract did not lead to eligible study being over-
looked. This was checked in an earlier stage of the review process with an earlier version 
of the search strategy.
table a2.1. spatial and temporal variables in obese compared to normal-weight subjects in studies on 
gait at a self-selected velocity.
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lai et al. - - 0 + +
segal et al. - / - a
de souza et al. - - - +
spyropoulos et al. - - + - 0 0 +
Vismara et al. - - 0 + -
Russell et al. - / - b - / 0 b 0 / 0 b
+: significantly higher in obese. -: significantly lower in obese. 0: no differences. a in central obese / lower 
obese. b on overground / treadmill. bh: body height.
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table a2.2. spatial and temporal variables in obese compared to normal-weight subjects in studies on 
gait at a standardized velocity.
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browning and Kram
0.50 m/s 0 0 + + +
0.75 m/s 0 0 + + +
1.00 m/s 0 0 + + +
1.25 m/s 0 0 + + 0
1.50 m/s 0 0 + + +
1.75 m/s 0 0 + + +
deVita and hortobagyi 1.5 m/s 0 0 +
Messier 0.893 m/s
Vismara et al. 0.833 m/s + + +
+: significantly higher in obese. -: significantly lower in obese. 0: no differences.
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table a2.3. angular differences between obese and normal-weight subjects in studies on gait at a self-
selected velocity.
hip joint       
flexion abduction exorotation
Vismara et al.
  weight 
initial 
contact            
stance  acceptance
loading 
response
phase single limb mid stance 0 a
  support
terminal 
stance
  pre swing
spyropoulos et al.
  weight 
initial 
contact 0 0 0
stance  acceptance
loading 
response 0 0 0
phase single limb mid stance 0 0 / 0 b +
  support
terminal 
stance 0 +
  pre swing 0 +
lai et al.
  weight 
initial 
contact
stance  acceptance
loading 
response 0 0 0
phase single limb mid stance 0 0 / 0 b 0 0 / 0 b 0 0 / 0 b
  support
terminal 
stance 0 - 0
  pre swing 0 - 0
+: significantly higher in obese. -: significantly lower in obese. 0: no differences. a total range of motion. b 
minimal / maximal angles.
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table a2.3. angular differences between obese and normal-weight subjects in studies on gait at a self-
selected velocity. (Continued)
Knee joint  
flexion abduction exorotation
Vismara et al.
  weight 
initial 
contact             
stance acceptance
loading 
response
phase single limb mid stance 0 a
  support
terminal 
stance
    pre swing
spyropoulos et al.
  weight 
initial 
contact 0
stance acceptance
loading 
response 0
phase single limb mid stance 0 0 b
  support
terminal 
stance 0
    pre swing 0
lai et al.
  weight 
initial 
contact
stance acceptance
loading 
response 0 0 0
phase single limb mid stance 0 0 / 0 c 0 - / 0 c 0 0 / 0 c
  support
terminal 
stance 0 0 0
  pre swing 0 0
+: significant higher in obese. -: significant lower in obese. 0: no differences. a total range of motion. 
b maximal angle. c minimal / maximal angle.
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table a2.3. angular differences between obese and normal-weight subjects in studies on gait at a self-
selected velocity. (Continued)
anKle joint
plantar flexion eversion toe-out angle
Vismara et al.
  weight 
initial 
contact          
stance acceptance
loading 
response
phase single limb mid stance 0 / 0 a +
  support
terminal 
stance
    pre swing
spyropoulos et al.
  weight 
initial 
contact 0
stance acceptance
loading 
response -
phase single limb mid stance - + / + c
  support
terminal 
stance -
    pre swing -
lai et al.
  weight 
initial 
contact
stance acceptance
loading 
response 0 0
phase single limb mid stance 0 0 / 0 d + 0 / + d
  support
terminal 
stance 0 +
    pre swing 0 +
de souza et al.
  weight 
initial 
contact
stance acceptance
loading 
response
phase single limb mid stance +
  support
terminal 
stance
    pre swing
+: significantly higher in obese. -: significantly lower in obese. 0: no differences. a total range of motion 
/ maximal angle. b total range of motion. c maximal plantar / dorsi flexion angles. d minimal / maximal 
angles.
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table a2.6. Kinetic differences between obese and normal-weight subjects on gait at standardized 
velocity.
hip joint extension
absolute (Nm) relative (Nm/kg)
browning and Kram
0.50 m/s + 0
0.75 m/s 0 0
stance 1.00 m/s + 0
phase 1.25 m/s + 0
1.50 m/s + 0
1.75 m/s + 0
deVita and hortobagyi 0
stance 1.5 m/s
phase
Knee joint extension adduction
absolute (Nm) relative (Nm/kg) absolute (Nm)
browning and Kram
0.50 m/s 0 0 0
0.75 m/s 0 0 +
stance 1.00 m/s 0 0 0
phase 1.25 m/s 0 0 +
1.50 m/s 0 0 +
1.75 m/s + 0 0
browning and Kram
0.50 m/s 0 0 0
0.75 m/s 0 0 +
stance 1.00 m/s 0 0 0
phase 1.25 m/s 0 0 +
1.50 m/s 0 0 +
1.75 m/s + 0 0
deVita and hortobagyi 0 -
stance 1.5 m/s
phase
+: significantly higher in obese. -: significantly lower in obese. 0: no differences.
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table a2.6. Kinetic differences between obese and normal-weight subjects on gait at standardized 
velocity. (Continued)
anKle joint plantar flexion
absolute (Nm) relative (Nm/kg)
browning and Kram
0.50 m/s 0 -
0.75 m/s 0 -
stance 1.00 m/s 0 -
phase 1.25 m/s 0 -
1.50 m/s 0 -
1.75 m/s 0 -
deVita and hortobagyi +
stance 1.5 m/s
phase
+: significantly higher in obese. -: significantly lower in obese. 0: no differences.
table a2.7. differences between obese and normal-weight subjects on sit-to-stand movement.
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Galli et al. - - - + ?
sibella et al. + - - + ?
+: significantly higher in obese. -: significantly lower in obese. 0: no differences. ?: unknown.
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appendix to Chapter 4
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figure a4.1. Mean quality of life (euroQol) scores within randomized intervention groups.
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figure a4.2. Mean WoMaC pain scores (range 0 – 100; higher scores mean more pain) within randomized 
intervention groups.
appendices 159
30 months24 months18 months12 months6 months0 months
M
ea
n 
± 
st
an
da
rd
 e
rr
or
12
10
8
6
4
DEP intervention / glucosamine
DEP intervention / placebo
DEP control / glucosamine
DEP control / placebo
figure a4.3. Mean WoMaC function scores (range 0 – 100; higher scores mean less function) within 
randomized intervention groups.
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figure a4.4. actual weight loss (compared to baseline) within randomized intervention groups.
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osteoarthritis (oa) is the most common joint disease for the middle-aged and older 
population worldwide. Clinically, it is characterized by joint pain and limited function. 
although the exact aetiology is still unknown, it is generally characterised by loss of 
articular cartilage, osteophyte formation, and subchondral bone sclerosis. Given the 
predominance of oa in the knee joint, main focus of scientific studies (including the 
present thesis) is on the knee joint.
for scientific studies, knee oa can be defined using the aCR criteria for clinical knee 
oa or the Kellgren & lawrence criteria for the structural changes. besides, the change in 
minimal joint space width (joint space narrowing) is also used as surrogate measure for 
the change in cartilage thickness. despite the fact that all three measurements define 
(marked features of ) knee oa, there is only moderate overlap between these measure-
ments. 
The strongest and most prevalent risk factors for the incidence of knee oa are 
overweight or obesity, a higher age, and female sex. in general, two main pathways 
are suggested for the onset of knee oa; biomechanical overload of the joint tissues 
and inflammation driven tissue breakdown. since true disease-modifying treatment 
options are lacking, at best pharmacological and non- pharmacological treatment of 
symptomatic patients provide relief of their joint complaints and possibly slowdown 
disease processes. With accumulated knowledge of risk factors for the development of 
knee oa, the first step toward disease prevention could be considered. in Chapter 4, the 
results of the first ever preventive trial in oa research are presented.
a high body weight is the only undisputed known modifiable risk factor for the de-
velopment of knee oa. in theory, based on an observational cohort with 40 years of 
follow-up, a weight reduction of 5 kg by overweight or obese women would reduce the 
incidence of knee oa by more than 50%. since fat mass is known to be an endocrine 
organ producing a variety of unfavourable pro-inflammatory factors, weight loss might 
reduce the production of these factors by the loss of fat mass. on the other hand, as 
demonstrated in Chapter 2, the load on the knee joint is also altered in obese compared 
to normal-weight individuals. The systematic search of the literature on studies evaluat-
ing the biomechanical differences between obese and normal-weight individuals dur-
ing every-day movements showed that obese individuals indeed alter their movement 
strategies. it could be suggested that the accompanied shift of the contact area towards 
infrequently loaded regions of the articular cartilage in the knee joint can cause knee 
oa. in theory, weight loss can also prevent knee oa since it is known that the alterations 
in movement patterns recover after weight loss.
a high body weight or body mass index (bMi) is known to be related to certain shape 
features of the femur and tibia. both these features and a high bMi are related to early 
signs of knee oa. Chapter 3 explores two possible pathways through which a high bMi 
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and bone shape features might be related to early signs of knee oa. The results show 
that not only a high bMi leads to shape alterations that are associated to early signs of 
knee oa, it was also shown that several shape features are only related to early signs 
of knee oa in the presence of a high bMi. interestingly, the shape of the tibial spines 
seemed to play a role in all shape variations related to early signs of knee oa in the 
presence of a high bMi.
The main body of this thesis is formed by the PRoof study; the first ever preventive 
study in oa worldwide. for this study a high-risk group of 407 women with a bMi ≥ 27 
kg/m2, aged 50 to 60 years without clinical signs of knee oa was studied. in this study, 
the preventive effects of a diet and exercise program and of oral glucosamine sulphate 
on the development of knee oa were tested over 30 months of follow-up. Given the fact 
that the PRoof study was the first ever preventive study in oa, it holds value information 
about the feasibility of preventive trials in oa. both the diet and exercise program and 
the glucosamine sulphate intervention showed trends towards a preventive effect (odds 
ratio 0.69, 95% Ci 0.39 – 1.21 and 0.59; 95% Ci 0.31 – 1.12, respectively). Unfortunately, 
the analyses were slightly underpowered due to the unexpected interaction between 
both interventions (Chapter 4). in Chapter 5, the diet and exercise program is evaluated 
in more detail. despite the fact that the applied program was very pragmatic and much 
less restrictive than other reported weight loss interventions, the results of the program 
over the first year are very comparable. subject randomized to the intervention group 
showed greater weight loss at 6 and 12 months compared to those randomized to the 
control group and also the number of subject fulfilling the target of ≥ 5 kg or 5% weight 
loss was significantly higher among subjects in the intervention group. Unfortunately, 
these effects did not last over the entire follow-up period of 30 months. 
after 30 months, 17% of all subjects (61 women) reached the weight loss target of ≥ 
5 kg or 5% weight loss compared to baseline. The effect of such substantial weight loss 
on the incidence of knee oa was evaluated in Chapter 6. besides the positive effects of 
substantial weight loss on several health measures (fat percentage, blood glucose, waist 
circumference, and blood pressure), we found that subjects who fulfilled the weight loss 
target had significantly less development of knee oa after 30 months (15%) compared 
to those who did not fulfil this target (20%; odds ratio 0.50, 95% Ci 0.27 – 0.91). 
in order to provide the subjects randomized to the control group of the diet and exer-
cise program with a possible preventive intervention as well, the PRoof study adopted 
a 2x2 factorial design using a glucosamine sulphate intervention. Glucosamine sulphate 
was thought to be an excellent intervention since there are indications that it is most 
effective in an early stage of the disease and should cause no harm to the subjects, as 
advocated by society of Prevention Research. over the 30 month follow-up period, the 
number of adverse and serious adverse events reported for both the placebo and the 
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glucosamine sulphate did not differ significantly and none of the events were reported 
to be related to the study drugs. Nevertheless, secondary analyses from the PRoof 
study showed that subjects randomized to glucosamine sulphate had a significantly 
increased risk (odds ratio 2.81, 95% Ci 1.12 – 7.04) of attaining an elevated blood glucose 
level (hba1c ≥ 42 mmol/mol) at follow-up (Chapter 7). This level of blood glucose is 
internationally marked as a ‘high risk for developing diabetes’. 
finally, Chapter 9 summarizes the main findings of this thesis and discusses the clini-
cal implications and directions for future studies. besides suggestions for optimizing the 
diet and exercise program as administered in the PRoof study, directions for new pre-
ventive measures are given. based on the results of the present thesis, the most obvious 
new preventive measure to test in future studies would be to target varus alignment in 
overweight or obese subjects. as indicated in Chapter 8, knees with a varus alignment 
(40%) had a significantly increased risk for developing knee oa compared to neutrally 
aligned knees, especially among obese subjects. since varus alignment can be opposed 
by non-surgical interventions, it might be a good target for future preventive studies.
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artrose is wereldwijd de meest voorkomende gewrichtsaandoening bij mensen van 
middelbare leeftijd en bij ouderen. Klachten die bij artrose horen zijn gewrichtspijn en 
beperkte functie van het aangedane gewricht. de exacte oorzaak van artrose is niet 
bekend, maar het wordt in het algemeen gekenmerkt door een verlies aan kraakbeen in 
het gewricht, de vorming van vergroeiingen aan het bot (osteofyten) aan de randen van 
het gewricht en verkalking van het bot direct onder het kraakbeen. artrose komt het 
meest voor in het knie gewricht. Vandaar dat de meerderheid van het wetenschappelijk 
onderzoek (inclusief dit proefschrift) zich focust op dit gewricht.
in wetenschappelijke studies wordt knie artrose gedefiniëerd met behulp van de aCR 
criteria voor symptomatisch knie artrose of met behulp van de Kellgren & lawrence 
criteria, die de afwijkingen in het gewricht zoals die te zien zijn op een röntgenfoto 
kwantificeert. daarnaast wordt gewrichtsspleet vernauwing gebruikt als maat voor de 
afname van gewrichtskraakbeen over tijd. ondanks dat al deze definities (kenmerken 
van) knie artrose vaststellen, is de overlap tussen deze definities maar gering. dit schets 
de beperkte kennis die er momenteel is over deze aandoening.
de sterkste en meest voorkomende risicofactoren voor het ontstaan van knie artrose 
zijn het hebben van overgewicht of obesitas, een hoge leeftijd en het vrouwelijk ge-
slacht. Men verondersteld twee specifieke ontstaansmechanismen voor knie artrose; 
overbelasting en ontsteking van het gewricht. Vandaag de dag is er nog geen medicatie 
beschikbaar die schade aan het artrotische gewricht kan herstellen. best mogelijke be-
handeling, zowel medicamenteuze als niet-medicamenteuze, voor mensen met artrose 
klachten biedt vermindering van pijn, verbeterde functie en, mogelijkerwijs, vertraging 
van het artrose proces. Met de kennis die over de afgelopen jaren is vergaard over de 
risicofactoren voor het ontstaan van knie artrose kunnen nu de eerste stappen worden 
gezet naar de preventie van deze aandoening. in hoofdstuk 4 worden de resultaten 
van de wereldwijd eerste wetenschappelijke studie naar de preventie van knie artrose 
gepresenteerd.
een hoog lichaamsgewicht is de enige bekende risicofactor voor knie artrose die te 
beinvloeden is. Uit langlopende obeservationele studies in berekend dat als vrouwen 
met overgewicht of obesitas 5 kg zouden afvallen, het ontstaan van knie artrose, in 
theorie, met meer dan 50% zou afnemen. aangezien vetcellen ontstekingsfactoren 
produceren zou deze afname in lichaamsgewicht leiden tot een verminderde productie 
door de afname in vetmassa en daarmee kunnen zorgen voor de verminderde incidentie 
van knie artrose. daarnaast laten de resultaten van hoofdstuk 2 ook zien dat mensen 
met obesitas niet alleen een hogere, maar vooral ook een veranderde belasting van 
hun knieën hebben. Uit een vergelijking van alle eerder uitgevoerde studies naar het 
de biomechanise verschillen tussen mensen met en zonder obesitas tijdens allerdaagse 
activiteiten bleek dat mensen met obesitas deze taken duidelijk anders uitvoeren dan 
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mensen zonder obesitas. deze veranderde uitvoering zou, in theorie, kunnen leiden tot 
de verschuiving van het contactpunt van het boven- en onderbeen in de knie naar delen 
van het kraakbeen die daar niet tegen bestand zijn en zo tot knie artrose kunnen leiden. 
aangezien het bekend is dat de veranderde uitvoering van de allerdaagse activiteiten 
zich hersteld indien men sterk afvalt, zou gewichtsverlies dus ook via deze weg kunnen 
leiden tot een verminderde incidentie van knie artrose.
een hoog lichaamsgewicht of bMi (body Mass index = gewicht / (lengte)2) hangt 
samen met de vormafwijkingen van het boven- en onderbeen in het knie gewricht. 
Zowel deze vormafwijkingen als een hoog bMi zijn ook gerelateerd aan vroege tekenen 
van knie artrose. in hoofdstuk 3 worden twee mogelijkheden onderzocht waardoor 
vormafwijkingen en een hoog bMi zouden kunnen leiden tot vroege tekenen van knie 
artrose. de resultaten in dit hoofdstuk laten zien dat een hoog bMi niet alleen kan leiden 
tot vormafwijkingen die samenhangen met vroege tekenen van knie artrose, maar dat 
er ook vormafwijkingen zijn die alleen tot vroege tekenen van knie artrose leiden in 
mensen met een verhoogde bMi. Uit de analyses in hoofdstuk 3 blijkt dat met name de 
vorm van de eminentia (waar de kruisbanden en menisci op aanhechten) op het onder-
been een rol spelen bij het ontstaan van knie artrose bij mensen met een hoog bMi. Tot 
nu toe is de rol van de eminentia in het artrose proces nog niet veelvuldig onderzocht.
het hart van dit proefschrift wordt gevormd door de PRoof studie (PRevention of 
knee oasteoarthritis in overweight females); wereldwijd de eerste studie naar de pre-
ventie van artrose. aan de PRoof studie deden 407 vrouwen met een hoog risico op, 
maar nog zonder tekenen of klachten van knie artrose mee. alle deelneemsters waren 
bij aanvang van de studie tussen de 50 en 60 jaar oud en hadden allemaal een bMi ≥ 
27 kg/m2. Gedurende de studie (30 maanden) hebben we de preventieve effecten van 
een dieet- en beweeginterventie en van glucosamine sulfaat op het ontstaan van knie 
artrose getest. aangezien dit de eerste keer is dat zo’n grootschalige preventieve studie 
is uitgevoerd, bevat het veel belangrijke informatie over de uitvoerbaarheid van studies 
naar de preventie van artrose; niet alleen voor knie artrose, maar ook voor artrose in 
andere gewrichten. beide interventies lijken een preventief effect te hebben op het 
ontstaan van knie artrose na 30 maanden (odds ratio 0.69; 95% Ci 0.39 – 1.21 en odds 
ratio 0.59; 95% Ci 0.31 – 1.12 voor de dieet- en beweeginterventie en de glucosamine 
interventie respectievelijk). echter was het effect van de dieet- en beweeginterventie bij 
de deelneemsters die placebo kregen tegenovergesteld aan van het effect bij de deel-
neemsters die de glucosamine kregen, en vice versa. door deze onverwachtte interactie 
tussen de interventies zijn de analyses naar de interventie effecten licht ‘underpowered’ 
(hoofdstuk 4). in hoofdstuk 5 wordt de dieet- en beweeginterventie gedetailleerd 
besproken. Voor deze interventie is er voor een eenvoudig en pragmatisch programma 
gekozen dat veel minder strikt is dan eerder onderzochtte afvalprogramma´s. desalniet-
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temin zijn de effecten over het eerste jaar zeer vergelijkbaar met deze programma´s. 
deelneemsters in de interventie groep hebben na 6 en 12 maanden significant meer 
gewicht verloren dan de deelneemsters in de controle groep. bovendien was het aantal 
deelneemsters dat het beoogde doel van minimaal 5 kg of 5% afvallen (t.o.v. het gewicht 
bij aanvang van de studie) behaald had ook signifcant hoger op deze tijdstippen. helaas 
hielden de interventie effecten niet aan tot aan het eind van de studie. in het totaal 
behaalde 17% van alle deelneemsters het doel van minimaal 5 kg of 5% afvallen na 30 
maanden. het effect van deze mate van gewichtsverlies op het ontstaan van knie artrose 
wordt besproken in hoofdstuk 6. hierin wordt aangetoond dat dit gewichtsverlies niet 
alleen leidt tot aan afname van het vetpercentage, bloedsuiker niveau, middelomtrek 
en bloeddruk optreedt, maar ook dat er significant minder knie artrose ontstaat (15% 
vs 20% in de deelneemsters die niet minimaal 5 kg of 5% afvallen. odds ratio 0.50; 95% 
Ci 0.27 – 0.91). 
om ook de deelneemsters in de controle groep van de dieet- en beweeginterventie 
een mogelijke preventieve interventie aan te bieden is er in de PRoof studie gekozen 
voor een 2x2 factorieel design. hierbij werd de helft van alle deelneemsters in zowel de 
interventie groep als de controle groep van de dieet- en beweeginterventie gerandomi-
seerd naar placebo en de andere helft naar glucosaminse sulfaat. Glucosamine sulfaat 
versus placebo werd gezien als uitstekende interventie aangezien er aanwijzingen zijn 
dat het met name in de begin fase van het ontstaan van knie artrose effectief zou zijn 
en, minstens zo belangrijk, het middel bekend staat als voedingssupplement zonder 
bijwerkingen. Gedurende de 30 maanden dat de deelneemsters van de PRoof studie 
het voedingssupplement hebben gebruikt is het aantal meldingen van (ernstige) bij-
werkingen als gevolg van de glucosamine sulfaat niet significant anders dan die van de 
placebo. bovendien werd geen van alle bijwerkingen toegeschreven aan het gebruik 
van de glucosamine sulfaat. echter bleek in secundaire analyses dat de deelneemsterd 
die gerandmiseerd waren naar de glucosamine sulfaat wel een significant verhoogd 
risico hadden (odds ratio 2.81; 95% Ci 1.12 – 7.04) op het krijgen van een verhoogd 
bloedsuiker level (hba1c ≥ 42 mmol/mol) na 30 maanden (hoofdstuk 7). internationaal 
worden mensen met dit bloedsuiker level aangeduid als personen met een ‘hoog risico 
op het ontwikkelen van diabetes’.
Tot slot worden alle resultaten van dit proefschrift bediscussieerd in hoofdstuk 9; 
klinische implicaties van de gevonden resultaten en mogelijkheden voor toekomstige 
studies worden besproken. Naast suggesties om de onderzochtte dieet- en bewee-
ginterventie te optimaliseren worden ook andere mogelijke preventieve maatregelen 
besproken. de meest voor de hand liggende nieuwe preventieve interventie die onder-
zocht zou moeten worden, op basis van de resultaten in hoofdstuk 8, is een interventie 
die zich richt op de belasting van de knie bij mensen met o-benen  (varus stand) en 
174 samenvatting
overgewicht of obesitas. in hoofdstuk 8 wordt aangetoond dat knieën met een varus 
stand (40% van de knieën binnen de PRoof studie) een significant hoger risico lopen 
op het ontwikkelen van knie artrose dan knieën zonder een standsafwijking; met name 
bij de mensen met obesitas. aangezien een varus stand (deels) kan worden opgeheven 
met niet-chirurgische ingrepen zoals een zooltje of een brace, lijkt het een goede moge-
lijkheid om dit in een nieuwe preventieve studie te onderzoeken.
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het is 1996; mijn moeder neemt mij mee naar de openbare verdediging van het proef-
schrift van onze buurman, simon van der Kerke, in de spuikerk te amsterdam. ik heb op 
dat moment geen flauw benul waar deze ceremonie voor dient, maar toch ga ik mee. 
immers, “misschien maak je dit wel nooit meer mee”, aldus mijn moeder en zij heeft altijd 
gelijk…… inmiddels staat de teller op 24 bijgewoonde promoties en heb ik zelfs mijn 
eigen proefschrift afgerond, maar toch had ze gelijk; jong geleerd is oud gedaan.
Uiteraard moet ik een aantal mensen bedanken die mijn proefschrift mede mogelijk 
hebben gemaakt.
sita, zonder jouw baanbrekende en gedurfde idee was de PRoof studie er nooit ge-
weest en was dit boekje er dus ook nooit gekomen. hartelijk dank voor de geboden 
begeleiding tijdens de uitvoer en analyse van de PRoof studie, alle suggesties voor 
nieuwe artikelen, presentaties en subsidieaanvragen, de geboden kansen voor een 
vervolg van mijn carrière in het onderzoek, maar uiteraard ook voor je geweldige manier 
van het leiden van je onderzoeksgroep. de goede sfeer, zowel op de afdeling en als 
tussen de onderzoekers, komt grotendeels op jouw conto; volledig terecht dat je bent 
uitgeroepen tot ‘Promotor of the year´ 2013!
als er lastige beslissingen genomen moesten worden omtrent de PRoof studie of als 
onze ‘vrienden uit italië’ dwarslagen was jij, bart, er altijd om tot een juiste oplossing 
te komen. bart, met name in de laatste fase ben je meer betrokken geweest bij mijn 
promotie traject. het was een fijn idee om te weten dat je altijd bereikbaar bent voor een 
objectief en betrouwbaar advies. Zeer bedankt voor je bijdrage aan de PRoof studie en 
dit proefschrift.
Mijn dank gaat ook uit naar alle deelneemsters en de betrokken huisartsen, fysiothera-
peuten en diëtisten van de PRoof studie. Mede dankzij jullie bereidwilligheid hebben 
we de studie tot een goed einde kunnen brengen en zijn de eerste stappen gezet op het 
gebied van preventie binnen het wereldwijde artrose onderzoek.
ik ben zeer veel dank verschuldigd aan diana, onderzoeksassistent van de PRoof studie. 
diana, als iemand het hart van de PRoof studie is, ben jij het wel. bescheiden als je bent 
zal je het zelf nooit zeggen, maar jij bent de reden dat de uitval van deelneemsters zo 
beperkt is gebleven en dankzij jouw precieze en gedreven manier van werken beschik-
ken we nu over een unieke en kwalitatief hoogstaande data set. dank voor al je inzet. 
liana en Marienke hartelijk dank voor jullie voorbereidende werk voor de PRoof studie; 
het was een gespreid bedje. Metthilde, Toke en evelien, heel fijn dat jullie konden in-
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springen bij de metingen toen de nood hoog was. bastiaan, bedankt voor je bijdrage aan 
dit proefschrift en het onderzoek op onze afdeling middels je keuzeonderzoeksproject.
het is vaker gezegd, maar ook ik wil nogmaals benadrukken dat er een unieke mix van 
onderzoekers en onderzoeksmedewerkers bij ons op de afdeling rondloopt. de gedre-
ven, maar zeker ook gezellige sfeer die er op de afdeling heerst zorgt er voor dat ik al 
ruim 5 jaar met veel plezier naar Rotterdam kom. en dat voor een amsterdammer! Jullie 
zijn top!
dank ook aan de goede collega’s bij de afdelingen orthopedie, radiologie en interne 
geneeskunde voor hun bijdrage aan de wetenschappelijke en sociale activiteiten tijdens 
mijn promotieonderzoek.
hoe leuk ik het ook vind in Rotterdam, toch ben ik blij met de afleiding die vrienden 
en familie geven. Vrienden van l2K en daar buiten en heren, dames en partners van 
de Wasvu, jullie weten niet half hoeveel voldoening en energie ik haal uit deze vriend-
schappen. dank voor alle gezellige, hilarische, sportieve, grootse, kleine, maar bovenal 
waardevolle momenten. arnold en Gertjan, ik ben zeer blij dat ik, niet alleen tijdens mijn 
promotie, maar ook bij de afsluiting daarvan, kan steunen op twee van zulke goede 
vrienden. 
daan, birgit, Niek, Nol, Wil, bob en indra, dank voor alle gezelligheid, jullie getoonde 
interesse, maar vooral jullie steun. bert en Roelie, ik houd van jullie; jullie zijn de beste! 
Meer hoef ik er eigenlijk niet aan toe te voegen. 
Ten slotte, mijn meiden. Judith, allereerst excuses voor de eindeloze verhalen over 
analyses, artikelen, presentaties en nieuwe subsidie-ideeën. Met andere woorden, dank 
voor een luisterend oor. in ons drukke leventje ben ik zeer gelukkig met de rust en liefde 
die jij mij geeft. britt, sorry dat papa niet beter kan uitleggen wat hij elke keer in Rot-
terdam gaat doen. ik ben zeer trots op je en ja, papa is ook een beetje verliefd op jou!
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in maart 2008 begonnen aan zijn eigen promotieonderzoek. op de afdeling huisarts-
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1. Vrouwen van middelbare leeftijd met een bMi ≥ 27 kg/m2, zonder knieklachten zijn 
zeer bereid om aan een studie ter preventie van knieartrose deel te nemen. (dit 
proefschrift)
2. een op het individu gerichte dieet- en beweeginterventie leidt tot een significante 
afname in lichaamsgewicht na 1 jaar bij vrouwen van middelbare leeftijd met een 
bMi ≥ 27 kg/m2. (dit proefschrift)
3. Vrouwen van middelbare leeftijd met een bMi ≥ 27 kg/m2 schatten hun gezond-
heidstoestand (te) hoog in. (dit proefschrift)
4. Vormafwijkingen van de intercondylaire eminentia op het tibia plateau hangen 
samen met vroege tekenen van knie artrose in vrouwen met overgewicht. (dit proef-
schrift)
5. het hebben van o-benen vormt een risico factor voor het ontstaan van knieartrose 
in vrouwen van middelbare leeftijd met een bMi ≥ 27 kg/m2. (dit proefschrift)
6. Kijken naar sportreclames leidt bij mensen met een hoog bMi tot een gezonder 
eetpattroon. (van Kleef et al. 2011)
7. Korte en lichte fysieke inspanningssessies tijdens het werk hebben een positief ef-
fect op het zelfvertrouwen, ervaren stress en lichamelijke klachten van werknemers. 
(barr-anderson et al. 2011)
8. fluoroscopie is een nauwkeurigere methode voor het bestuderen van de biome-
chanische risicofactoren voor het ontstaan van knieartrose dan de traditionele 
bewegingsanalyses met huidmarkers.  (anderst et al. 2009)
9. Jonge, actieve volwassenen moeten na een kruisband ruptuur kiezen voor een uitge-
breide fysieke revalidatie alvorens alsnog een kruisband reconstructie te overwegen. 
(frobell et al. 2013)
10. de effecten van een meniscusscheur op het onderliggende kraakbeen is in de medi-
ale meniscus veel lokaler dan in de laterale meniscus. (Chang et al. 2011)
11. The time you enjoy wasting is not wasted time (bertrand Russell)
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Knee osteoarthritis (OA) affects a large 
portion of the middle aged and older 
population and has a great burden on 
healthcare costs worldwide. This thesis 
focusses on the development of knee OA 
in subjects with overweight or obesity. 
The results of the first ever preventive 
trial in OA research are presented. The 
primary and secondary effects of a diet 
and exercise program and of glucosamine 
sulphate on the development of knee OA 
are discussed and implications for future 
(preventive) studies on knee OA are given.
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